Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 1 (antibodies: [AR5A])

Y/TND/R/R 99.47% (n=7199)
Y/SND/R/R 0.11% (n=8)
Y/TND/R/G 0.07% (n=5)
Y/TND/G/R 0.06% (n=4)
C/TND/R/R 0.06% (n=4)
Y/TNG/R/R 0.06% (n=4)
Y/TND/R/W 0.03% (n=2)
Y/TDD/R/R 0.03% (n=2)
Y/TNN/R/R 0.03% (n=2)
Y/TNH/R/R 0.01% (n=1)
Y/AND/R/R 0.01% (n=1)
H/TND/R/R 0.01% (n=1)
R/TMS/Q/Q 0.01% (n=1)
F/SKP/R/R 0.01% (n=1)
Y/TSD/R/R 0.01% (n=1)
D/TND/R/R 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 1a (antibodies: [AR5A])

Y/TND/R/R 99.55% (n=5589)
Y/TND/G/R 0.07% (n=4)
Y/TND/R/G 0.07% (n=4)
Y/TNG/R/R 0.07% (n=4)
C/TND/R/R 0.04% (n=2)
Y/TND/R/W 0.04% (n=2)
Y/TNN/R/R 0.04% (n=2)
Y/TNH/R/R 0.02% (n=1)
Y/AND/R/R 0.02% (n=1)
H/TND/R/R 0.02% (n=1)
R/TMS/Q/Q 0.02% (n=1)
Y/TDD/R/R 0.02% (n=1)
F/SKP/R/R 0.02% (n=1)
Y/TSD/R/R 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 1b (antibodies: [AR5A])

Y/TND/R/R 99.18% (n=1579)
Y/SND/R/R 0.50% (n=8)
C/TND/R/R 0.13% (n=2)
Y/TND/R/G 0.06% (n=1)
Y/TDD/R/R 0.06% (n=1)
D/TND/R/R 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 2 (antibodies: [AR5A])

Y/TND/R/R 99.48% (n=381)
Y/AND/R/R 0.26% (n=1)
Y/TND/A/Q 0.26% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 2a (antibodies: [AR5A])

Y/TND/R/R 98.39% (n=61)
Y/AND/R/R 1.61% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 2b (antibodies: [AR5A])

Y/TND/R/R 99.62% (n=261)
Y/TND/A/Q 0.38% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 2c (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 3 (antibodies: [AR5A])

Y/TND/R/R 99.36% (n=1704)
Y/TND/W/R 0.23% (n=4)
H/TND/R/R 0.12% (n=2)
Y/TNA/R/R 0.06% (n=1)
Y/ANG/R/R 0.06% (n=1)
Y/TNN/R/R 0.06% (n=1)
Y/TND/R/H 0.06% (n=1)
C/TND/R/R 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 3a (antibodies: [AR5A])

Y/TND/R/R 99.32% (n=1613)
Y/TND/W/R 0.25% (n=4)
H/TND/R/R 0.12% (n=2)
Y/TNA/R/R 0.06% (n=1)
Y/ANG/R/R 0.06% (n=1)
Y/TNN/R/R 0.06% (n=1)
Y/TND/R/H 0.06% (n=1)
C/TND/R/R 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 3b (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=73)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 4 (antibodies: [AR5A])

Y/TND/R/R 97.54% (n=198)
Y/SND/R/R 1.97% (n=4)
Y/YKD/R/R 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 4a (antibodies: [AR5A])

Y/TND/R/R 96.12% (n=124)
Y/SND/R/R 3.10% (n=4)
Y/YKD/R/R 0.78% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 4d (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 5 (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=37)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 6 (antibodies: [AR5A])

Y/TND/R/R 99.10% (n=220)
Y/TYD/R/R 0.45% (n=1)
Y/TND/Q/R 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Subtype 6a (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=102)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,639,657 in HCV Genotype 7 (antibodies: [AR5A])

Y/TND/R/R 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 1 (antibodies: [AR4A])

Y/TND/R/L/D 99.29% (n=7163)
Y/SND/R/L/D 0.11% (n=8)
Y/TND/R/P/D 0.10% (n=7)
Y/TND/G/L/D 0.07% (n=5)
C/TND/R/L/D 0.06% (n=4)
Y/TNG/R/L/D 0.06% (n=4)
Y/TND/R/I/D 0.04% (n=3)
Y/TND/R/L/A 0.03% (n=2)
Y/TND/W/L/D 0.03% (n=2)
Y/TND/R/L/G 0.03% (n=2)
Y/TDD/R/L/D 0.03% (n=2)
Y/TNN/R/L/D 0.03% (n=2)
Y/TNH/R/L/D 0.01% (n=1)
Y/AND/R/L/D 0.01% (n=1)
H/TND/R/L/D 0.01% (n=1)
R/TMS/Q/L/D 0.01% (n=1)
Y/TND/R/L/E 0.01% (n=1)
Y/TND/R/R/D 0.01% (n=1)
F/SKP/R/L/D 0.01% (n=1)
Y/TSD/R/L/D 0.01% (n=1)
Y/TND/R/L/H 0.01% (n=1)
D/TND/R/L/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 1a (antibodies: [AR4A])

Y/TND/R/L/D 99.39% (n=5559)
Y/TND/R/P/D 0.11% (n=6)
Y/TND/G/L/D 0.07% (n=4)
Y/TNG/R/L/D 0.07% (n=4)
Y/TND/R/L/A 0.04% (n=2)
C/TND/R/L/D 0.04% (n=2)
Y/TND/W/L/D 0.04% (n=2)
Y/TND/R/L/G 0.04% (n=2)
Y/TNN/R/L/D 0.04% (n=2)
Y/TNH/R/L/D 0.02% (n=1)
Y/AND/R/L/D 0.02% (n=1)
Y/TND/R/I/D 0.02% (n=1)
H/TND/R/L/D 0.02% (n=1)
R/TMS/Q/L/D 0.02% (n=1)
Y/TND/R/L/E 0.02% (n=1)
Y/TDD/R/L/D 0.02% (n=1)
Y/TND/R/R/D 0.02% (n=1)
F/SKP/R/L/D 0.02% (n=1)
Y/TSD/R/L/D 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 1b (antibodies: [AR4A])

Y/TND/R/L/D 98.93% (n=1573)
Y/SND/R/L/D 0.50% (n=8)
Y/TND/R/I/D 0.13% (n=2)
C/TND/R/L/D 0.13% (n=2)
Y/TND/R/L/H 0.06% (n=1)
Y/TND/R/P/D 0.06% (n=1)
Y/TND/G/L/D 0.06% (n=1)
Y/TDD/R/L/D 0.06% (n=1)
D/TND/R/L/D 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 2 (antibodies: [AR4A])

Y/TND/R/L/D 99.22% (n=380)
Y/AND/R/L/D 0.26% (n=1)
Y/TND/R/L/N 0.26% (n=1)
Y/TND/Q/L/D 0.26% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 2a (antibodies: [AR4A])

Y/TND/R/L/D 98.39% (n=61)
Y/AND/R/L/D 1.61% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 2b (antibodies: [AR4A])

Y/TND/R/L/D 99.24% (n=260)
Y/TND/R/L/N 0.38% (n=1)
Y/TND/Q/L/D 0.38% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 2c (antibodies: [AR4A])

Y/TND/R/L/D 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 3 (antibodies: [AR4A])

Y/TND/R/L/D 99.24% (n=1703)
Y/TND/R/L/G 0.17% (n=3)
H/TND/R/L/D 0.12% (n=2)
Y/TND/R/P/D 0.12% (n=2)
Y/TND/C/L/D 0.06% (n=1)
Y/TNA/R/L/D 0.06% (n=1)
Y/ANG/R/L/D 0.06% (n=1)
Y/TNN/R/L/D 0.06% (n=1)
Y/TND/H/L/D 0.06% (n=1)
C/TND/R/L/D 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 3a (antibodies: [AR4A])

Y/TND/R/L/D 99.38% (n=1615)
H/TND/R/L/D 0.12% (n=2)
Y/TND/R/P/D 0.12% (n=2)
Y/TND/C/L/D 0.06% (n=1)
Y/TNA/R/L/D 0.06% (n=1)
Y/ANG/R/L/D 0.06% (n=1)
Y/TNN/R/L/D 0.06% (n=1)
Y/TND/H/L/D 0.06% (n=1)
C/TND/R/L/D 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 3b (antibodies: [AR4A])

Y/TND/R/L/D 95.89% (n=70)
Y/TND/R/L/G 4.11% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 4 (antibodies: [AR4A])

Y/TND/R/L/D 97.54% (n=198)
Y/SND/R/L/D 1.97% (n=4)
Y/YKD/R/L/D 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 4a (antibodies: [AR4A])

Y/TND/R/L/D 96.15% (n=125)
Y/SND/R/L/D 3.08% (n=4)
Y/YKD/R/L/D 0.77% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 4d (antibodies: [AR4A])

Y/TND/R/L/D 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 5 (antibodies: [AR4A])

Y/TND/R/L/D 100.00% (n=37)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 6 (antibodies: [AR4A])

Y/TND/R/L/D 99.55% (n=221)
Y/TYD/R/L/D 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Subtype 6a (antibodies: [AR4A])

Y/TND/R/L/D 100.00% (n=102)
---------------------------------------------------------------------------------------
Motifs for binding location set: 201,204,205,206,657,692,698 in HCV Genotype 7 (antibodies: [AR4A])

Y/TND/R/L/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 403,406 in HCV Genotype 1 (antibodies: [J6.36])

F/G 84.92% (n=19958)
L/G 14.74% (n=3463)
S/G 0.09% (n=21)
I/G 0.04% (n=9)
P/G 0.04% (n=9)
F/D 0.03% (n=7)
W/G 0.03% (n=6)
F/E 0.03% (n=6)
F/S 0.02% (n=4)
Y/G 0.01% (n=3)
V/G 0.01% (n=2)
F/W 0.01% (n=2)
F/R 0.01% (n=2)
L/W 0.01% (n=2)
F/C 0.00% (n=1)
F/A 0.00% (n=1)
L/D 0.00% (n=1)
C/G 0.00% (n=1)
S/R 0.00% (n=1)
R/G 0.00% (n=1)
R/H 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 1a (antibodies: [J6.36])

F/G 82.56% (n=11316)
L/G 17.06% (n=2338)
S/G 0.12% (n=17)
I/G 0.06% (n=8)
F/D 0.05% (n=7)
W/G 0.04% (n=6)
P/G 0.04% (n=5)
F/S 0.03% (n=4)
V/G 0.01% (n=2)
F/C 0.01% (n=1)
F/A 0.01% (n=1)
Y/G 0.01% (n=1)
L/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 1b (antibodies: [J6.36])

F/G 88.22% (n=8601)
L/G 11.50% (n=1121)
F/E 0.06% (n=6)
S/G 0.04% (n=4)
P/G 0.04% (n=4)
F/W 0.02% (n=2)
F/R 0.02% (n=2)
L/W 0.02% (n=2)
Y/G 0.02% (n=2)
I/G 0.01% (n=1)
C/G 0.01% (n=1)
S/R 0.01% (n=1)
R/G 0.01% (n=1)
R/H 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 2 (antibodies: [J6.36])

F/G 85.14% (n=1157)
T/G 11.41% (n=155)
L/G 2.80% (n=38)
S/G 0.29% (n=4)
F/C 0.07% (n=1)
L/C 0.07% (n=1)
F/P 0.07% (n=1)
I/G 0.07% (n=1)
M/G 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 2a (antibodies: [J6.36])

F/G 95.55% (n=279)
L/G 4.45% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 2b (antibodies: [J6.36])

F/G 95.44% (n=440)
L/G 3.04% (n=14)
S/G 0.87% (n=4)
F/C 0.22% (n=1)
L/C 0.22% (n=1)
F/P 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 2c (antibodies: [J6.36])

F/G 64.55% (n=295)
T/G 33.92% (n=155)
L/G 1.09% (n=5)
I/G 0.22% (n=1)
M/G 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 3 (antibodies: [J6.36])

F/G 81.49% (n=3210)
L/G 18.20% (n=717)
I/G 0.10% (n=4)
S/G 0.08% (n=3)
T/E 0.03% (n=1)
C/G 0.03% (n=1)
V/A 0.03% (n=1)
T/G 0.03% (n=1)
M/G 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 3a (antibodies: [J6.36])

F/G 80.54% (n=2678)
L/G 19.10% (n=635)
I/G 0.12% (n=4)
S/G 0.09% (n=3)
T/E 0.03% (n=1)
C/G 0.03% (n=1)
V/A 0.03% (n=1)
T/G 0.03% (n=1)
M/G 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 3b (antibodies: [J6.36])

F/G 98.53% (n=403)
L/G 1.47% (n=6)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 4 (antibodies: [J6.36])

F/G 92.85% (n=714)
L/G 7.15% (n=55)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 4a (antibodies: [J6.36])

F/G 76.54% (n=124)
L/G 23.46% (n=38)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 4d (antibodies: [J6.36])

F/G 98.71% (n=534)
L/G 1.29% (n=7)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 5 (antibodies: [J6.36])

F/G 91.28% (n=136)
L/G 6.04% (n=9)
F/S 0.67% (n=1)
F/R 0.67% (n=1)
L/R 0.67% (n=1)
I/G 0.67% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 6 (antibodies: [J6.36])

F/G 91.91% (n=557)
L/G 8.09% (n=49)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Subtype 6a (antibodies: [J6.36])

F/G 93.66% (n=310)
L/G 6.34% (n=21)
---------------------------------------------------------------------------------------
Motifs for binding location set: 403,406 in HCV Genotype 7 (antibodies: [J6.36])

L/G 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 406,410,411 in HCV Genotype 1 (antibodies: [H77.16])

G/NI 49.17% (n=11313)
G/KI 22.00% (n=5062)
G/NV 8.91% (n=2049)
G/DI 5.05% (n=1162)
G/KL 3.75% (n=862)
G/RI 3.11% (n=716)
G/DV 1.48% (n=341)
G/KV 1.43% (n=328)
G/NL 1.24% (n=285)
G/HI 0.95% (n=218)
G/SI 0.62% (n=143)
G/TI 0.50% (n=116)
G/QI 0.49% (n=113)
G/EI 0.47% (n=108)
G/RV 0.10% (n=22)
G/EV 0.07% (n=17)
G/AI 0.07% (n=15)
G/GV 0.05% (n=12)
G/EL 0.05% (n=12)
G/NT 0.04% (n=10)
G/GI 0.03% (n=7)
G/PI 0.03% (n=7)
G/RL 0.03% (n=7)
G/QL 0.03% (n=6)
G/SV 0.02% (n=5)
G/HV 0.02% (n=5)
G/KP 0.02% (n=5)
G/DL 0.02% (n=4)
G/SL 0.02% (n=4)
D/DI 0.01% (n=3)
E/KI 0.01% (n=3)
G/NA 0.01% (n=2)
G/QV 0.01% (n=2)
D/NI 0.01% (n=2)
D/KI 0.01% (n=2)
G/YV 0.01% (n=2)
S/NI 0.01% (n=2)
W/NI 0.01% (n=2)
G/PL 0.01% (n=2)
G/TL 0.01% (n=2)
G/HL 0.01% (n=2)
C/NI 0.00% (n=1)
G/DT 0.00% (n=1)
A/VI 0.00% (n=1)
S/DI 0.00% (n=1)
D/NL 0.00% (n=1)
G/TV 0.00% (n=1)
G/KA 0.00% (n=1)
G/ND 0.00% (n=1)
G/YI 0.00% (n=1)
S/NV 0.00% (n=1)
E/KN 0.00% (n=1)
G/KD 0.00% (n=1)
G/EN 0.00% (n=1)
R/KI 0.00% (n=1)
E/KV 0.00% (n=1)
G/MI 0.00% (n=1)
G/KF 0.00% (n=1)
G/CI 0.00% (n=1)
W/KI 0.00% (n=1)
G/HT 0.00% (n=1)
E/KL 0.00% (n=1)
R/KL 0.00% (n=1)
G/KT 0.00% (n=1)
W/NL 0.00% (n=1)
G/*L 0.00% (n=1)
H/KI 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 1a (antibodies: [H77.16])

G/NI 63.60% (n=8710)
G/NV 14.63% (n=2003)
G/DI 8.32% (n=1140)
G/KI 5.73% (n=785)
G/DV 2.48% (n=340)
G/KL 1.47% (n=201)
G/NL 0.85% (n=116)
G/SI 0.81% (n=111)
G/HI 0.53% (n=73)
G/EI 0.46% (n=63)
G/KV 0.28% (n=38)
G/TI 0.12% (n=17)
G/AI 0.11% (n=15)
G/GV 0.09% (n=12)
G/RI 0.07% (n=9)
G/QI 0.05% (n=7)
G/NT 0.04% (n=6)
G/HV 0.04% (n=5)
G/SV 0.03% (n=4)
G/GI 0.03% (n=4)
G/DL 0.03% (n=4)
G/EV 0.03% (n=4)
D/DI 0.02% (n=3)
G/RV 0.02% (n=3)
G/NA 0.01% (n=2)
D/NI 0.01% (n=2)
D/KI 0.01% (n=2)
G/YV 0.01% (n=2)
S/NI 0.01% (n=2)
C/NI 0.01% (n=1)
G/DT 0.01% (n=1)
A/VI 0.01% (n=1)
S/DI 0.01% (n=1)
G/QV 0.01% (n=1)
D/NL 0.01% (n=1)
G/PI 0.01% (n=1)
G/TV 0.01% (n=1)
G/KA 0.01% (n=1)
G/ND 0.01% (n=1)
G/YI 0.01% (n=1)
S/NV 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 1b (antibodies: [H77.16])

G/KI 46.10% (n=4272)
G/NI 27.88% (n=2584)
G/RI 7.59% (n=703)
G/KL 7.10% (n=658)
G/KV 3.12% (n=289)
G/NL 1.80% (n=167)
G/HI 1.56% (n=145)
G/QI 1.14% (n=106)
G/TI 1.07% (n=99)
G/NV 0.49% (n=45)
G/EI 0.49% (n=45)
G/SI 0.35% (n=32)
G/DI 0.24% (n=22)
G/RV 0.21% (n=19)
G/EV 0.14% (n=13)
G/EL 0.13% (n=12)
G/PI 0.06% (n=6)
G/KP 0.05% (n=5)
G/NT 0.04% (n=4)
G/RL 0.04% (n=4)
G/QL 0.04% (n=4)
G/GI 0.03% (n=3)
E/KI 0.03% (n=3)
W/NI 0.02% (n=2)
G/PL 0.02% (n=2)
G/TL 0.02% (n=2)
G/HL 0.02% (n=2)
E/KN 0.01% (n=1)
G/KD 0.01% (n=1)
G/SV 0.01% (n=1)
G/EN 0.01% (n=1)
R/KI 0.01% (n=1)
G/SL 0.01% (n=1)
G/QV 0.01% (n=1)
E/KV 0.01% (n=1)
G/MI 0.01% (n=1)
G/KF 0.01% (n=1)
G/CI 0.01% (n=1)
W/KI 0.01% (n=1)
G/HT 0.01% (n=1)
E/KL 0.01% (n=1)
R/KL 0.01% (n=1)
G/KT 0.01% (n=1)
W/NL 0.01% (n=1)
G/*L 0.01% (n=1)
H/KI 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 2 (antibodies: [H77.16])

G/NI 36.27% (n=490)
G/HI 17.39% (n=235)
G/KI 14.21% (n=192)
G/KL 11.55% (n=156)
G/RI 4.89% (n=66)
G/EI 2.89% (n=39)
G/QI 2.59% (n=35)
G/NL 2.15% (n=29)
G/RL 2.00% (n=27)
G/TL 1.26% (n=17)
G/NV 1.04% (n=14)
G/QL 0.74% (n=10)
G/DI 0.52% (n=7)
G/TI 0.52% (n=7)
G/SI 0.44% (n=6)
G/NT 0.15% (n=2)
C/KI 0.15% (n=2)
G/PL 0.15% (n=2)
G/HL 0.15% (n=2)
G/HV 0.07% (n=1)
G/QV 0.07% (n=1)
G/II 0.07% (n=1)
G/DL 0.07% (n=1)
G/KN 0.07% (n=1)
G/PI 0.07% (n=1)
G/TV 0.07% (n=1)
G/KF 0.07% (n=1)
P/SV 0.07% (n=1)
G/RV 0.07% (n=1)
G/AI 0.07% (n=1)
G/KT 0.07% (n=1)
G/SL 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 2a (antibodies: [H77.16])

G/NI 84.51% (n=240)
G/KI 4.93% (n=14)
G/NL 2.82% (n=8)
G/NV 2.46% (n=7)
G/KL 1.06% (n=3)
G/DI 0.70% (n=2)
G/RI 0.70% (n=2)
G/SI 0.70% (n=2)
G/II 0.35% (n=1)
G/NT 0.35% (n=1)
G/QI 0.35% (n=1)
G/DL 0.35% (n=1)
G/HI 0.35% (n=1)
G/TI 0.35% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 2b (antibodies: [H77.16])

G/KL 32.25% (n=149)
G/KI 17.32% (n=80)
G/NI 11.90% (n=55)
G/EI 8.44% (n=39)
G/QI 6.93% (n=32)
G/RI 6.28% (n=29)
G/NL 3.46% (n=16)
G/TL 3.46% (n=16)
G/RL 3.03% (n=14)
G/QL 2.16% (n=10)
G/TI 0.87% (n=4)
G/NV 0.65% (n=3)
G/SI 0.65% (n=3)
G/DI 0.43% (n=2)
C/KI 0.43% (n=2)
G/PL 0.43% (n=2)
G/KN 0.22% (n=1)
G/PI 0.22% (n=1)
G/TV 0.22% (n=1)
G/KF 0.22% (n=1)
P/SV 0.22% (n=1)
G/HI 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 2c (antibodies: [H77.16])

G/HI 50.44% (n=230)
G/NI 36.18% (n=165)
G/RI 6.80% (n=31)
G/KI 1.97% (n=9)
G/RL 1.75% (n=8)
G/DI 0.66% (n=3)
G/QI 0.44% (n=2)
G/TI 0.44% (n=2)
G/RV 0.22% (n=1)
G/KL 0.22% (n=1)
G/SI 0.22% (n=1)
G/AI 0.22% (n=1)
G/NV 0.22% (n=1)
G/NT 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 3 (antibodies: [H77.16])

G/KL 46.05% (n=1797)
G/NL 42.64% (n=1664)
G/RL 3.02% (n=118)
G/KI 2.67% (n=104)
G/NI 2.02% (n=79)
G/SL 1.36% (n=53)
G/DL 0.79% (n=31)
G/QL 0.36% (n=14)
G/EL 0.21% (n=8)
G/HL 0.21% (n=8)
G/TL 0.13% (n=5)
G/PL 0.13% (n=5)
G/NV 0.08% (n=3)
G/RI 0.05% (n=2)
G/NQ 0.03% (n=1)
G/KP 0.03% (n=1)
E/GH 0.03% (n=1)
G/NP 0.03% (n=1)
G/WL 0.03% (n=1)
G/VL 0.03% (n=1)
G/AL 0.03% (n=1)
G/GL 0.03% (n=1)
G/TI 0.03% (n=1)
G/QI 0.03% (n=1)
G/HI 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 3a (antibodies: [H77.16])

G/KL 53.49% (n=1762)
G/NL 40.01% (n=1318)
G/RL 3.58% (n=118)
G/SL 0.82% (n=27)
G/DL 0.70% (n=23)
G/QL 0.30% (n=10)
G/EL 0.21% (n=7)
G/HL 0.18% (n=6)
G/KI 0.15% (n=5)
G/NV 0.09% (n=3)
G/TL 0.09% (n=3)
G/NI 0.09% (n=3)
G/PL 0.09% (n=3)
G/NQ 0.03% (n=1)
G/KP 0.03% (n=1)
E/GH 0.03% (n=1)
G/NP 0.03% (n=1)
G/WL 0.03% (n=1)
G/VL 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 3b (antibodies: [H77.16])

G/NL 81.68% (n=330)
G/KL 8.17% (n=33)
G/SL 6.44% (n=26)
G/DL 1.98% (n=8)
G/QL 0.50% (n=2)
G/HL 0.50% (n=2)
G/EL 0.25% (n=1)
G/AL 0.25% (n=1)
G/GL 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 4 (antibodies: [H77.16])

G/NV 44.33% (n=340)
G/NL 31.42% (n=241)
G/NI 13.56% (n=104)
G/RI 3.78% (n=29)
G/KL 3.39% (n=26)
G/KI 0.65% (n=5)
G/RL 0.39% (n=3)
G/DL 0.39% (n=3)
G/DV 0.26% (n=2)
G/QL 0.26% (n=2)
G/DI 0.26% (n=2)
G/TL 0.13% (n=1)
G/RM 0.13% (n=1)
G/HI 0.13% (n=1)
G/EM 0.13% (n=1)
G/EI 0.13% (n=1)
G/HL 0.13% (n=1)
G/AL 0.13% (n=1)
G/RV 0.13% (n=1)
G/PL 0.13% (n=1)
G/SL 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 4a (antibodies: [H77.16])

G/NL 62.96% (n=102)
G/RI 16.67% (n=27)
G/KL 13.58% (n=22)
G/NV 3.70% (n=6)
G/TL 0.62% (n=1)
G/RL 0.62% (n=1)
G/RM 0.62% (n=1)
G/DV 0.62% (n=1)
G/NI 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 4d (antibodies: [H77.16])

G/NV 61.62% (n=334)
G/NL 20.11% (n=109)
G/NI 17.16% (n=93)
G/HI 0.18% (n=1)
G/KI 0.18% (n=1)
G/KL 0.18% (n=1)
G/EM 0.18% (n=1)
G/EI 0.18% (n=1)
G/DL 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 5 (antibodies: [H77.16])

G/NL 56.16% (n=82)
G/KL 16.44% (n=24)
G/DL 6.85% (n=10)
G/QL 4.11% (n=6)
G/PL 4.11% (n=6)
G/RL 3.42% (n=5)
G/NI 2.74% (n=4)
G/HL 1.37% (n=2)
G/NV 0.68% (n=1)
G/SL 0.68% (n=1)
S/HL 0.68% (n=1)
R/EL 0.68% (n=1)
G/ES 0.68% (n=1)
G/EL 0.68% (n=1)
R/KL 0.68% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 6 (antibodies: [H77.16])

G/NL 63.15% (n=377)
G/NI 21.44% (n=128)
G/KL 6.20% (n=37)
G/RL 1.34% (n=8)
G/KI 1.17% (n=7)
G/NV 1.01% (n=6)
G/HL 1.01% (n=6)
G/SI 0.84% (n=5)
G/SL 0.84% (n=5)
G/DL 0.67% (n=4)
G/TL 0.50% (n=3)
G/HI 0.50% (n=3)
G/TI 0.34% (n=2)
G/RI 0.34% (n=2)
G/GL 0.17% (n=1)
G/YL 0.17% (n=1)
G/DI 0.17% (n=1)
G/QL 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Subtype 6a (antibodies: [H77.16])

G/NL 85.11% (n=280)
G/KL 6.38% (n=21)
G/NI 4.26% (n=14)
G/TL 0.91% (n=3)
G/SL 0.91% (n=3)
G/NV 0.91% (n=3)
G/SI 0.30% (n=1)
G/GL 0.30% (n=1)
G/DL 0.30% (n=1)
G/TI 0.30% (n=1)
G/RL 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 406,410,411 in HCV Genotype 7 (antibodies: [H77.16])

G/RL 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 408,413,418,420 in HCV Genotype 1 (antibodies: [HC33.29, HC33.8])

K/L/G/W 36.79% (n=8444)
S/L/G/W 30.24% (n=6941)
R/L/G/W 11.82% (n=2713)
Q/L/G/W 11.67% (n=2679)
A/L/G/W 3.93% (n=903)
M/L/G/W 1.63% (n=373)
N/L/G/W 1.04% (n=238)
T/L/G/W 0.85% (n=194)
H/L/G/W 0.46% (n=106)
Y/L/G/W 0.33% (n=75)
G/L/G/W 0.27% (n=63)
K/L/N/W 0.19% (n=44)
L/L/G/W 0.05% (n=12)
P/L/G/W 0.05% (n=12)
E/L/G/W 0.05% (n=11)
K/L/G/R 0.05% (n=11)
S/L/G/R 0.05% (n=11)
K/P/G/W 0.04% (n=10)
K/L/D/W 0.04% (n=9)
K/L/G/C 0.04% (n=9)
Q/L/G/R 0.02% (n=5)
K/L/G/* 0.02% (n=5)
S/L/D/W 0.02% (n=5)
S/P/G/W 0.02% (n=5)
R/L/G/R 0.02% (n=5)
F/L/G/W 0.02% (n=5)
K/L/S/W 0.02% (n=4)
V/L/G/W 0.02% (n=4)
Q/L/S/W 0.01% (n=3)
K/L/G/G 0.01% (n=3)
R/M/G/W 0.01% (n=3)
S/L/S/W 0.01% (n=3)
Q/L/G/G 0.01% (n=2)
R/L/G/S 0.01% (n=2)
M/L/G/R 0.01% (n=2)
M/L/G/* 0.01% (n=2)
K/F/G/W 0.01% (n=2)
Q/L/G/* 0.01% (n=2)
K/V/G/W 0.01% (n=2)
S/L/R/W 0.01% (n=2)
C/L/G/W 0.01% (n=2)
A/L/S/W 0.01% (n=2)
R/P/G/W 0.00% (n=1)
S/L/G/* 0.00% (n=1)
R/V/G/W 0.00% (n=1)
S/Q/G/W 0.00% (n=1)
Q/L/D/W 0.00% (n=1)
R/L/D/W 0.00% (n=1)
Q/P/G/W 0.00% (n=1)
R/L/R/W 0.00% (n=1)
K/M/G/W 0.00% (n=1)
R/L/G/* 0.00% (n=1)
S/L/V/W 0.00% (n=1)
S/A/A/W 0.00% (n=1)
T/A/G/W 0.00% (n=1)
R/I/G/W 0.00% (n=1)
S/L/G/C 0.00% (n=1)
A/L/G/R 0.00% (n=1)
I/L/G/W 0.00% (n=1)
S/I/G/W 0.00% (n=1)
D/L/G/W 0.00% (n=1)
*/L/G/W 0.00% (n=1)
A/L/D/W 0.00% (n=1)
S/H/G/W 0.00% (n=1)
K/I/G/W 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 1a (antibodies: [HC33.29, HC33.8])

K/L/G/W 58.57% (n=7993)
R/L/G/W 14.96% (n=2042)
Q/L/G/W 14.33% (n=1955)
S/L/G/W 7.21% (n=984)
M/L/G/W 2.73% (n=373)
N/L/G/W 1.03% (n=141)
K/L/N/W 0.32% (n=44)
K/L/G/R 0.08% (n=11)
E/L/G/W 0.07% (n=10)
K/P/G/W 0.07% (n=10)
K/L/D/W 0.07% (n=9)
K/L/G/C 0.07% (n=9)
G/L/G/W 0.04% (n=6)
K/L/G/* 0.04% (n=5)
K/L/S/W 0.03% (n=4)
Q/L/G/R 0.03% (n=4)
R/L/G/R 0.03% (n=4)
K/L/G/G 0.02% (n=3)
R/M/G/W 0.02% (n=3)
L/L/G/W 0.02% (n=3)
Q/L/G/G 0.01% (n=2)
T/L/G/W 0.01% (n=2)
H/L/G/W 0.01% (n=2)
A/L/G/W 0.01% (n=2)
R/L/G/S 0.01% (n=2)
M/L/G/R 0.01% (n=2)
M/L/G/* 0.01% (n=2)
K/F/G/W 0.01% (n=2)
K/V/G/W 0.01% (n=2)
R/P/G/W 0.01% (n=1)
S/L/G/* 0.01% (n=1)
Q/L/S/W 0.01% (n=1)
R/V/G/W 0.01% (n=1)
S/Q/G/W 0.01% (n=1)
S/L/D/W 0.01% (n=1)
S/P/G/W 0.01% (n=1)
Q/L/D/W 0.01% (n=1)
R/L/D/W 0.01% (n=1)
Q/P/G/W 0.01% (n=1)
R/L/R/W 0.01% (n=1)
P/L/G/W 0.01% (n=1)
K/M/G/W 0.01% (n=1)
Q/L/G/* 0.01% (n=1)
R/L/G/* 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 1b (antibodies: [HC33.29, HC33.8])

S/L/G/W 64.22% (n=5947)
A/L/G/W 9.72% (n=900)
Q/L/G/W 7.68% (n=711)
R/L/G/W 7.19% (n=666)
K/L/G/W 4.74% (n=439)
T/L/G/W 2.06% (n=191)
H/L/G/W 1.11% (n=103)
N/L/G/W 1.04% (n=96)
Y/L/G/W 0.81% (n=75)
G/L/G/W 0.62% (n=57)
P/L/G/W 0.12% (n=11)
S/L/G/R 0.12% (n=11)
L/L/G/W 0.10% (n=9)
F/L/G/W 0.05% (n=5)
S/L/D/W 0.04% (n=4)
V/L/G/W 0.04% (n=4)
S/P/G/W 0.04% (n=4)
S/L/S/W 0.03% (n=3)
S/L/R/W 0.02% (n=2)
C/L/G/W 0.02% (n=2)
Q/L/S/W 0.02% (n=2)
A/L/S/W 0.02% (n=2)
S/L/V/W 0.01% (n=1)
S/A/A/W 0.01% (n=1)
T/A/G/W 0.01% (n=1)
R/I/G/W 0.01% (n=1)
S/L/G/C 0.01% (n=1)
A/L/G/R 0.01% (n=1)
I/L/G/W 0.01% (n=1)
S/I/G/W 0.01% (n=1)
D/L/G/W 0.01% (n=1)
Q/L/G/* 0.01% (n=1)
R/L/G/R 0.01% (n=1)
Q/L/G/R 0.01% (n=1)
*/L/G/W 0.01% (n=1)
A/L/D/W 0.01% (n=1)
S/H/G/W 0.01% (n=1)
E/L/G/W 0.01% (n=1)
K/I/G/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 2 (antibodies: [HC33.29, HC33.8])

K/L/G/W 33.41% (n=442)
R/L/G/W 24.64% (n=326)
Q/L/G/W 23.36% (n=309)
S/L/G/W 16.63% (n=220)
N/L/G/W 0.53% (n=7)
H/L/G/W 0.23% (n=3)
T/L/G/W 0.23% (n=3)
Q/L/G/L 0.23% (n=3)
I/L/G/W 0.08% (n=1)
M/L/G/W 0.08% (n=1)
Q/L/V/W 0.08% (n=1)
E/L/G/* 0.08% (n=1)
*/L/G/W 0.08% (n=1)
Q/L/S/W 0.08% (n=1)
Q/L/G/R 0.08% (n=1)
K/L/G/L 0.08% (n=1)
A/L/G/W 0.08% (n=1)
R/L/A/W 0.08% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 2a (antibodies: [HC33.29, HC33.8])

K/L/G/W 53.99% (n=142)
R/L/G/W 25.10% (n=66)
Q/L/G/W 17.11% (n=45)
S/L/G/W 1.90% (n=5)
T/L/G/W 0.76% (n=2)
H/L/G/W 0.38% (n=1)
N/L/G/W 0.38% (n=1)
M/L/G/W 0.38% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 2b (antibodies: [HC33.29, HC33.8])

Q/L/G/W 46.10% (n=213)
S/L/G/W 24.68% (n=114)
K/L/G/W 17.10% (n=79)
R/L/G/W 8.87% (n=41)
Q/L/G/L 0.65% (n=3)
H/L/G/W 0.43% (n=2)
Q/L/V/W 0.22% (n=1)
E/L/G/* 0.22% (n=1)
*/L/G/W 0.22% (n=1)
Q/L/S/W 0.22% (n=1)
Q/L/G/R 0.22% (n=1)
K/L/G/L 0.22% (n=1)
T/L/G/W 0.22% (n=1)
A/L/G/W 0.22% (n=1)
R/L/A/W 0.22% (n=1)
N/L/G/W 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 2c (antibodies: [HC33.29, HC33.8])

R/L/G/W 45.83% (n=209)
K/L/G/W 45.61% (n=208)
Q/L/G/W 6.14% (n=28)
S/L/G/W 1.32% (n=6)
N/L/G/W 1.10% (n=5)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 3 (antibodies: [HC33.29, HC33.8])

Q/L/G/W 28.03% (n=1085)
R/L/G/W 25.52% (n=988)
K/L/G/W 21.80% (n=844)
S/L/G/W 16.33% (n=632)
N/L/G/W 7.41% (n=287)
A/L/G/W 0.18% (n=7)
H/L/G/W 0.13% (n=5)
T/L/G/W 0.10% (n=4)
G/L/G/W 0.08% (n=3)
Q/L/D/W 0.05% (n=2)
R/P/G/W 0.05% (n=2)
S/L/D/W 0.03% (n=1)
Q/L/G/G 0.03% (n=1)
Q/L/G/L 0.03% (n=1)
L/L/A/W 0.03% (n=1)
K/L/G/R 0.03% (n=1)
E/L/G/W 0.03% (n=1)
K/L/D/W 0.03% (n=1)
I/L/G/W 0.03% (n=1)
M/L/G/W 0.03% (n=1)
R/L/N/W 0.03% (n=1)
V/L/G/W 0.03% (n=1)
R/L/G/R 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 3a (antibodies: [HC33.29, HC33.8])

Q/L/G/W 29.09% (n=954)
R/L/G/W 23.64% (n=775)
K/L/G/W 22.66% (n=743)
S/L/G/W 15.22% (n=499)
N/L/G/W 8.63% (n=283)
H/L/G/W 0.15% (n=5)
G/L/G/W 0.09% (n=3)
Q/L/D/W 0.06% (n=2)
R/P/G/W 0.06% (n=2)
A/L/G/W 0.06% (n=2)
S/L/D/W 0.03% (n=1)
Q/L/G/G 0.03% (n=1)
Q/L/G/L 0.03% (n=1)
L/L/A/W 0.03% (n=1)
K/L/G/R 0.03% (n=1)
E/L/G/W 0.03% (n=1)
K/L/D/W 0.03% (n=1)
I/L/G/W 0.03% (n=1)
M/L/G/W 0.03% (n=1)
R/L/N/W 0.03% (n=1)
T/L/G/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 3b (antibodies: [HC33.29, HC33.8])

R/L/G/W 33.25% (n=132)
S/L/G/W 33.00% (n=131)
K/L/G/W 23.93% (n=95)
Q/L/G/W 7.30% (n=29)
N/L/G/W 1.01% (n=4)
A/L/G/W 0.50% (n=2)
T/L/G/W 0.50% (n=2)
V/L/G/W 0.25% (n=1)
R/L/G/R 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 4 (antibodies: [HC33.29, HC33.8])

Q/L/G/W 55.40% (n=426)
K/L/G/W 16.78% (n=129)
R/L/G/W 15.60% (n=120)
S/L/G/W 11.31% (n=87)
A/L/G/W 0.13% (n=1)
Q/L/E/W 0.13% (n=1)
H/L/G/W 0.13% (n=1)
T/L/G/W 0.13% (n=1)
M/L/G/W 0.13% (n=1)
E/L/G/W 0.13% (n=1)
N/L/G/W 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 4a (antibodies: [HC33.29, HC33.8])

S/L/G/W 50.93% (n=82)
Q/L/G/W 26.09% (n=42)
K/L/G/W 16.77% (n=27)
R/L/G/W 5.59% (n=9)
A/L/G/W 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 4d (antibodies: [HC33.29, HC33.8])

Q/L/G/W 68.45% (n=371)
R/L/G/W 16.79% (n=91)
K/L/G/W 14.21% (n=77)
Q/L/E/W 0.18% (n=1)
H/L/G/W 0.18% (n=1)
S/L/G/W 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 5 (antibodies: [HC33.29, HC33.8])

Q/L/G/W 25.56% (n=34)
K/L/G/W 24.81% (n=33)
R/L/G/W 20.30% (n=27)
S/L/G/W 12.03% (n=16)
N/L/G/W 4.51% (n=6)
A/L/G/W 3.01% (n=4)
H/L/G/W 2.26% (n=3)
Q/F/G/W 1.50% (n=2)
S/I/G/W 0.75% (n=1)
H/L/G/C 0.75% (n=1)
K/L/E/W 0.75% (n=1)
Q/A/G/W 0.75% (n=1)
Y/L/G/W 0.75% (n=1)
T/L/G/W 0.75% (n=1)
I/L/G/W 0.75% (n=1)
K/L/S/W 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 6 (antibodies: [HC33.29, HC33.8])

K/L/G/W 50.65% (n=272)
R/L/G/W 29.05% (n=156)
Q/L/G/W 12.29% (n=66)
S/L/G/W 5.03% (n=27)
N/L/G/W 0.93% (n=5)
A/L/G/W 0.93% (n=5)
S/L/S/W 0.19% (n=1)
M/L/G/W 0.19% (n=1)
K/L/G/R 0.19% (n=1)
R/F/G/W 0.19% (n=1)
H/L/G/W 0.19% (n=1)
T/L/G/W 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Subtype 6a (antibodies: [HC33.29, HC33.8])

K/L/G/W 59.74% (n=181)
R/L/G/W 28.05% (n=85)
Q/L/G/W 5.94% (n=18)
S/L/G/W 4.29% (n=13)
N/L/G/W 0.66% (n=2)
S/L/S/W 0.33% (n=1)
M/L/G/W 0.33% (n=1)
K/L/G/R 0.33% (n=1)
R/F/G/W 0.33% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,418,420 in HCV Genotype 7 (antibodies: [HC33.29, HC33.8])

S/L/G/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 408,413,420 in HCV Genotype 1 (antibodies: [HC33.4])

K/L/W 37.04% (n=8502)
S/L/W 30.29% (n=6952)
R/L/W 11.83% (n=2715)
Q/L/W 11.69% (n=2683)
A/L/W 3.95% (n=906)
M/L/W 1.63% (n=373)
N/L/W 1.04% (n=238)
T/L/W 0.85% (n=194)
H/L/W 0.46% (n=106)
Y/L/W 0.33% (n=75)
G/L/W 0.27% (n=63)
L/L/W 0.05% (n=12)
P/L/W 0.05% (n=12)
E/L/W 0.05% (n=11)
K/L/R 0.05% (n=11)
S/L/R 0.05% (n=11)
K/P/W 0.04% (n=10)
K/L/C 0.04% (n=9)
Q/L/R 0.02% (n=5)
K/L/* 0.02% (n=5)
S/P/W 0.02% (n=5)
R/L/R 0.02% (n=5)
F/L/W 0.02% (n=5)
V/L/W 0.02% (n=4)
K/L/G 0.01% (n=3)
R/M/W 0.01% (n=3)
Q/L/G 0.01% (n=2)
R/L/S 0.01% (n=2)
M/L/R 0.01% (n=2)
M/L/* 0.01% (n=2)
K/F/W 0.01% (n=2)
Q/L/* 0.01% (n=2)
K/V/W 0.01% (n=2)
C/L/W 0.01% (n=2)
R/P/W 0.00% (n=1)
S/L/* 0.00% (n=1)
R/V/W 0.00% (n=1)
S/Q/W 0.00% (n=1)
Q/P/W 0.00% (n=1)
K/M/W 0.00% (n=1)
R/L/* 0.00% (n=1)
S/A/W 0.00% (n=1)
T/A/W 0.00% (n=1)
R/I/W 0.00% (n=1)
S/L/C 0.00% (n=1)
A/L/R 0.00% (n=1)
I/L/W 0.00% (n=1)
S/I/W 0.00% (n=1)
D/L/W 0.00% (n=1)
*/L/W 0.00% (n=1)
S/H/W 0.00% (n=1)
K/I/W 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 1a (antibodies: [HC33.4])

K/L/W 58.99% (n=8051)
R/L/W 14.98% (n=2044)
Q/L/W 14.34% (n=1957)
S/L/W 7.22% (n=985)
M/L/W 2.73% (n=373)
N/L/W 1.03% (n=141)
K/L/R 0.08% (n=11)
E/L/W 0.07% (n=10)
K/P/W 0.07% (n=10)
K/L/C 0.07% (n=9)
G/L/W 0.04% (n=6)
K/L/* 0.04% (n=5)
Q/L/R 0.03% (n=4)
R/L/R 0.03% (n=4)
K/L/G 0.02% (n=3)
R/M/W 0.02% (n=3)
L/L/W 0.02% (n=3)
Q/L/G 0.01% (n=2)
T/L/W 0.01% (n=2)
H/L/W 0.01% (n=2)
A/L/W 0.01% (n=2)
R/L/S 0.01% (n=2)
M/L/R 0.01% (n=2)
M/L/* 0.01% (n=2)
K/F/W 0.01% (n=2)
K/V/W 0.01% (n=2)
R/P/W 0.01% (n=1)
S/L/* 0.01% (n=1)
R/V/W 0.01% (n=1)
S/Q/W 0.01% (n=1)
S/P/W 0.01% (n=1)
Q/P/W 0.01% (n=1)
P/L/W 0.01% (n=1)
K/M/W 0.01% (n=1)
Q/L/* 0.01% (n=1)
R/L/* 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 1b (antibodies: [HC33.4])

S/L/W 64.32% (n=5957)
A/L/W 9.75% (n=903)
Q/L/W 7.70% (n=713)
R/L/W 7.19% (n=666)
K/L/W 4.74% (n=439)
T/L/W 2.06% (n=191)
H/L/W 1.11% (n=103)
N/L/W 1.04% (n=96)
Y/L/W 0.81% (n=75)
G/L/W 0.62% (n=57)
P/L/W 0.12% (n=11)
S/L/R 0.12% (n=11)
L/L/W 0.10% (n=9)
F/L/W 0.05% (n=5)
V/L/W 0.04% (n=4)
S/P/W 0.04% (n=4)
C/L/W 0.02% (n=2)
S/A/W 0.01% (n=1)
T/A/W 0.01% (n=1)
R/I/W 0.01% (n=1)
S/L/C 0.01% (n=1)
A/L/R 0.01% (n=1)
I/L/W 0.01% (n=1)
S/I/W 0.01% (n=1)
D/L/W 0.01% (n=1)
Q/L/* 0.01% (n=1)
R/L/R 0.01% (n=1)
Q/L/R 0.01% (n=1)
*/L/W 0.01% (n=1)
S/H/W 0.01% (n=1)
E/L/W 0.01% (n=1)
K/I/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 2 (antibodies: [HC33.4])

K/L/W 33.41% (n=442)
R/L/W 24.72% (n=327)
Q/L/W 23.51% (n=311)
S/L/W 16.63% (n=220)
N/L/W 0.53% (n=7)
H/L/W 0.23% (n=3)
T/L/W 0.23% (n=3)
Q/L/L 0.23% (n=3)
I/L/W 0.08% (n=1)
M/L/W 0.08% (n=1)
E/L/* 0.08% (n=1)
*/L/W 0.08% (n=1)
Q/L/R 0.08% (n=1)
K/L/L 0.08% (n=1)
A/L/W 0.08% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 2a (antibodies: [HC33.4])

K/L/W 53.99% (n=142)
R/L/W 25.10% (n=66)
Q/L/W 17.11% (n=45)
S/L/W 1.90% (n=5)
T/L/W 0.76% (n=2)
H/L/W 0.38% (n=1)
N/L/W 0.38% (n=1)
M/L/W 0.38% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 2b (antibodies: [HC33.4])

Q/L/W 46.54% (n=215)
S/L/W 24.68% (n=114)
K/L/W 17.10% (n=79)
R/L/W 9.09% (n=42)
Q/L/L 0.65% (n=3)
H/L/W 0.43% (n=2)
E/L/* 0.22% (n=1)
*/L/W 0.22% (n=1)
Q/L/R 0.22% (n=1)
K/L/L 0.22% (n=1)
T/L/W 0.22% (n=1)
A/L/W 0.22% (n=1)
N/L/W 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 2c (antibodies: [HC33.4])

R/L/W 45.83% (n=209)
K/L/W 45.61% (n=208)
Q/L/W 6.14% (n=28)
S/L/W 1.32% (n=6)
N/L/W 1.10% (n=5)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 3 (antibodies: [HC33.4])

Q/L/W 28.08% (n=1087)
R/L/W 25.55% (n=989)
K/L/W 21.83% (n=845)
S/L/W 16.35% (n=633)
N/L/W 7.41% (n=287)
A/L/W 0.18% (n=7)
H/L/W 0.13% (n=5)
T/L/W 0.10% (n=4)
G/L/W 0.08% (n=3)
R/P/W 0.05% (n=2)
Q/L/G 0.03% (n=1)
Q/L/L 0.03% (n=1)
L/L/W 0.03% (n=1)
K/L/R 0.03% (n=1)
E/L/W 0.03% (n=1)
I/L/W 0.03% (n=1)
M/L/W 0.03% (n=1)
V/L/W 0.03% (n=1)
R/L/R 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 3a (antibodies: [HC33.4])

Q/L/W 29.16% (n=956)
R/L/W 23.67% (n=776)
K/L/W 22.69% (n=744)
S/L/W 15.25% (n=500)
N/L/W 8.63% (n=283)
H/L/W 0.15% (n=5)
G/L/W 0.09% (n=3)
R/P/W 0.06% (n=2)
A/L/W 0.06% (n=2)
Q/L/G 0.03% (n=1)
Q/L/L 0.03% (n=1)
L/L/W 0.03% (n=1)
K/L/R 0.03% (n=1)
E/L/W 0.03% (n=1)
I/L/W 0.03% (n=1)
M/L/W 0.03% (n=1)
T/L/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 3b (antibodies: [HC33.4])

R/L/W 33.25% (n=132)
S/L/W 33.00% (n=131)
K/L/W 23.93% (n=95)
Q/L/W 7.30% (n=29)
N/L/W 1.01% (n=4)
A/L/W 0.50% (n=2)
T/L/W 0.50% (n=2)
V/L/W 0.25% (n=1)
R/L/R 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 4 (antibodies: [HC33.4])

Q/L/W 55.53% (n=427)
K/L/W 16.78% (n=129)
R/L/W 15.60% (n=120)
S/L/W 11.31% (n=87)
A/L/W 0.13% (n=1)
H/L/W 0.13% (n=1)
T/L/W 0.13% (n=1)
M/L/W 0.13% (n=1)
E/L/W 0.13% (n=1)
N/L/W 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 4a (antibodies: [HC33.4])

S/L/W 50.93% (n=82)
Q/L/W 26.09% (n=42)
K/L/W 16.77% (n=27)
R/L/W 5.59% (n=9)
A/L/W 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 4d (antibodies: [HC33.4])

Q/L/W 68.63% (n=372)
R/L/W 16.79% (n=91)
K/L/W 14.21% (n=77)
H/L/W 0.18% (n=1)
S/L/W 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 5 (antibodies: [HC33.4])

K/L/W 26.32% (n=35)
Q/L/W 25.56% (n=34)
R/L/W 20.30% (n=27)
S/L/W 12.03% (n=16)
N/L/W 4.51% (n=6)
A/L/W 3.01% (n=4)
H/L/W 2.26% (n=3)
Q/F/W 1.50% (n=2)
S/I/W 0.75% (n=1)
H/L/C 0.75% (n=1)
Q/A/W 0.75% (n=1)
Y/L/W 0.75% (n=1)
T/L/W 0.75% (n=1)
I/L/W 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 6 (antibodies: [HC33.4])

K/L/W 50.65% (n=272)
R/L/W 29.05% (n=156)
Q/L/W 12.29% (n=66)
S/L/W 5.21% (n=28)
N/L/W 0.93% (n=5)
A/L/W 0.93% (n=5)
M/L/W 0.19% (n=1)
K/L/R 0.19% (n=1)
R/F/W 0.19% (n=1)
H/L/W 0.19% (n=1)
T/L/W 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Subtype 6a (antibodies: [HC33.4])

K/L/W 59.74% (n=181)
R/L/W 28.05% (n=85)
Q/L/W 5.94% (n=18)
S/L/W 4.62% (n=14)
N/L/W 0.66% (n=2)
M/L/W 0.33% (n=1)
K/L/R 0.33% (n=1)
R/F/W 0.33% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 408,413,420 in HCV Genotype 7 (antibodies: [HC33.4])

S/L/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 413,415,418,420 in HCV Genotype 1 (antibodies: [AP33, HCV1])

L/N/G/W 96.83% (n=22290)
L/K/G/W 1.11% (n=256)
L/S/G/W 0.79% (n=183)
L/H/G/W 0.25% (n=58)
L/N/N/W 0.19% (n=44)
L/N/G/R 0.15% (n=34)
L/Y/G/W 0.10% (n=23)
L/D/G/W 0.09% (n=20)
P/N/G/W 0.07% (n=17)
L/N/D/W 0.07% (n=15)
L/N/S/W 0.05% (n=12)
L/N/G/* 0.05% (n=11)
L/N/G/C 0.04% (n=10)
L/N/G/G 0.02% (n=5)
L/R/G/W 0.02% (n=5)
M/N/G/W 0.02% (n=4)
L/E/G/W 0.02% (n=4)
V/N/G/W 0.01% (n=3)
L/T/G/W 0.01% (n=3)
L/N/R/W 0.01% (n=3)
I/N/G/W 0.01% (n=3)
L/K/D/W 0.01% (n=2)
L/N/G/S 0.01% (n=2)
F/N/G/W 0.01% (n=2)
L/A/G/W 0.01% (n=2)
L/K/G/R 0.00% (n=1)
L/Q/G/W 0.00% (n=1)
Q/N/G/W 0.00% (n=1)
L/G/G/W 0.00% (n=1)
L/N/V/W 0.00% (n=1)
A/N/A/W 0.00% (n=1)
A/N/G/W 0.00% (n=1)
H/N/G/W 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 1a (antibodies: [AP33, HCV1])

L/N/G/W 96.03% (n=13144)
L/K/G/W 1.62% (n=222)
L/S/G/W 1.00% (n=137)
L/N/N/W 0.32% (n=44)
L/N/G/R 0.15% (n=20)
L/Y/G/W 0.14% (n=19)
L/D/G/W 0.12% (n=16)
P/N/G/W 0.09% (n=13)
L/N/D/W 0.07% (n=10)
L/N/G/* 0.07% (n=10)
L/N/G/C 0.07% (n=9)
L/H/G/W 0.07% (n=9)
L/N/S/W 0.04% (n=5)
L/N/G/G 0.04% (n=5)
M/N/G/W 0.03% (n=4)
V/N/G/W 0.02% (n=3)
L/R/G/W 0.02% (n=3)
L/K/D/W 0.01% (n=2)
L/N/G/S 0.01% (n=2)
F/N/G/W 0.01% (n=2)
L/A/G/W 0.01% (n=2)
L/K/G/R 0.01% (n=1)
L/Q/G/W 0.01% (n=1)
Q/N/G/W 0.01% (n=1)
L/T/G/W 0.01% (n=1)
L/N/R/W 0.01% (n=1)
L/G/G/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 1b (antibodies: [AP33, HCV1])

L/N/G/W 98.06% (n=9108)
L/H/G/W 0.51% (n=47)
L/S/G/W 0.45% (n=42)
L/K/G/W 0.37% (n=34)
L/N/G/R 0.15% (n=14)
L/N/S/W 0.08% (n=7)
L/N/D/W 0.05% (n=5)
L/Y/G/W 0.04% (n=4)
P/N/G/W 0.04% (n=4)
L/E/G/W 0.04% (n=4)
L/D/G/W 0.04% (n=4)
I/N/G/W 0.03% (n=3)
L/N/R/W 0.02% (n=2)
L/R/G/W 0.02% (n=2)
L/T/G/W 0.02% (n=2)
L/N/V/W 0.01% (n=1)
A/N/A/W 0.01% (n=1)
A/N/G/W 0.01% (n=1)
L/N/G/C 0.01% (n=1)
L/N/G/* 0.01% (n=1)
H/N/G/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 2 (antibodies: [AP33, HCV1])

L/N/G/W 71.89% (n=972)
L/H/G/W 20.93% (n=283)
L/S/G/W 3.62% (n=49)
L/K/G/W 1.55% (n=21)
L/Y/G/W 0.74% (n=10)
L/R/G/W 0.37% (n=5)
L/N/G/L 0.30% (n=4)
L/D/G/W 0.22% (n=3)
L/N/V/W 0.07% (n=1)
L/N/G/* 0.07% (n=1)
L/N/S/W 0.07% (n=1)
L/N/G/R 0.07% (n=1)
L/P/A/W 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 2a (antibodies: [AP33, HCV1])

L/N/G/W 97.27% (n=285)
L/K/G/W 0.68% (n=2)
L/Y/G/W 0.68% (n=2)
L/D/G/W 0.68% (n=2)
L/S/G/W 0.68% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 2b (antibodies: [AP33, HCV1])

L/N/G/W 81.21% (n=376)
L/S/G/W 9.94% (n=46)
L/K/G/W 3.46% (n=16)
L/H/G/W 3.24% (n=15)
L/N/G/L 0.86% (n=4)
L/N/V/W 0.22% (n=1)
L/N/G/* 0.22% (n=1)
L/N/S/W 0.22% (n=1)
L/N/G/R 0.22% (n=1)
L/Y/G/W 0.22% (n=1)
L/P/A/W 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 2c (antibodies: [AP33, HCV1])

L/H/G/W 57.80% (n=263)
L/N/G/W 39.34% (n=179)
L/Y/G/W 1.32% (n=6)
L/R/G/W 1.10% (n=5)
L/K/G/W 0.22% (n=1)
L/S/G/W 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 3 (antibodies: [AP33, HCV1])

L/N/G/W 86.56% (n=3374)
L/R/G/W 8.08% (n=315)
L/Y/G/W 2.95% (n=115)
L/E/G/W 1.00% (n=39)
L/H/G/W 0.41% (n=16)
L/S/G/W 0.26% (n=10)
L/K/G/W 0.26% (n=10)
L/D/G/W 0.15% (n=6)
L/N/D/W 0.08% (n=3)
P/N/G/W 0.05% (n=2)
L/N/G/R 0.05% (n=2)
L/N/G/G 0.03% (n=1)
L/N/G/L 0.03% (n=1)
L/C/A/W 0.03% (n=1)
L/K/D/W 0.03% (n=1)
L/Q/G/W 0.03% (n=1)
L/K/N/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 3a (antibodies: [AP33, HCV1])

L/N/G/W 84.54% (n=2789)
L/R/G/W 9.55% (n=315)
L/Y/G/W 3.43% (n=113)
L/E/G/W 1.09% (n=36)
L/H/G/W 0.39% (n=13)
L/K/G/W 0.27% (n=9)
L/S/G/W 0.21% (n=7)
L/D/G/W 0.15% (n=5)
L/N/D/W 0.09% (n=3)
P/N/G/W 0.06% (n=2)
L/N/G/G 0.03% (n=1)
L/N/G/L 0.03% (n=1)
L/C/A/W 0.03% (n=1)
L/N/G/R 0.03% (n=1)
L/K/D/W 0.03% (n=1)
L/Q/G/W 0.03% (n=1)
L/K/N/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 3b (antibodies: [AP33, HCV1])

L/N/G/W 97.52% (n=394)
L/H/G/W 0.74% (n=3)
L/E/G/W 0.74% (n=3)
L/S/G/W 0.50% (n=2)
L/Y/G/W 0.25% (n=1)
L/N/G/R 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 4 (antibodies: [AP33, HCV1])

L/N/G/W 94.80% (n=729)
L/H/G/W 2.34% (n=18)
L/S/G/W 1.43% (n=11)
L/D/G/W 0.65% (n=5)
L/Y/G/W 0.39% (n=3)
L/K/G/W 0.26% (n=2)
L/N/E/W 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 4a (antibodies: [AP33, HCV1])

L/N/G/W 100.00% (n=161)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 4d (antibodies: [AP33, HCV1])

L/N/G/W 93.73% (n=508)
L/H/G/W 2.58% (n=14)
L/S/G/W 2.03% (n=11)
L/D/G/W 0.74% (n=4)
L/Y/G/W 0.37% (n=2)
L/K/G/W 0.37% (n=2)
L/N/E/W 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 5 (antibodies: [AP33, HCV1])

L/N/G/W 82.71% (n=110)
L/H/G/W 5.26% (n=7)
L/S/G/W 2.26% (n=3)
L/R/G/W 2.26% (n=3)
L/K/G/W 1.50% (n=2)
F/N/G/W 1.50% (n=2)
I/N/G/W 0.75% (n=1)
L/N/G/C 0.75% (n=1)
L/K/E/W 0.75% (n=1)
A/N/G/W 0.75% (n=1)
L/E/G/W 0.75% (n=1)
L/Q/S/W 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 6 (antibodies: [AP33, HCV1])

L/N/G/W 95.21% (n=557)
L/K/G/W 1.54% (n=9)
L/H/G/W 1.37% (n=8)
L/Y/G/W 0.68% (n=4)
L/K/S/W 0.17% (n=1)
L/R/G/W 0.17% (n=1)
L/C/G/W 0.17% (n=1)
L/N/G/R 0.17% (n=1)
F/N/G/W 0.17% (n=1)
L/E/G/W 0.17% (n=1)
L/S/G/W 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Subtype 6a (antibodies: [AP33, HCV1])

L/N/G/W 95.22% (n=319)
L/K/G/W 1.49% (n=5)
L/H/G/W 1.19% (n=4)
L/Y/G/W 0.60% (n=2)
L/K/S/W 0.30% (n=1)
L/R/G/W 0.30% (n=1)
L/C/G/W 0.30% (n=1)
L/N/G/R 0.30% (n=1)
F/N/G/W 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,415,418,420 in HCV Genotype 7 (antibodies: [AP33, HCV1])

L/N/G/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 413,417,420,422 in HCV Genotype 1 (antibodies: [Hu5B3.v3])

L/N/W/I 94.99% (n=21830)
L/N/W/L 2.37% (n=545)
L/N/W/V 1.40% (n=321)
L/S/W/I 0.40% (n=92)
L/D/W/I 0.16% (n=37)
L/N/R/I 0.13% (n=31)
L/N/W/T 0.10% (n=22)
P/N/W/I 0.07% (n=15)
L/R/W/I 0.05% (n=12)
L/N/*/I 0.05% (n=11)
L/N/C/I 0.04% (n=10)
L/N/G/I 0.02% (n=5)
L/E/W/I 0.02% (n=4)
L/N/W/F 0.02% (n=4)
V/N/W/I 0.01% (n=3)
M/N/W/I 0.01% (n=3)
L/K/W/I 0.01% (n=3)
L/N/R/L 0.01% (n=3)
I/N/W/I 0.01% (n=3)
L/H/W/I 0.01% (n=2)
L/N/W/S 0.01% (n=2)
L/T/S/I 0.01% (n=2)
L/N/W/P 0.01% (n=2)
F/N/W/I 0.01% (n=2)
L/I/W/I 0.01% (n=2)
L/N/W/N 0.01% (n=2)
L/N/W/A 0.00% (n=1)
L/S/W/T 0.00% (n=1)
Q/N/W/I 0.00% (n=1)
L/G/W/I 0.00% (n=1)
P/N/W/L 0.00% (n=1)
P/H/W/I 0.00% (n=1)
L/T/W/I 0.00% (n=1)
L/N/R/V 0.00% (n=1)
M/N/W/L 0.00% (n=1)
L/S/W/V 0.00% (n=1)
A/N/W/T 0.00% (n=1)
A/N/W/I 0.00% (n=1)
H/N/W/I 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 1a (antibodies: [Hu5B3.v3])

L/N/W/I 93.29% (n=12753)
L/N/W/L 3.96% (n=541)
L/N/W/V 1.38% (n=188)
L/S/W/I 0.32% (n=44)
L/D/W/I 0.21% (n=29)
L/N/R/I 0.12% (n=17)
L/N/W/T 0.11% (n=15)
L/R/W/I 0.09% (n=12)
P/N/W/I 0.08% (n=11)
L/N/*/I 0.07% (n=10)
L/N/C/I 0.07% (n=9)
L/N/G/I 0.04% (n=5)
L/E/W/I 0.02% (n=3)
V/N/W/I 0.02% (n=3)
M/N/W/I 0.02% (n=3)
L/N/R/L 0.02% (n=3)
L/H/W/I 0.01% (n=2)
L/N/W/S 0.01% (n=2)
L/K/W/I 0.01% (n=2)
L/T/S/I 0.01% (n=2)
L/N/W/P 0.01% (n=2)
F/N/W/I 0.01% (n=2)
L/I/W/I 0.01% (n=2)
L/N/W/A 0.01% (n=1)
L/S/W/T 0.01% (n=1)
Q/N/W/I 0.01% (n=1)
L/G/W/I 0.01% (n=1)
L/N/W/F 0.01% (n=1)
P/N/W/L 0.01% (n=1)
P/H/W/I 0.01% (n=1)
L/T/W/I 0.01% (n=1)
L/N/R/V 0.01% (n=1)
M/N/W/L 0.01% (n=1)
L/N/W/N 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 1b (antibodies: [Hu5B3.v3])

L/N/W/I 97.55% (n=9039)
L/N/W/V 1.41% (n=131)
L/S/W/I 0.51% (n=47)
L/N/R/I 0.15% (n=14)
L/D/W/I 0.09% (n=8)
L/N/W/T 0.08% (n=7)
P/N/W/I 0.04% (n=4)
L/N/W/F 0.03% (n=3)
I/N/W/I 0.03% (n=3)
L/E/W/I 0.01% (n=1)
L/S/W/V 0.01% (n=1)
A/N/W/T 0.01% (n=1)
A/N/W/I 0.01% (n=1)
L/N/C/I 0.01% (n=1)
L/N/*/I 0.01% (n=1)
L/K/W/I 0.01% (n=1)
L/N/W/N 0.01% (n=1)
H/N/W/I 0.01% (n=1)
L/N/W/L 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 2 (antibodies: [Hu5B3.v3])

L/N/W/I 96.08% (n=1300)
L/N/W/V 2.59% (n=35)
L/S/W/I 0.37% (n=5)
L/N/L/I 0.30% (n=4)
L/D/W/I 0.15% (n=2)
L/N/W/T 0.07% (n=1)
L/N/W/L 0.07% (n=1)
L/K/W/I 0.07% (n=1)
L/N/*/I 0.07% (n=1)
L/N/R/I 0.07% (n=1)
L/T/W/V 0.07% (n=1)
L/A/W/I 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 2a (antibodies: [Hu5B3.v3])

L/N/W/I 91.44% (n=267)
L/N/W/V 5.82% (n=17)
L/S/W/I 1.71% (n=5)
L/N/W/T 0.34% (n=1)
L/N/W/L 0.34% (n=1)
L/K/W/I 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 2b (antibodies: [Hu5B3.v3])

L/N/W/I 97.84% (n=453)
L/N/L/I 0.86% (n=4)
L/N/*/I 0.22% (n=1)
L/N/R/I 0.22% (n=1)
L/T/W/V 0.22% (n=1)
L/D/W/I 0.22% (n=1)
L/A/W/I 0.22% (n=1)
L/N/W/V 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 2c (antibodies: [Hu5B3.v3])

L/N/W/I 96.71% (n=441)
L/N/W/V 3.07% (n=14)
L/D/W/I 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 3 (antibodies: [Hu5B3.v3])

L/N/W/I 96.07% (n=3742)
L/N/W/V 2.70% (n=105)
L/Q/W/I 0.62% (n=24)
L/S/W/I 0.23% (n=9)
L/N/W/T 0.05% (n=2)
P/N/W/I 0.05% (n=2)
L/N/R/I 0.05% (n=2)
L/H/W/I 0.05% (n=2)
L/D/W/I 0.05% (n=2)
L/Y/G/I 0.03% (n=1)
L/Y/L/I 0.03% (n=1)
L/K/W/I 0.03% (n=1)
L/G/W/I 0.03% (n=1)
L/N/W/L 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 3a (antibodies: [Hu5B3.v3])

L/N/W/I 95.57% (n=3149)
L/N/W/V 3.10% (n=102)
L/Q/W/I 0.73% (n=24)
L/S/W/I 0.21% (n=7)
L/N/W/T 0.06% (n=2)
P/N/W/I 0.06% (n=2)
L/H/W/I 0.06% (n=2)
L/D/W/I 0.06% (n=2)
L/Y/G/I 0.03% (n=1)
L/Y/L/I 0.03% (n=1)
L/N/R/I 0.03% (n=1)
L/K/W/I 0.03% (n=1)
L/G/W/I 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 3b (antibodies: [Hu5B3.v3])

L/N/W/I 99.26% (n=402)
L/S/W/I 0.49% (n=2)
L/N/R/I 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 4 (antibodies: [Hu5B3.v3])

L/N/W/I 97.66% (n=751)
L/N/W/V 1.30% (n=10)
L/N/W/L 0.65% (n=5)
L/G/W/I 0.39% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 4a (antibodies: [Hu5B3.v3])

L/N/W/I 98.77% (n=160)
L/N/W/V 1.23% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 4d (antibodies: [Hu5B3.v3])

L/N/W/I 99.45% (n=539)
L/G/W/I 0.55% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 5 (antibodies: [Hu5B3.v3])

L/N/W/I 92.48% (n=123)
L/Q/W/I 1.50% (n=2)
L/G/W/I 1.50% (n=2)
F/N/W/I 1.50% (n=2)
L/S/W/I 0.75% (n=1)
I/N/W/I 0.75% (n=1)
L/N/C/I 0.75% (n=1)
A/N/W/I 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 6 (antibodies: [Hu5B3.v3])

L/N/W/I 86.99% (n=508)
L/N/W/V 11.30% (n=66)
L/N/W/L 0.51% (n=3)
L/S/W/I 0.34% (n=2)
L/G/W/I 0.17% (n=1)
L/K/W/I 0.17% (n=1)
L/N/R/I 0.17% (n=1)
F/N/W/I 0.17% (n=1)
L/D/W/I 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Subtype 6a (antibodies: [Hu5B3.v3])

L/N/W/I 98.21% (n=329)
L/S/W/I 0.60% (n=2)
L/G/W/I 0.30% (n=1)
L/K/W/I 0.30% (n=1)
L/N/R/I 0.30% (n=1)
F/N/W/I 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,417,420,422 in HCV Genotype 7 (antibodies: [Hu5B3.v3])

L/N/W/I 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 413,418,420 in HCV Genotype 1 (antibodies: [HC33.1, HC33.32])

L/G/W 99.25% (n=22851)
L/N/W 0.19% (n=44)
L/G/R 0.15% (n=35)
P/G/W 0.07% (n=17)
L/D/W 0.07% (n=17)
L/S/W 0.05% (n=12)
L/G/* 0.05% (n=11)
L/G/C 0.04% (n=10)
L/G/G 0.02% (n=5)
M/G/W 0.02% (n=4)
V/G/W 0.01% (n=3)
L/R/W 0.01% (n=3)
I/G/W 0.01% (n=3)
L/G/S 0.01% (n=2)
F/G/W 0.01% (n=2)
Q/G/W 0.00% (n=1)
L/V/W 0.00% (n=1)
A/A/W 0.00% (n=1)
A/G/W 0.00% (n=1)
H/G/W 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 1a (antibodies: [HC33.1, HC33.32])

L/G/W 99.04% (n=13558)
L/N/W 0.32% (n=44)
L/G/R 0.15% (n=21)
P/G/W 0.09% (n=13)
L/D/W 0.09% (n=12)
L/G/* 0.07% (n=10)
L/G/C 0.07% (n=9)
L/S/W 0.04% (n=5)
L/G/G 0.04% (n=5)
M/G/W 0.03% (n=4)
V/G/W 0.02% (n=3)
L/G/S 0.01% (n=2)
F/G/W 0.01% (n=2)
Q/G/W 0.01% (n=1)
L/R/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 1b (antibodies: [HC33.1, HC33.32])

L/G/W 99.56% (n=9249)
L/G/R 0.15% (n=14)
L/S/W 0.08% (n=7)
L/D/W 0.05% (n=5)
P/G/W 0.04% (n=4)
I/G/W 0.03% (n=3)
L/R/W 0.02% (n=2)
L/V/W 0.01% (n=1)
A/A/W 0.01% (n=1)
A/G/W 0.01% (n=1)
L/G/C 0.01% (n=1)
L/G/* 0.01% (n=1)
H/G/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 2 (antibodies: [HC33.1, HC33.32])

L/G/W 99.34% (n=1347)
L/G/L 0.29% (n=4)
L/V/W 0.07% (n=1)
L/G/* 0.07% (n=1)
L/S/W 0.07% (n=1)
L/G/R 0.07% (n=1)
L/A/W 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 2a (antibodies: [HC33.1, HC33.32])

L/G/W 100.00% (n=295)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 2b (antibodies: [HC33.1, HC33.32])

L/G/W 98.06% (n=454)
L/G/L 0.86% (n=4)
L/V/W 0.22% (n=1)
L/G/* 0.22% (n=1)
L/S/W 0.22% (n=1)
L/G/R 0.22% (n=1)
L/A/W 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 2c (antibodies: [HC33.1, HC33.32])

L/G/W 100.00% (n=456)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 3 (antibodies: [HC33.1, HC33.32])

L/G/W 99.69% (n=3886)
L/D/W 0.10% (n=4)
P/G/W 0.05% (n=2)
L/G/R 0.05% (n=2)
L/G/G 0.03% (n=1)
L/G/L 0.03% (n=1)
L/A/W 0.03% (n=1)
L/N/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 3a (antibodies: [HC33.1, HC33.32])

L/G/W 99.67% (n=3288)
L/D/W 0.12% (n=4)
P/G/W 0.06% (n=2)
L/G/G 0.03% (n=1)
L/G/L 0.03% (n=1)
L/A/W 0.03% (n=1)
L/G/R 0.03% (n=1)
L/N/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 3b (antibodies: [HC33.1, HC33.32])

L/G/W 99.75% (n=403)
L/G/R 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 4 (antibodies: [HC33.1, HC33.32])

L/G/W 99.87% (n=769)
L/E/W 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 4a (antibodies: [HC33.1, HC33.32])

L/G/W 100.00% (n=162)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 4d (antibodies: [HC33.1, HC33.32])

L/G/W 99.82% (n=541)
L/E/W 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 5 (antibodies: [HC33.1, HC33.32])

L/G/W 94.78% (n=127)
F/G/W 1.49% (n=2)
I/G/W 0.75% (n=1)
L/G/C 0.75% (n=1)
L/E/W 0.75% (n=1)
A/G/W 0.75% (n=1)
L/S/W 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 6 (antibodies: [HC33.1, HC33.32])

L/G/W 99.49% (n=583)
L/S/W 0.17% (n=1)
L/G/R 0.17% (n=1)
F/G/W 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Subtype 6a (antibodies: [HC33.1, HC33.32])

L/G/W 99.10% (n=332)
L/S/W 0.30% (n=1)
L/G/R 0.30% (n=1)
F/G/W 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,418,420 in HCV Genotype 7 (antibodies: [HC33.1, HC33.32])

L/G/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 413,420 in HCV Genotype 1 (antibodies: [95-2])

L/W 99.58% (n=22930)
L/R 0.15% (n=35)
P/W 0.07% (n=17)
L/* 0.05% (n=11)
L/C 0.04% (n=10)
L/G 0.02% (n=5)
M/W 0.02% (n=4)
V/W 0.01% (n=3)
I/W 0.01% (n=3)
L/S 0.01% (n=2)
F/W 0.01% (n=2)
A/W 0.01% (n=2)
Q/W 0.00% (n=1)
H/W 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 1a (antibodies: [95-2])

L/W 99.49% (n=13622)
L/R 0.15% (n=21)
P/W 0.09% (n=13)
L/* 0.07% (n=10)
L/C 0.07% (n=9)
L/G 0.04% (n=5)
M/W 0.03% (n=4)
V/W 0.02% (n=3)
L/S 0.01% (n=2)
F/W 0.01% (n=2)
Q/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 1b (antibodies: [95-2])

L/W 99.72% (n=9264)
L/R 0.15% (n=14)
P/W 0.04% (n=4)
I/W 0.03% (n=3)
A/W 0.02% (n=2)
L/C 0.01% (n=1)
L/* 0.01% (n=1)
H/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 2 (antibodies: [95-2])

L/W 99.56% (n=1350)
L/L 0.29% (n=4)
L/* 0.07% (n=1)
L/R 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 2a (antibodies: [95-2])

L/W 100.00% (n=295)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 2b (antibodies: [95-2])

L/W 98.70% (n=457)
L/L 0.86% (n=4)
L/* 0.22% (n=1)
L/R 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 2c (antibodies: [95-2])

L/W 100.00% (n=456)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 3 (antibodies: [95-2])

L/W 99.85% (n=3893)
P/W 0.05% (n=2)
L/R 0.05% (n=2)
L/G 0.03% (n=1)
L/L 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 3a (antibodies: [95-2])

L/W 99.85% (n=3294)
P/W 0.06% (n=2)
L/G 0.03% (n=1)
L/L 0.03% (n=1)
L/R 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 3b (antibodies: [95-2])

L/W 99.75% (n=404)
L/R 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 4 (antibodies: [95-2])

L/W 100.00% (n=770)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 4a (antibodies: [95-2])

L/W 100.00% (n=162)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 4d (antibodies: [95-2])

L/W 100.00% (n=542)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 5 (antibodies: [95-2])

L/W 96.27% (n=129)
F/W 1.49% (n=2)
I/W 0.75% (n=1)
L/C 0.75% (n=1)
A/W 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 6 (antibodies: [95-2])

L/W 99.66% (n=584)
L/R 0.17% (n=1)
F/W 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Subtype 6a (antibodies: [95-2])

L/W 99.40% (n=333)
L/R 0.30% (n=1)
F/W 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 413,420 in HCV Genotype 7 (antibodies: [95-2])

L/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 415,417 in HCV Genotype 1 (antibodies: [H77.39])

N/N 96.89% (n=22311)
K/N 1.12% (n=257)
S/N 0.79% (n=183)
N/S 0.40% (n=93)
H/N 0.25% (n=58)
N/D 0.16% (n=36)
Y/N 0.10% (n=23)
D/N 0.08% (n=19)
N/R 0.05% (n=12)
R/N 0.02% (n=5)
E/N 0.02% (n=4)
N/E 0.01% (n=3)
N/H 0.01% (n=3)
N/K 0.01% (n=3)
T/N 0.01% (n=3)
N/T 0.01% (n=3)
N/I 0.01% (n=2)
A/N 0.01% (n=2)
Q/N 0.00% (n=1)
K/D 0.00% (n=1)
N/G 0.00% (n=1)
D/S 0.00% (n=1)
G/N 0.00% (n=1)
K/E 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 1a (antibodies: [H77.39])

N/N 96.26% (n=13182)
K/N 1.64% (n=224)
S/N 1.00% (n=137)
N/S 0.32% (n=44)
N/D 0.20% (n=28)
Y/N 0.14% (n=19)
D/N 0.11% (n=15)
N/R 0.09% (n=12)
H/N 0.07% (n=9)
N/E 0.02% (n=3)
N/H 0.02% (n=3)
N/T 0.02% (n=3)
R/N 0.02% (n=3)
N/K 0.01% (n=2)
N/I 0.01% (n=2)
A/N 0.01% (n=2)
Q/N 0.01% (n=1)
K/D 0.01% (n=1)
T/N 0.01% (n=1)
N/G 0.01% (n=1)
D/S 0.01% (n=1)
G/N 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 1b (antibodies: [H77.39])

N/N 97.89% (n=9092)
N/S 0.52% (n=48)
H/N 0.51% (n=47)
S/N 0.45% (n=42)
K/N 0.36% (n=33)
N/D 0.09% (n=8)
Y/N 0.04% (n=4)
E/N 0.04% (n=4)
D/N 0.04% (n=4)
R/N 0.02% (n=2)
T/N 0.02% (n=2)
K/E 0.01% (n=1)
N/K 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 2 (antibodies: [H77.39])

N/N 71.89% (n=972)
H/N 20.93% (n=283)
S/N 3.62% (n=49)
K/N 1.55% (n=21)
Y/N 0.74% (n=10)
N/S 0.37% (n=5)
R/N 0.37% (n=5)
D/N 0.15% (n=2)
N/D 0.15% (n=2)
D/K 0.07% (n=1)
N/T 0.07% (n=1)
P/A 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 2a (antibodies: [H77.39])

N/N 95.56% (n=280)
N/S 1.71% (n=5)
K/N 0.68% (n=2)
Y/N 0.68% (n=2)
S/N 0.68% (n=2)
D/K 0.34% (n=1)
D/N 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 2b (antibodies: [H77.39])

N/N 82.51% (n=382)
S/N 9.94% (n=46)
K/N 3.46% (n=16)
H/N 3.24% (n=15)
N/T 0.22% (n=1)
N/D 0.22% (n=1)
Y/N 0.22% (n=1)
P/A 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 2c (antibodies: [H77.39])

H/N 57.80% (n=263)
N/N 39.12% (n=178)
Y/N 1.32% (n=6)
R/N 1.10% (n=5)
K/N 0.22% (n=1)
S/N 0.22% (n=1)
N/D 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 3 (antibodies: [H77.39])

N/N 86.46% (n=3384)
R/N 8.05% (n=315)
Y/N 2.94% (n=115)
E/Q 0.61% (n=24)
H/N 0.41% (n=16)
E/N 0.36% (n=14)
K/N 0.28% (n=11)
S/N 0.26% (n=10)
N/S 0.23% (n=9)
D/N 0.15% (n=6)
N/Y 0.05% (n=2)
N/H 0.05% (n=2)
N/D 0.05% (n=2)
C/N 0.03% (n=1)
E/K 0.03% (n=1)
K/G 0.03% (n=1)
Q/N 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 3a (antibodies: [H77.39])

N/N 84.46% (n=2798)
R/N 9.51% (n=315)
Y/N 3.41% (n=113)
E/Q 0.72% (n=24)
H/N 0.39% (n=13)
E/N 0.33% (n=11)
K/N 0.30% (n=10)
N/S 0.21% (n=7)
S/N 0.21% (n=7)
D/N 0.15% (n=5)
N/Y 0.06% (n=2)
N/H 0.06% (n=2)
N/D 0.06% (n=2)
C/N 0.03% (n=1)
E/K 0.03% (n=1)
K/G 0.03% (n=1)
Q/N 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 3b (antibodies: [H77.39])

N/N 97.29% (n=395)
H/N 0.74% (n=3)
E/N 0.74% (n=3)
S/N 0.49% (n=2)
N/S 0.49% (n=2)
Y/N 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 4 (antibodies: [H77.39])

N/N 94.66% (n=727)
H/N 2.21% (n=17)
S/N 1.43% (n=11)
D/N 0.65% (n=5)
Y/N 0.39% (n=3)
N/G 0.39% (n=3)
K/N 0.26% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 4a (antibodies: [H77.39])

N/N 100.00% (n=161)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 4d (antibodies: [H77.39])

N/N 93.36% (n=506)
H/N 2.58% (n=14)
S/N 2.03% (n=11)
D/N 0.74% (n=4)
N/G 0.55% (n=3)
Y/N 0.37% (n=2)
K/N 0.37% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 5 (antibodies: [H77.39])

N/N 83.58% (n=112)
H/N 5.22% (n=7)
S/N 2.24% (n=3)
K/N 2.24% (n=3)
R/N 2.24% (n=3)
N/Q 1.49% (n=2)
N/S 0.75% (n=1)
K/G 0.75% (n=1)
E/N 0.75% (n=1)
Q/G 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 6 (antibodies: [H77.39])

N/N 94.88% (n=556)
K/N 1.54% (n=9)
H/N 1.37% (n=8)
Y/N 0.68% (n=4)
N/S 0.34% (n=2)
K/G 0.17% (n=1)
N/K 0.17% (n=1)
R/N 0.17% (n=1)
C/N 0.17% (n=1)
N/D 0.17% (n=1)
E/N 0.17% (n=1)
S/N 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Subtype 6a (antibodies: [H77.39])

N/N 94.93% (n=318)
K/N 1.49% (n=5)
H/N 1.19% (n=4)
N/S 0.60% (n=2)
Y/N 0.60% (n=2)
K/G 0.30% (n=1)
N/K 0.30% (n=1)
R/N 0.30% (n=1)
C/N 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,417 in HCV Genotype 7 (antibodies: [H77.39])

N/N 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 415,420,421 in HCV Genotype 1 (antibodies: [3/11])

N/WH 97.09% (n=22316)
K/WH 1.12% (n=258)
S/WH 0.80% (n=183)
H/WH 0.24% (n=56)
N/RH 0.15% (n=34)
N/WR 0.10% (n=23)
Y/WH 0.10% (n=22)
D/WH 0.09% (n=20)
N/WY 0.06% (n=13)
N/*H 0.05% (n=11)
N/CH 0.04% (n=9)
N/WL 0.03% (n=6)
N/GH 0.02% (n=5)
R/WH 0.02% (n=5)
E/WH 0.02% (n=4)
N/WD 0.01% (n=3)
T/WH 0.01% (n=3)
N/WQ 0.01% (n=2)
N/SH 0.01% (n=2)
A/WH 0.01% (n=2)
K/RH 0.00% (n=1)
Q/WH 0.00% (n=1)
N/CA 0.00% (n=1)
Y/WR 0.00% (n=1)
G/WH 0.00% (n=1)
N/WG 0.00% (n=1)
H/WD 0.00% (n=1)
N/WN 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 1a (antibodies: [3/11])

N/WH 96.43% (n=13184)
K/WH 1.64% (n=224)
S/WH 1.00% (n=137)
N/RH 0.15% (n=20)
Y/WH 0.13% (n=18)
D/WH 0.12% (n=16)
N/WR 0.10% (n=13)
N/*H 0.07% (n=10)
H/WH 0.07% (n=9)
N/WY 0.06% (n=8)
N/CH 0.06% (n=8)
N/GH 0.04% (n=5)
N/WD 0.02% (n=3)
R/WH 0.02% (n=3)
N/WQ 0.01% (n=2)
N/WL 0.01% (n=2)
N/SH 0.01% (n=2)
A/WH 0.01% (n=2)
K/RH 0.01% (n=1)
Q/WH 0.01% (n=1)
N/CA 0.01% (n=1)
T/WH 0.01% (n=1)
Y/WR 0.01% (n=1)
G/WH 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 1b (antibodies: [3/11])

N/WH 98.11% (n=9094)
H/WH 0.49% (n=45)
S/WH 0.45% (n=42)
K/WH 0.37% (n=34)
N/RH 0.15% (n=14)
N/WR 0.11% (n=10)
N/WY 0.05% (n=5)
Y/WH 0.04% (n=4)
N/WL 0.04% (n=4)
E/WH 0.04% (n=4)
D/WH 0.04% (n=4)
R/WH 0.02% (n=2)
T/WH 0.02% (n=2)
N/WG 0.01% (n=1)
H/WD 0.01% (n=1)
N/CH 0.01% (n=1)
N/*H 0.01% (n=1)
N/WN 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 2 (antibodies: [3/11])

N/WH 72.09% (n=974)
H/WH 20.95% (n=283)
S/WH 3.63% (n=49)
K/WH 1.55% (n=21)
Y/WH 0.74% (n=10)
R/WH 0.37% (n=5)
D/WH 0.22% (n=3)
N/LH 0.22% (n=3)
N/*H 0.07% (n=1)
N/RH 0.07% (n=1)
N/LD 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 2a (antibodies: [3/11])

N/WH 97.27% (n=285)
K/WH 0.68% (n=2)
Y/WH 0.68% (n=2)
D/WH 0.68% (n=2)
S/WH 0.68% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 2b (antibodies: [3/11])

N/WH 81.82% (n=378)
S/WH 9.96% (n=46)
K/WH 3.46% (n=16)
H/WH 3.25% (n=15)
N/LH 0.65% (n=3)
N/*H 0.22% (n=1)
N/RH 0.22% (n=1)
N/LD 0.22% (n=1)
Y/WH 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 2c (antibodies: [3/11])

H/WH 57.80% (n=263)
N/WH 39.34% (n=179)
Y/WH 1.32% (n=6)
R/WH 1.10% (n=5)
K/WH 0.22% (n=1)
S/WH 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 3 (antibodies: [3/11])

N/WH 85.90% (n=3358)
R/WH 8.06% (n=315)
Y/WH 2.94% (n=115)
E/WH 1.00% (n=39)
N/WY 0.82% (n=32)
H/WH 0.41% (n=16)
K/WH 0.31% (n=12)
S/WH 0.26% (n=10)
D/WH 0.15% (n=6)
N/RH 0.05% (n=2)
N/GH 0.03% (n=1)
N/LH 0.03% (n=1)
C/WH 0.03% (n=1)
Q/WH 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 3a (antibodies: [3/11])

N/WH 83.77% (n=2772)
R/WH 9.52% (n=315)
Y/WH 3.41% (n=113)
E/WH 1.09% (n=36)
N/WY 0.97% (n=32)
H/WH 0.39% (n=13)
K/WH 0.33% (n=11)
S/WH 0.21% (n=7)
D/WH 0.15% (n=5)
N/GH 0.03% (n=1)
N/LH 0.03% (n=1)
C/WH 0.03% (n=1)
N/RH 0.03% (n=1)
Q/WH 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 3b (antibodies: [3/11])

N/WH 97.53% (n=395)
H/WH 0.74% (n=3)
E/WH 0.74% (n=3)
S/WH 0.49% (n=2)
Y/WH 0.25% (n=1)
N/RH 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 4 (antibodies: [3/11])

N/WH 94.93% (n=730)
H/WH 2.34% (n=18)
S/WH 1.43% (n=11)
D/WH 0.65% (n=5)
Y/WH 0.39% (n=3)
K/WH 0.26% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 4a (antibodies: [3/11])

N/WH 100.00% (n=161)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 4d (antibodies: [3/11])

N/WH 93.91% (n=509)
H/WH 2.58% (n=14)
S/WH 2.03% (n=11)
D/WH 0.74% (n=4)
Y/WH 0.37% (n=2)
K/WH 0.37% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 5 (antibodies: [3/11])

N/WH 84.96% (n=113)
H/WH 5.26% (n=7)
S/WH 2.26% (n=3)
K/WH 2.26% (n=3)
R/WH 2.26% (n=3)
N/CH 0.75% (n=1)
N/WY 0.75% (n=1)
E/WH 0.75% (n=1)
Q/WH 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 6 (antibodies: [3/11])

N/WH 95.38% (n=558)
K/WH 1.71% (n=10)
H/WH 1.37% (n=8)
Y/WH 0.68% (n=4)
R/WH 0.17% (n=1)
C/WH 0.17% (n=1)
N/RH 0.17% (n=1)
E/WH 0.17% (n=1)
S/WH 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Subtype 6a (antibodies: [3/11])

N/WH 95.52% (n=320)
K/WH 1.79% (n=6)
H/WH 1.19% (n=4)
Y/WH 0.60% (n=2)
R/WH 0.30% (n=1)
C/WH 0.30% (n=1)
N/RH 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 415,420,421 in HCV Genotype 7 (antibodies: [3/11])

N/WH 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 416,418,420,421 in HCV Genotype 1 (antibodies: [Mab24])

T/G/WH 90.31% (n=20752)
S/G/WH 7.05% (n=1619)
A/G/WH 1.28% (n=294)
E/G/WH 0.24% (n=56)
T/N/WH 0.19% (n=44)
T/G/RH 0.13% (n=31)
R/G/WH 0.11% (n=26)
T/G/WR 0.10% (n=22)
T/D/WH 0.06% (n=13)
T/S/WH 0.05% (n=12)
N/G/WH 0.05% (n=12)
T/G/WY 0.05% (n=12)
T/G/*H 0.05% (n=11)
K/G/WH 0.05% (n=11)
P/G/WH 0.04% (n=9)
T/G/CH 0.04% (n=9)
I/G/WH 0.03% (n=8)
T/G/WL 0.03% (n=6)
T/G/GH 0.02% (n=4)
S/G/RH 0.02% (n=4)
T/G/WD 0.01% (n=3)
T/R/WH 0.01% (n=3)
T/G/WQ 0.01% (n=2)
S/G/WR 0.01% (n=2)
T/G/SH 0.01% (n=2)
F/G/WH 0.00% (n=1)
S/G/WY 0.00% (n=1)
T/G/CA 0.00% (n=1)
E/D/WH 0.00% (n=1)
S/G/WD 0.00% (n=1)
A/D/WH 0.00% (n=1)
V/D/WH 0.00% (n=1)
S/G/GH 0.00% (n=1)
S/D/WH 0.00% (n=1)
T/V/WH 0.00% (n=1)
T/A/WG 0.00% (n=1)
T/G/WN 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 1a (antibodies: [Mab24])

T/G/WH 86.22% (n=11784)
S/G/WH 10.06% (n=1375)
A/G/WH 1.88% (n=257)
E/G/WH 0.41% (n=56)
T/N/WH 0.32% (n=44)
R/G/WH 0.18% (n=25)
T/G/RH 0.13% (n=18)
T/G/WR 0.10% (n=13)
K/G/WH 0.08% (n=11)
T/G/*H 0.07% (n=10)
N/G/WH 0.07% (n=9)
T/D/WH 0.06% (n=8)
T/G/CH 0.06% (n=8)
P/G/WH 0.05% (n=7)
T/G/WY 0.05% (n=7)
T/S/WH 0.04% (n=5)
I/G/WH 0.03% (n=4)
T/G/GH 0.03% (n=4)
S/G/RH 0.02% (n=3)
T/G/WQ 0.01% (n=2)
T/G/WL 0.01% (n=2)
T/G/WD 0.01% (n=2)
T/G/SH 0.01% (n=2)
F/G/WH 0.01% (n=1)
S/G/WY 0.01% (n=1)
T/G/CA 0.01% (n=1)
S/G/WR 0.01% (n=1)
E/D/WH 0.01% (n=1)
S/G/WD 0.01% (n=1)
A/D/WH 0.01% (n=1)
V/D/WH 0.01% (n=1)
T/R/WH 0.01% (n=1)
S/G/GH 0.01% (n=1)
S/D/WH 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 1b (antibodies: [Mab24])

T/G/WH 96.37% (n=8932)
S/G/WH 2.55% (n=236)
A/G/WH 0.40% (n=37)
T/G/RH 0.14% (n=13)
T/G/WR 0.10% (n=9)
T/S/WH 0.08% (n=7)
T/G/WY 0.05% (n=5)
T/D/WH 0.05% (n=5)
T/G/WL 0.04% (n=4)
I/G/WH 0.04% (n=4)
N/G/WH 0.03% (n=3)
T/R/WH 0.02% (n=2)
P/G/WH 0.02% (n=2)
T/V/WH 0.01% (n=1)
T/A/WG 0.01% (n=1)
T/G/WD 0.01% (n=1)
T/G/CH 0.01% (n=1)
R/G/WH 0.01% (n=1)
S/G/WR 0.01% (n=1)
T/G/*H 0.01% (n=1)
T/G/WN 0.01% (n=1)
S/G/RH 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 2 (antibodies: [Mab24])

T/G/WH 62.67% (n=846)
S/G/WH 29.19% (n=394)
N/G/WH 6.59% (n=89)
A/G/WH 0.59% (n=8)
T/G/LH 0.22% (n=3)
D/G/WH 0.15% (n=2)
K/G/WH 0.07% (n=1)
T/V/WH 0.07% (n=1)
T/G/*H 0.07% (n=1)
T/S/WH 0.07% (n=1)
T/G/RH 0.07% (n=1)
T/G/LD 0.07% (n=1)
E/G/WH 0.07% (n=1)
P/G/WH 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 2a (antibodies: [Mab24])

T/G/WH 56.36% (n=164)
S/G/WH 41.92% (n=122)
N/G/WH 0.69% (n=2)
A/G/WH 0.69% (n=2)
D/G/WH 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 2b (antibodies: [Mab24])

T/G/WH 92.64% (n=428)
S/G/WH 3.90% (n=18)
A/G/WH 0.65% (n=3)
N/G/WH 0.65% (n=3)
T/G/LH 0.65% (n=3)
K/G/WH 0.22% (n=1)
T/V/WH 0.22% (n=1)
T/G/*H 0.22% (n=1)
T/S/WH 0.22% (n=1)
T/G/RH 0.22% (n=1)
T/G/LD 0.22% (n=1)
E/G/WH 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 2c (antibodies: [Mab24])

S/G/WH 53.19% (n=242)
T/G/WH 27.91% (n=127)
N/G/WH 18.46% (n=84)
A/G/WH 0.22% (n=1)
D/G/WH 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 3 (antibodies: [Mab24])

T/G/WH 83.19% (n=3251)
S/G/WH 14.97% (n=585)
T/G/WY 0.82% (n=32)
A/G/WH 0.59% (n=23)
T/D/WH 0.10% (n=4)
D/G/WH 0.08% (n=3)
N/G/WH 0.05% (n=2)
I/G/WH 0.03% (n=1)
T/G/GH 0.03% (n=1)
T/G/LH 0.03% (n=1)
T/A/WH 0.03% (n=1)
T/G/RH 0.03% (n=1)
T/N/WH 0.03% (n=1)
K/G/WH 0.03% (n=1)
S/G/RH 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 3a (antibodies: [Mab24])

T/G/WH 96.16% (n=3182)
S/G/WH 1.69% (n=56)
T/G/WY 0.97% (n=32)
A/G/WH 0.70% (n=23)
T/D/WH 0.12% (n=4)
D/G/WH 0.09% (n=3)
N/G/WH 0.06% (n=2)
I/G/WH 0.03% (n=1)
T/G/GH 0.03% (n=1)
T/G/LH 0.03% (n=1)
T/A/WH 0.03% (n=1)
T/G/RH 0.03% (n=1)
T/N/WH 0.03% (n=1)
K/G/WH 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 3b (antibodies: [Mab24])

S/G/WH 87.13% (n=352)
T/G/WH 12.62% (n=51)
S/G/RH 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 4 (antibodies: [Mab24])

T/G/WH 85.71% (n=660)
S/G/WH 10.39% (n=80)
K/G/WH 3.77% (n=29)
T/E/WH 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 4a (antibodies: [Mab24])

T/G/WH 41.98% (n=68)
S/G/WH 40.12% (n=65)
K/G/WH 17.90% (n=29)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 4d (antibodies: [Mab24])

T/G/WH 99.63% (n=540)
T/E/WH 0.18% (n=1)
S/G/WH 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 5 (antibodies: [Mab24])

T/G/WH 84.33% (n=113)
S/G/WH 11.19% (n=15)
N/G/WH 1.49% (n=2)
T/G/CH 0.75% (n=1)
T/E/WH 0.75% (n=1)
T/G/WY 0.75% (n=1)
N/S/WH 0.75% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 6 (antibodies: [Mab24])

T/G/WH 80.93% (n=471)
S/G/WH 18.04% (n=105)
N/S/WH 0.17% (n=1)
N/G/WH 0.17% (n=1)
A/G/WH 0.17% (n=1)
K/G/WH 0.17% (n=1)
T/G/RH 0.17% (n=1)
I/G/WH 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Subtype 6a (antibodies: [Mab24])

T/G/WH 92.17% (n=306)
S/G/WH 6.33% (n=21)
N/S/WH 0.30% (n=1)
N/G/WH 0.30% (n=1)
A/G/WH 0.30% (n=1)
K/G/WH 0.30% (n=1)
T/G/RH 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 416,418,420,421 in HCV Genotype 7 (antibodies: [Mab24])

T/G/WH 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 1 (antibodies: [HC84.21])

W/N/W/LFY 43.08% (n=9880)
W/N/F/LFY 37.10% (n=8508)
W/N/W/LLY 10.97% (n=2516)
W/N/W/LIY 3.93% (n=901)
W/N/F/LLY 1.20% (n=276)
W/N/F/LIY 0.88% (n=202)
W/N/F/LFH 0.35% (n=80)
W/N/W/LVY 0.35% (n=80)
W/S/W/LFY 0.28% (n=65)
W/N/W/LMY 0.26% (n=59)
W/N/F/LVY 0.15% (n=34)
W/N/W/LFH 0.14% (n=32)
W/S/F/LFY 0.08% (n=19)
R/N/F/LFY 0.07% (n=15)
R/N/W/LFY 0.06% (n=14)
W/N/F/LSY 0.06% (n=13)
W/N/L/LFY 0.05% (n=12)
W/D/F/LFY 0.05% (n=11)
W/N/S/LFY 0.05% (n=11)
W/S/F/LLY 0.05% (n=11)
W/N/F/PFY 0.04% (n=9)
C/N/W/LLY 0.04% (n=9)
W/N/*/LFY 0.03% (n=8)
W/N/W/LFN 0.03% (n=8)
W/N/W/PFY 0.03% (n=7)
*/N/W/LFY 0.03% (n=7)
W/N/R/LFY 0.03% (n=6)
W/N/W/LFS 0.03% (n=6)
W/N/F/LMY 0.03% (n=6)
W/N/F/LFC 0.03% (n=6)
W/T/W/LFY 0.02% (n=5)
W/N/W/LFC 0.02% (n=5)
W/N/G/LLY 0.02% (n=5)
W/N/G/LFY 0.02% (n=4)
W/N/W/LSY 0.02% (n=4)
G/N/W/LFY 0.01% (n=3)
R/N/W/LLY 0.01% (n=3)
W/N/F/LFN 0.01% (n=3)
W/N/F/LFA 0.01% (n=3)
W/N/W/LPY 0.01% (n=2)
W/I/W/LFY 0.01% (n=2)
W/N/W/LF* 0.01% (n=2)
W/N/W/LIH 0.01% (n=2)
W/S/W/LIY 0.01% (n=2)
W/N/W/LHY 0.01% (n=2)
W/N/W/FLY 0.01% (n=2)
W/N/C/LFY 0.01% (n=2)
W/D/W/LFY 0.01% (n=2)
W/N/W/PLY 0.01% (n=2)
G/N/W/LLY 0.01% (n=2)
W/N/W/LLH 0.01% (n=2)
W/D/W/LLY 0.01% (n=2)
W/N/F/LFS 0.01% (n=2)
W/S/W/LFH 0.01% (n=2)
W/N/W/PFS 0.01% (n=2)
S/N/W/LFY 0.01% (n=2)
W/N/*/LLY 0.01% (n=2)
W/H/W/LFY 0.01% (n=2)
W/N/F/LFF 0.01% (n=2)
W/N/V/LFY 0.01% (n=2)
W/K/F/LFY 0.01% (n=2)
W/K/W/LFY 0.00% (n=1)
W/N/R/LLY 0.00% (n=1)
R/N/W/LLC 0.00% (n=1)
W/K/W/LIY 0.00% (n=1)
W/N/W/FSY 0.00% (n=1)
W/P/W/LFY 0.00% (n=1)
W/N/W/PSY 0.00% (n=1)
W/N/W/AFL 0.00% (n=1)
W/N/R/LIY 0.00% (n=1)
W/N/W/RAS 0.00% (n=1)
W/N/W/LLP 0.00% (n=1)
W/N/W/HFY 0.00% (n=1)
W/N/W/LNY 0.00% (n=1)
W/T/W/LLY 0.00% (n=1)
W/N/W/LTY 0.00% (n=1)
W/N/L/LLY 0.00% (n=1)
W/D/W/LIY 0.00% (n=1)
*/N/W/LIY 0.00% (n=1)
W/N/*/LIY 0.00% (n=1)
W/N/W/PIY 0.00% (n=1)
W/G/W/LFY 0.00% (n=1)
*/S/W/LFY 0.00% (n=1)
W/S/W/LLY 0.00% (n=1)
*/N/W/LLY 0.00% (n=1)
W/N/W/APL 0.00% (n=1)
W/N/W/FFY 0.00% (n=1)
W/N/W/LST 0.00% (n=1)
W/N/W/LLN 0.00% (n=1)
W/A/W/LFY 0.00% (n=1)
W/N/W/LFF 0.00% (n=1)
W/D/F/LLY 0.00% (n=1)
W/E/F/LFY 0.00% (n=1)
W/N/F/VFY 0.00% (n=1)
W/N/F/RFY 0.00% (n=1)
C/N/F/LFY 0.00% (n=1)
W/N/I/LFY 0.00% (n=1)
W/Y/F/LFY 0.00% (n=1)
W/R/F/LIY 0.00% (n=1)
W/R/F/LFY 0.00% (n=1)
*/N/F/LFY 0.00% (n=1)
R/N/L/LFY 0.00% (n=1)
R/S/F/LFY 0.00% (n=1)
W/S/F/LVY 0.00% (n=1)
W/N/F/LFL 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 1a (antibodies: [HC84.21])

W/N/W/LFY 68.11% (n=9287)
W/N/W/LLY 18.42% (n=2512)
W/N/W/LIY 6.61% (n=901)
W/N/F/LFY 2.35% (n=320)
W/N/F/LLY 0.92% (n=125)
W/N/W/LVY 0.59% (n=80)
W/N/F/LFH 0.54% (n=74)
W/S/W/LFY 0.47% (n=64)
W/N/W/LMY 0.43% (n=59)
W/N/W/LFH 0.23% (n=32)
R/N/W/LFY 0.10% (n=14)
C/N/W/LLY 0.07% (n=9)
W/N/*/LFY 0.06% (n=8)
W/N/W/LFN 0.06% (n=8)
W/N/F/LIY 0.06% (n=8)
W/N/W/PFY 0.05% (n=7)
*/N/W/LFY 0.05% (n=7)
W/N/R/LFY 0.04% (n=6)
W/N/W/LFS 0.04% (n=6)
W/T/W/LFY 0.04% (n=5)
W/N/W/LFC 0.04% (n=5)
W/N/G/LLY 0.04% (n=5)
W/N/G/LFY 0.03% (n=4)
W/N/W/LSY 0.03% (n=4)
G/N/W/LFY 0.02% (n=3)
W/N/F/PFY 0.02% (n=3)
R/N/W/LLY 0.02% (n=3)
R/N/F/LFY 0.02% (n=3)
W/N/W/LPY 0.01% (n=2)
W/I/W/LFY 0.01% (n=2)
W/N/W/LF* 0.01% (n=2)
W/N/W/LIH 0.01% (n=2)
W/N/W/LHY 0.01% (n=2)
W/N/W/FLY 0.01% (n=2)
W/N/C/LFY 0.01% (n=2)
W/D/W/LFY 0.01% (n=2)
W/N/W/PLY 0.01% (n=2)
G/N/W/LLY 0.01% (n=2)
W/N/W/LLH 0.01% (n=2)
W/D/W/LLY 0.01% (n=2)
W/N/F/LFS 0.01% (n=2)
W/N/F/LMY 0.01% (n=2)
W/S/W/LFH 0.01% (n=2)
W/N/W/PFS 0.01% (n=2)
S/N/W/LFY 0.01% (n=2)
W/N/L/LFY 0.01% (n=2)
W/N/F/LFC 0.01% (n=2)
W/N/*/LLY 0.01% (n=2)
W/H/W/LFY 0.01% (n=2)
W/K/W/LFY 0.01% (n=1)
W/N/R/LLY 0.01% (n=1)
R/N/W/LLC 0.01% (n=1)
W/K/W/LIY 0.01% (n=1)
W/N/W/FSY 0.01% (n=1)
W/P/W/LFY 0.01% (n=1)
W/N/W/PSY 0.01% (n=1)
W/N/W/AFL 0.01% (n=1)
W/N/R/LIY 0.01% (n=1)
W/S/W/LIY 0.01% (n=1)
W/N/W/RAS 0.01% (n=1)
W/N/W/LLP 0.01% (n=1)
W/N/W/HFY 0.01% (n=1)
W/N/W/LNY 0.01% (n=1)
W/T/W/LLY 0.01% (n=1)
W/N/W/LTY 0.01% (n=1)
W/N/L/LLY 0.01% (n=1)
W/D/F/LFY 0.01% (n=1)
W/D/W/LIY 0.01% (n=1)
*/N/W/LIY 0.01% (n=1)
W/N/*/LIY 0.01% (n=1)
W/N/W/PIY 0.01% (n=1)
W/G/W/LFY 0.01% (n=1)
*/S/W/LFY 0.01% (n=1)
W/S/W/LLY 0.01% (n=1)
*/N/W/LLY 0.01% (n=1)
W/N/W/APL 0.01% (n=1)
W/N/W/FFY 0.01% (n=1)
W/N/W/LST 0.01% (n=1)
W/N/W/LLN 0.01% (n=1)
W/A/W/LFY 0.01% (n=1)
W/N/W/LFF 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 1b (antibodies: [HC84.21])

W/N/F/LFY 88.30% (n=8172)
W/N/W/LFY 6.26% (n=579)
W/N/F/LIY 2.09% (n=193)
W/N/F/LLY 1.58% (n=146)
W/N/F/LVY 0.37% (n=34)
W/S/F/LFY 0.19% (n=18)
W/N/F/LSY 0.14% (n=13)
R/N/F/LFY 0.13% (n=12)
W/N/S/LFY 0.12% (n=11)
W/S/F/LLY 0.12% (n=11)
W/D/F/LFY 0.11% (n=10)
W/N/L/LFY 0.11% (n=10)
W/N/F/PFY 0.06% (n=6)
W/N/F/LFH 0.06% (n=6)
W/N/F/LMY 0.04% (n=4)
W/N/F/LFC 0.04% (n=4)
W/N/F/LFN 0.03% (n=3)
W/N/W/LLY 0.03% (n=3)
W/N/F/LFF 0.02% (n=2)
W/N/V/LFY 0.02% (n=2)
W/K/F/LFY 0.02% (n=2)
W/D/F/LLY 0.01% (n=1)
W/E/F/LFY 0.01% (n=1)
W/N/F/VFY 0.01% (n=1)
W/N/F/RFY 0.01% (n=1)
C/N/F/LFY 0.01% (n=1)
W/S/W/LIY 0.01% (n=1)
W/S/W/LFY 0.01% (n=1)
W/N/I/LFY 0.01% (n=1)
W/Y/F/LFY 0.01% (n=1)
W/R/F/LIY 0.01% (n=1)
W/R/F/LFY 0.01% (n=1)
*/N/F/LFY 0.01% (n=1)
R/N/L/LFY 0.01% (n=1)
R/S/F/LFY 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 2 (antibodies: [HC84.21])

W/N/F/LFY 92.98% (n=1259)
W/N/W/LFY 3.84% (n=52)
W/N/F/LLY 0.37% (n=5)
W/N/F/LFH 0.30% (n=4)
W/N/F/LFF 0.30% (n=4)
W/N/S/LFY 0.30% (n=4)
W/N/L/LFY 0.22% (n=3)
W/N/F/LIY 0.15% (n=2)
W/N/C/LFY 0.15% (n=2)
L/N/F/LFY 0.15% (n=2)
W/K/F/LFH 0.07% (n=1)
W/N/F/PFY 0.07% (n=1)
W/T/F/LVY 0.07% (n=1)
W/N/F/LFR 0.07% (n=1)
W/K/F/LFY 0.07% (n=1)
W/N/F/LVY 0.07% (n=1)
W/D/W/LFY 0.07% (n=1)
L/N/W/LFY 0.07% (n=1)
*/N/W/LFY 0.07% (n=1)
W/N/W/LVY 0.07% (n=1)
W/N/W/LLY 0.07% (n=1)
R/N/F/LFY 0.07% (n=1)
L/D/F/LFY 0.07% (n=1)
W/N/F/LFC 0.07% (n=1)
W/D/F/LFY 0.07% (n=1)
W/N/I/LFY 0.07% (n=1)
W/N/F/LSY 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 2a (antibodies: [HC84.21])

W/N/F/LFY 95.92% (n=282)
W/N/F/LFF 1.36% (n=4)
W/N/F/LFH 0.68% (n=2)
W/N/F/LIY 0.34% (n=1)
W/N/F/PFY 0.34% (n=1)
W/N/W/LFY 0.34% (n=1)
W/N/F/LLY 0.34% (n=1)
W/T/F/LVY 0.34% (n=1)
W/N/F/LFR 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 2b (antibodies: [HC84.21])

W/N/F/LFY 85.93% (n=397)
W/N/W/LFY 10.61% (n=49)
W/N/C/LFY 0.43% (n=2)
L/N/F/LFY 0.43% (n=2)
W/N/F/LLY 0.43% (n=2)
W/K/F/LFY 0.22% (n=1)
W/N/F/LVY 0.22% (n=1)
W/D/W/LFY 0.22% (n=1)
L/N/W/LFY 0.22% (n=1)
*/N/W/LFY 0.22% (n=1)
W/N/W/LVY 0.22% (n=1)
W/N/W/LLY 0.22% (n=1)
W/N/L/LFY 0.22% (n=1)
R/N/F/LFY 0.22% (n=1)
L/D/F/LFY 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 2c (antibodies: [HC84.21])

W/N/F/LFY 97.15% (n=443)
W/N/S/LFY 0.88% (n=4)
W/N/W/LFY 0.44% (n=2)
W/N/F/LFC 0.22% (n=1)
W/N/F/LIY 0.22% (n=1)
W/N/F/LFH 0.22% (n=1)
W/N/F/LLY 0.22% (n=1)
W/D/F/LFY 0.22% (n=1)
W/N/L/LFY 0.22% (n=1)
W/N/I/LFY 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 3 (antibodies: [HC84.21])

W/N/F/LFY 70.75% (n=2741)
W/N/F/LIY 16.03% (n=621)
W/N/F/LLY 3.48% (n=135)
W/S/F/LIY 2.50% (n=97)
W/N/F/LMY 1.70% (n=66)
W/N/F/LFS 1.65% (n=64)
W/N/F/LFH 1.34% (n=52)
W/S/F/LMY 0.77% (n=30)
W/N/F/LVY 0.46% (n=18)
W/S/F/LFY 0.34% (n=13)
W/N/F/LFN 0.28% (n=11)
W/N/L/LFY 0.08% (n=3)
W/N/S/LFY 0.05% (n=2)
W/D/F/LFY 0.05% (n=2)
W/H/F/LFY 0.05% (n=2)
W/N/F/LFR 0.03% (n=1)
W/N/F/MFY 0.03% (n=1)
W/N/F/LFC 0.03% (n=1)
W/N/F/LSY 0.03% (n=1)
W/N/S/LMY 0.03% (n=1)
W/N/S/LLY 0.03% (n=1)
G/N/F/LFY 0.03% (n=1)
L/T/F/LFY 0.03% (n=1)
W/N/S/LIY 0.03% (n=1)
W/N/F/SFY 0.03% (n=1)
R/N/F/LFY 0.03% (n=1)
W/N/F/FDY 0.03% (n=1)
W/N/F/CFY 0.03% (n=1)
W/N/F/LFF 0.03% (n=1)
W/S/F/LLY 0.03% (n=1)
R/S/F/LIY 0.03% (n=1)
W/T/F/LFY 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 3a (antibodies: [HC84.21])

W/N/F/LFY 75.20% (n=2465)
W/N/F/LIY 14.83% (n=486)
W/N/F/LLY 3.48% (n=114)
W/N/F/LFS 1.89% (n=62)
W/N/F/LFH 1.56% (n=51)
W/N/F/LMY 1.56% (n=51)
W/N/F/LVY 0.40% (n=13)
W/N/F/LFN 0.31% (n=10)
W/N/L/LFY 0.09% (n=3)
W/S/F/LFY 0.09% (n=3)
W/N/S/LFY 0.06% (n=2)
W/D/F/LFY 0.06% (n=2)
W/H/F/LFY 0.06% (n=2)
W/N/F/LFR 0.03% (n=1)
W/N/F/MFY 0.03% (n=1)
W/N/F/LFC 0.03% (n=1)
W/N/F/LSY 0.03% (n=1)
W/N/S/LMY 0.03% (n=1)
W/N/S/LLY 0.03% (n=1)
G/N/F/LFY 0.03% (n=1)
L/T/F/LFY 0.03% (n=1)
W/N/S/LIY 0.03% (n=1)
W/N/F/SFY 0.03% (n=1)
R/N/F/LFY 0.03% (n=1)
W/N/F/FDY 0.03% (n=1)
W/N/F/CFY 0.03% (n=1)
W/N/F/LFF 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 3b (antibodies: [HC84.21])

W/N/F/LIY 32.92% (n=132)
W/S/F/LIY 24.19% (n=97)
W/N/F/LFY 22.19% (n=89)
W/S/F/LMY 7.48% (n=30)
W/N/F/LLY 4.74% (n=19)
W/N/F/LMY 2.99% (n=12)
W/S/F/LFY 2.49% (n=10)
W/N/F/LVY 1.25% (n=5)
W/N/F/LFS 0.50% (n=2)
W/N/F/LFN 0.25% (n=1)
W/S/F/LLY 0.25% (n=1)
R/S/F/LIY 0.25% (n=1)
W/T/F/LFY 0.25% (n=1)
W/N/F/LFH 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 4 (antibodies: [HC84.21])

W/N/F/LFY 94.76% (n=724)
W/N/F/LLY 3.27% (n=25)
W/N/W/LFY 0.92% (n=7)
W/N/F/LIY 0.52% (n=4)
W/N/L/LFY 0.13% (n=1)
W/N/F/LFR 0.13% (n=1)
W/S/F/LFY 0.13% (n=1)
W/N/F/LMY 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 4a (antibodies: [HC84.21])

W/N/F/LFY 99.38% (n=161)
W/N/F/LLY 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 4d (antibodies: [HC84.21])

W/N/F/LFY 96.86% (n=525)
W/N/F/LLY 2.77% (n=15)
W/N/L/LFY 0.18% (n=1)
W/N/F/LFR 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 5 (antibodies: [HC84.21])

W/N/F/LMY 35.90% (n=14)
W/N/F/LLY 23.08% (n=9)
W/N/F/LFY 20.51% (n=8)
W/N/F/LIY 17.95% (n=7)
W/N/F/LVY 2.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 6 (antibodies: [HC84.21])

W/N/F/LFY 88.09% (n=503)
W/N/F/LLY 5.25% (n=30)
W/N/F/LIY 2.98% (n=17)
W/N/F/LMY 0.88% (n=5)
W/N/F/LFA 0.53% (n=3)
W/N/F/LFS 0.53% (n=3)
W/S/F/LFY 0.53% (n=3)
W/N/W/LFY 0.35% (n=2)
R/N/F/LFY 0.18% (n=1)
W/N/F/LVY 0.18% (n=1)
W/N/F/LFN 0.18% (n=1)
W/N/F/LFT 0.18% (n=1)
W/N/W/LLY 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Subtype 6a (antibodies: [HC84.21])

W/N/F/LFY 96.99% (n=322)
W/N/F/LIY 1.20% (n=4)
W/N/F/LLY 1.20% (n=4)
R/N/F/LFY 0.30% (n=1)
W/N/F/LMY 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443 in HCV Genotype 7 (antibodies: [HC84.21])

W/N/F/LFY 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 1 (antibodies: [HC84.22])

W/N/W/LFY/W 60.66% (n=4845)
W/N/F/LFY/W 19.32% (n=1543)
W/N/W/LLY/W 13.68% (n=1093)
W/N/W/LIY/W 2.04% (n=163)
W/N/W/LVY/W 0.93% (n=74)
W/N/F/LFH/W 0.88% (n=70)
W/N/F/LIY/W 0.51% (n=41)
W/N/F/LLY/W 0.26% (n=21)
W/N/W/LFH/W 0.18% (n=14)
W/S/W/LFY/W 0.16% (n=13)
W/N/F/LVY/W 0.15% (n=12)
W/N/W/LMY/W 0.10% (n=8)
W/S/F/LFY/W 0.09% (n=7)
R/N/W/LFY/W 0.06% (n=5)
W/N/W/LFS/W 0.05% (n=4)
W/T/W/LFY/W 0.05% (n=4)
W/N/W/LFN/W 0.05% (n=4)
W/N/L/LFY/W 0.05% (n=4)
W/N/W/PFY/W 0.04% (n=3)
W/N/R/LFY/W 0.04% (n=3)
R/N/F/LFY/W 0.04% (n=3)
W/N/F/LSY/W 0.04% (n=3)
W/N/F/LFA/W 0.04% (n=3)
*/N/W/LFY/W 0.03% (n=2)
W/N/F/LFS/W 0.03% (n=2)
W/N/F/LMY/W 0.03% (n=2)
S/N/W/LFY/W 0.03% (n=2)
W/N/F/LFC/W 0.03% (n=2)
W/D/F/LFY/W 0.03% (n=2)
W/N/F/LFF/W 0.03% (n=2)
W/N/S/LFY/W 0.03% (n=2)
W/N/W/HFY/W 0.01% (n=1)
W/N/W/PLY/W 0.01% (n=1)
W/N/W/LNY/W 0.01% (n=1)
W/N/W/LFY/R 0.01% (n=1)
W/N/W/PFS/W 0.01% (n=1)
W/N/W/LIH/W 0.01% (n=1)
W/D/W/LFY/W 0.01% (n=1)
W/N/C/LFY/W 0.01% (n=1)
W/N/W/LFY/G 0.01% (n=1)
R/N/W/LLY/W 0.01% (n=1)
W/N/F/PFY/W 0.01% (n=1)
W/N/F/LFY/R 0.01% (n=1)
W/N/*/LLY/W 0.01% (n=1)
W/N/W/APL/W 0.01% (n=1)
W/N/W/LFY/T 0.01% (n=1)
W/N/W/FFY/W 0.01% (n=1)
W/N/W/LST/W 0.01% (n=1)
G/N/W/LFY/W 0.01% (n=1)
W/A/W/LFY/W 0.01% (n=1)
W/N/W/LFF/W 0.01% (n=1)
W/N/W/LFY/* 0.01% (n=1)
W/N/W/LFC/W 0.01% (n=1)
W/D/F/LLY/W 0.01% (n=1)
W/N/F/LFN/W 0.01% (n=1)
W/N/F/VFY/W 0.01% (n=1)
W/S/W/LIY/W 0.01% (n=1)
W/S/F/LLY/W 0.01% (n=1)
W/Y/F/LFY/W 0.01% (n=1)
R/S/F/LFY/W 0.01% (n=1)
W/S/F/LVY/W 0.01% (n=1)
W/N/F/LFL/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 1a (antibodies: [HC84.22])

W/N/W/LFY/W 72.42% (n=4456)
W/N/W/LLY/W 17.75% (n=1092)
W/N/F/LFY/W 3.02% (n=186)
W/N/W/LIY/W 2.65% (n=163)
W/N/W/LVY/W 1.20% (n=74)
W/N/F/LFH/W 1.12% (n=69)
W/N/W/LFH/W 0.23% (n=14)
W/N/F/LLY/W 0.20% (n=12)
W/S/W/LFY/W 0.20% (n=12)
W/N/W/LMY/W 0.13% (n=8)
W/N/F/LIY/W 0.11% (n=7)
R/N/W/LFY/W 0.08% (n=5)
W/N/W/LFS/W 0.07% (n=4)
W/T/W/LFY/W 0.07% (n=4)
W/N/W/LFN/W 0.07% (n=4)
W/N/W/PFY/W 0.05% (n=3)
W/N/R/LFY/W 0.05% (n=3)
*/N/W/LFY/W 0.03% (n=2)
W/N/F/LFS/W 0.03% (n=2)
W/N/F/LMY/W 0.03% (n=2)
S/N/W/LFY/W 0.03% (n=2)
R/N/F/LFY/W 0.03% (n=2)
W/N/L/LFY/W 0.03% (n=2)
W/N/F/LFC/W 0.03% (n=2)
W/N/W/HFY/W 0.02% (n=1)
W/N/W/PLY/W 0.02% (n=1)
W/N/W/LNY/W 0.02% (n=1)
W/N/W/LFY/R 0.02% (n=1)
W/N/W/PFS/W 0.02% (n=1)
W/N/W/LIH/W 0.02% (n=1)
W/D/W/LFY/W 0.02% (n=1)
W/N/C/LFY/W 0.02% (n=1)
W/N/W/LFY/G 0.02% (n=1)
R/N/W/LLY/W 0.02% (n=1)
W/N/F/PFY/W 0.02% (n=1)
W/N/F/LFY/R 0.02% (n=1)
W/D/F/LFY/W 0.02% (n=1)
W/N/*/LLY/W 0.02% (n=1)
W/N/W/APL/W 0.02% (n=1)
W/N/W/LFY/T 0.02% (n=1)
W/N/W/FFY/W 0.02% (n=1)
W/N/W/LST/W 0.02% (n=1)
G/N/W/LFY/W 0.02% (n=1)
W/A/W/LFY/W 0.02% (n=1)
W/N/W/LFF/W 0.02% (n=1)
W/N/W/LFY/* 0.02% (n=1)
W/N/W/LFC/W 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 1b (antibodies: [HC84.22])

W/N/F/LFY/W 74.45% (n=1343)
W/N/W/LFY/W 21.23% (n=383)
W/N/F/LIY/W 1.83% (n=33)
W/N/F/LVY/W 0.67% (n=12)
W/N/F/LLY/W 0.39% (n=7)
W/S/F/LFY/W 0.33% (n=6)
W/N/F/LSY/W 0.17% (n=3)
W/N/F/LFF/W 0.11% (n=2)
W/N/S/LFY/W 0.11% (n=2)
W/N/L/LFY/W 0.11% (n=2)
W/D/F/LLY/W 0.06% (n=1)
W/N/F/LFN/W 0.06% (n=1)
W/N/F/VFY/W 0.06% (n=1)
W/S/W/LIY/W 0.06% (n=1)
W/N/F/LFH/W 0.06% (n=1)
W/S/F/LLY/W 0.06% (n=1)
W/S/W/LFY/W 0.06% (n=1)
W/Y/F/LFY/W 0.06% (n=1)
R/N/F/LFY/W 0.06% (n=1)
W/D/F/LFY/W 0.06% (n=1)
R/S/F/LFY/W 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 2 (antibodies: [HC84.22])

W/N/F/LFY/W 97.05% (n=461)
W/N/F/LLY/W 0.63% (n=3)
W/N/F/LFY/G 0.42% (n=2)
W/N/C/LFY/W 0.42% (n=2)
W/N/F/LIY/W 0.21% (n=1)
W/N/F/PFY/W 0.21% (n=1)
W/T/F/LVY/W 0.21% (n=1)
W/N/F/LFR/W 0.21% (n=1)
W/K/F/LFY/W 0.21% (n=1)
W/N/F/LVY/W 0.21% (n=1)
W/N/F/LFH/W 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 2a (antibodies: [HC84.22])

W/N/F/LFY/W 92.31% (n=60)
W/N/F/LIY/W 1.54% (n=1)
W/N/F/LFY/G 1.54% (n=1)
W/N/F/PFY/W 1.54% (n=1)
W/T/F/LVY/W 1.54% (n=1)
W/N/F/LFR/W 1.54% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 2b (antibodies: [HC84.22])

W/N/F/LFY/W 98.01% (n=344)
W/N/C/LFY/W 0.57% (n=2)
W/N/F/LLY/W 0.57% (n=2)
W/K/F/LFY/W 0.28% (n=1)
W/N/F/LVY/W 0.28% (n=1)
W/N/F/LFY/G 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 2c (antibodies: [HC84.22])

W/N/F/LFY/W 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 3 (antibodies: [HC84.22])

W/N/F/LFY/W 68.61% (n=1672)
W/N/F/LIY/W 20.76% (n=506)
W/S/F/LIY/W 3.04% (n=74)
W/N/F/LLY/W 2.42% (n=59)
W/N/F/LFH/W 1.40% (n=34)
W/S/F/LMY/W 1.19% (n=29)
W/N/F/LMY/W 0.66% (n=16)
W/N/F/LFN/W 0.37% (n=9)
W/N/F/LVY/W 0.33% (n=8)
W/N/F/LFS/W 0.29% (n=7)
W/S/F/LFY/W 0.21% (n=5)
W/D/F/LFY/W 0.08% (n=2)
W/H/F/LFY/L 0.08% (n=2)
W/N/F/LFR/W 0.04% (n=1)
G/N/F/LFY/W 0.04% (n=1)
L/T/F/LFY/W 0.04% (n=1)
W/N/S/LIY/W 0.04% (n=1)
W/N/F/LFY/R 0.04% (n=1)
W/N/F/SFY/W 0.04% (n=1)
R/N/F/LFY/W 0.04% (n=1)
W/N/L/LFY/W 0.04% (n=1)
W/N/F/LFY/C 0.04% (n=1)
W/N/F/FDY/W 0.04% (n=1)
W/N/F/CFY/W 0.04% (n=1)
W/N/F/LFH/* 0.04% (n=1)
W/N/S/LFY/W 0.04% (n=1)
W/N/F/LFF/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 3a (antibodies: [HC84.22])

W/N/F/LFY/W 73.44% (n=1659)
W/N/F/LIY/W 20.45% (n=462)
W/N/F/LLY/W 2.26% (n=51)
W/N/F/LFH/W 1.51% (n=34)
W/N/F/LMY/W 0.44% (n=10)
W/N/F/LFN/W 0.40% (n=9)
W/N/F/LVY/W 0.35% (n=8)
W/N/F/LFS/W 0.31% (n=7)
W/D/F/LFY/W 0.09% (n=2)
W/H/F/LFY/L 0.09% (n=2)
W/N/F/LFR/W 0.04% (n=1)
G/N/F/LFY/W 0.04% (n=1)
L/T/F/LFY/W 0.04% (n=1)
W/N/S/LIY/W 0.04% (n=1)
W/N/F/LFY/R 0.04% (n=1)
W/N/F/SFY/W 0.04% (n=1)
R/N/F/LFY/W 0.04% (n=1)
W/S/F/LFY/W 0.04% (n=1)
W/N/L/LFY/W 0.04% (n=1)
W/N/F/LFY/C 0.04% (n=1)
W/N/F/FDY/W 0.04% (n=1)
W/N/F/CFY/W 0.04% (n=1)
W/N/F/LFH/* 0.04% (n=1)
W/N/S/LFY/W 0.04% (n=1)
W/N/F/LFF/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 3b (antibodies: [HC84.22])

W/S/F/LIY/W 46.25% (n=74)
W/N/F/LIY/W 25.63% (n=41)
W/S/F/LMY/W 18.13% (n=29)
W/N/F/LLY/W 3.75% (n=6)
W/S/F/LFY/W 2.50% (n=4)
W/N/F/LFY/W 1.88% (n=3)
W/N/F/LMY/W 1.88% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 4 (antibodies: [HC84.22])

W/N/F/LFY/W 87.32% (n=179)
W/N/F/LLY/W 5.37% (n=11)
W/N/W/LFY/W 3.41% (n=7)
W/N/F/LIY/W 1.95% (n=4)
W/N/F/LFY/V 0.49% (n=1)
W/N/L/LFY/W 0.49% (n=1)
W/S/F/LFY/W 0.49% (n=1)
W/N/F/LMY/W 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 4a (antibodies: [HC84.22])

W/N/F/LFY/W 98.48% (n=130)
W/N/F/LFY/V 0.76% (n=1)
W/N/F/LLY/W 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 4d (antibodies: [HC84.22])

W/N/F/LFY/W 84.62% (n=11)
W/N/L/LFY/W 7.69% (n=1)
W/N/F/LLY/W 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 5 (antibodies: [HC84.22])

W/N/F/LMY/W 35.14% (n=13)
W/N/F/LLY/W 24.32% (n=9)
W/N/F/LFY/W 18.92% (n=7)
W/N/F/LIY/W 18.92% (n=7)
W/N/F/LVY/W 2.70% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 6 (antibodies: [HC84.22])

W/N/F/LFY/W 81.36% (n=179)
W/N/F/LLY/W 7.73% (n=17)
W/N/F/LIY/W 3.64% (n=8)
W/N/F/LMY/W 1.36% (n=3)
W/N/F/LFA/W 1.36% (n=3)
W/S/F/LFY/W 1.36% (n=3)
W/N/W/LFY/W 0.91% (n=2)
R/N/F/LFY/W 0.45% (n=1)
W/N/F/LFS/W 0.45% (n=1)
W/N/F/LVY/W 0.45% (n=1)
W/N/F/LFT/W 0.45% (n=1)
W/N/W/LLY/W 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Subtype 6a (antibodies: [HC84.22])

W/N/F/LFY/W 97.03% (n=98)
R/N/F/LFY/W 0.99% (n=1)
W/N/F/LLY/W 0.99% (n=1)
W/N/F/LMY/W 0.99% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 420,428,437,441,442,443,616 in HCV Genotype 7 (antibodies: [HC84.22])

W/N/F/LFY/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 1 (antibodies: [AR3A])

R/G/P/G/D/N 74.31% (n=7534)
S/G/P/G/D/N 23.57% (n=2390)
S/G/P/G/D/T 0.95% (n=96)
R/G/P/G/G/N 0.10% (n=10)
S/G/P/G/D/D 0.10% (n=10)
R/G/P/G/D/K 0.08% (n=8)
R/G/A/G/D/N 0.07% (n=7)
S/G/S/G/D/N 0.05% (n=5)
R/G/P/G/D/T 0.04% (n=4)
G/G/P/G/D/N 0.04% (n=4)
R/G/L/G/D/N 0.04% (n=4)
R/G/P/G/D/D 0.03% (n=3)
C/G/P/G/D/N 0.03% (n=3)
S/E/P/G/D/N 0.03% (n=3)
R/D/P/G/D/N 0.03% (n=3)
R/G/P/G/D/S 0.03% (n=3)
T/G/P/G/D/N 0.03% (n=3)
R/S/P/G/D/N 0.03% (n=3)
R/G/P/G/N/N 0.03% (n=3)
S/G/P/G/N/N 0.02% (n=2)
S/G/P/G/Y/N 0.02% (n=2)
R/G/P/V/D/N 0.02% (n=2)
Q/G/P/G/D/N 0.02% (n=2)
S/G/A/G/D/N 0.02% (n=2)
N/G/P/G/D/N 0.02% (n=2)
R/G/A/G/G/N 0.02% (n=2)
L/G/P/G/D/N 0.02% (n=2)
R/G/P/S/D/N 0.02% (n=2)
R/G/R/G/D/N 0.02% (n=2)
R/G/S/G/D/N 0.02% (n=2)
S/D/P/G/D/N 0.01% (n=1)
R/G/P/G/V/N 0.01% (n=1)
R/G/P/C/G/N 0.01% (n=1)
S/C/P/G/D/K 0.01% (n=1)
S/E/P/G/G/N 0.01% (n=1)
R/N/P/G/D/N 0.01% (n=1)
S/R/P/G/D/N 0.01% (n=1)
S/G/P/G/D/K 0.01% (n=1)
S/G/P/G/G/N 0.01% (n=1)
S/G/L/G/D/N 0.01% (n=1)
R/G/P/G/A/N 0.01% (n=1)
S/G/P/G/D/I 0.01% (n=1)
H/G/P/G/D/N 0.01% (n=1)
R/G/P/G/D/Y 0.01% (n=1)
R/G/P/R/D/N 0.01% (n=1)
R/G/P/R/D/K 0.01% (n=1)
R/G/P/G/C/N 0.01% (n=1)
R/G/P/E/D/N 0.01% (n=1)
E/G/P/G/D/N 0.01% (n=1)
R/S/R/G/D/N 0.01% (n=1)
K/G/P/G/D/N 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 1a (antibodies: [AR3A])

R/G/P/G/D/N 64.98% (n=4712)
S/G/P/G/D/N 32.64% (n=2367)
S/G/P/G/D/T 1.32% (n=96)
S/G/P/G/D/D 0.14% (n=10)
R/G/A/G/D/N 0.08% (n=6)
S/G/S/G/D/N 0.07% (n=5)
R/G/P/G/G/N 0.06% (n=4)
R/G/L/G/D/N 0.06% (n=4)
C/G/P/G/D/N 0.04% (n=3)
S/E/P/G/D/N 0.04% (n=3)
T/G/P/G/D/N 0.04% (n=3)
S/G/P/G/N/N 0.03% (n=2)
S/G/P/G/Y/N 0.03% (n=2)
R/G/P/V/D/N 0.03% (n=2)
Q/G/P/G/D/N 0.03% (n=2)
S/G/A/G/D/N 0.03% (n=2)
N/G/P/G/D/N 0.03% (n=2)
R/G/A/G/G/N 0.03% (n=2)
L/G/P/G/D/N 0.03% (n=2)
R/G/P/S/D/N 0.03% (n=2)
R/S/P/G/D/N 0.03% (n=2)
S/D/P/G/D/N 0.01% (n=1)
R/G/P/G/V/N 0.01% (n=1)
R/G/P/C/G/N 0.01% (n=1)
R/G/P/G/D/D 0.01% (n=1)
S/C/P/G/D/K 0.01% (n=1)
S/E/P/G/G/N 0.01% (n=1)
R/D/P/G/D/N 0.01% (n=1)
R/G/P/G/D/T 0.01% (n=1)
G/G/P/G/D/N 0.01% (n=1)
R/N/P/G/D/N 0.01% (n=1)
S/R/P/G/D/N 0.01% (n=1)
S/G/P/G/D/K 0.01% (n=1)
S/G/P/G/G/N 0.01% (n=1)
S/G/L/G/D/N 0.01% (n=1)
R/G/P/G/A/N 0.01% (n=1)
R/G/P/G/D/S 0.01% (n=1)
S/G/P/G/D/I 0.01% (n=1)
H/G/P/G/D/N 0.01% (n=1)
R/G/P/G/D/Y 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 1b (antibodies: [AR3A])

R/G/P/G/D/N 97.79% (n=2790)
S/G/P/G/D/N 0.74% (n=21)
R/G/P/G/D/K 0.28% (n=8)
R/G/P/G/G/N 0.21% (n=6)
R/G/P/G/N/N 0.11% (n=3)
G/G/P/G/D/N 0.11% (n=3)
R/G/P/G/D/T 0.11% (n=3)
R/G/R/G/D/N 0.07% (n=2)
R/G/P/G/D/S 0.07% (n=2)
R/G/S/G/D/N 0.07% (n=2)
R/G/P/G/D/D 0.07% (n=2)
R/D/P/G/D/N 0.07% (n=2)
R/G/P/R/D/N 0.04% (n=1)
R/G/P/R/D/K 0.04% (n=1)
R/S/P/G/D/N 0.04% (n=1)
R/G/P/G/C/N 0.04% (n=1)
R/G/P/E/D/N 0.04% (n=1)
R/G/A/G/D/N 0.04% (n=1)
E/G/P/G/D/N 0.04% (n=1)
R/S/R/G/D/N 0.04% (n=1)
K/G/P/G/D/N 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 2 (antibodies: [AR3A])

R/G/P/G/D/N 96.97% (n=512)
R/G/P/E/D/N 1.33% (n=7)
S/E/P/G/D/N 0.19% (n=1)
R/G/P/G/N/N 0.19% (n=1)
R/G/P/G/D/K 0.19% (n=1)
R/G/P/G/D/G 0.19% (n=1)
S/G/P/G/D/N 0.19% (n=1)
R/G/P/R/D/N 0.19% (n=1)
R/G/P/G/D/S 0.19% (n=1)
R/G/A/G/D/N 0.19% (n=1)
R/R/P/G/D/N 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 2a (antibodies: [AR3A])

R/G/P/G/D/N 85.53% (n=65)
R/G/P/E/D/N 7.89% (n=6)
S/E/P/G/D/N 1.32% (n=1)
R/G/P/G/N/N 1.32% (n=1)
R/G/P/G/D/K 1.32% (n=1)
R/G/P/G/D/G 1.32% (n=1)
S/G/P/G/D/N 1.32% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 2b (antibodies: [AR3A])

R/G/P/G/D/N 99.15% (n=348)
R/G/P/R/D/N 0.28% (n=1)
R/G/P/G/D/S 0.28% (n=1)
R/G/A/G/D/N 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 2c (antibodies: [AR3A])

R/G/P/G/D/N 98.44% (n=63)
R/G/P/E/D/N 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 3 (antibodies: [AR3A])

R/G/P/G/D/E 24.85% (n=686)
R/G/P/G/D/K 14.23% (n=393)
S/G/P/G/D/E 12.64% (n=349)
S/G/P/G/D/K 12.10% (n=334)
S/G/P/G/D/R 11.70% (n=323)
S/G/P/G/D/T 9.05% (n=250)
S/G/P/G/D/N 2.32% (n=64)
R/G/P/G/D/D 1.81% (n=50)
R/G/P/G/D/Q 1.56% (n=43)
R/G/P/G/D/N 1.45% (n=40)
R/G/P/G/D/G 1.30% (n=36)
R/G/P/G/D/T 1.30% (n=36)
S/G/P/G/D/G 1.01% (n=28)
S/G/P/G/D/D 0.94% (n=26)
S/G/P/G/D/Q 0.58% (n=16)
S/G/P/G/D/S 0.47% (n=13)
R/G/P/G/D/R 0.40% (n=11)
R/G/P/G/D/A 0.36% (n=10)
S/G/P/G/D/A 0.33% (n=9)
R/G/P/G/D/S 0.25% (n=7)
S/G/P/G/D/P 0.14% (n=4)
T/G/P/G/D/T 0.11% (n=3)
R/G/S/G/D/K 0.07% (n=2)
S/G/P/S/D/E 0.07% (n=2)
R/G/P/G/D/H 0.07% (n=2)
R/G/P/D/D/N 0.04% (n=1)
G/G/P/G/D/N 0.04% (n=1)
W/G/S/G/D/K 0.04% (n=1)
S/G/P/S/D/K 0.04% (n=1)
G/G/P/G/D/E 0.04% (n=1)
R/G/P/S/D/G 0.04% (n=1)
R/G/S/G/D/G 0.04% (n=1)
R/G/P/G/G/E 0.04% (n=1)
R/G/P/G/E/N 0.04% (n=1)
R/G/P/S/D/T 0.04% (n=1)
R/G/P/G/N/T 0.04% (n=1)
R/G/P/S/E/L 0.04% (n=1)
R/G/P/G/E/Q 0.04% (n=1)
S/G/P/N/D/N 0.04% (n=1)
S/G/P/G/D/H 0.04% (n=1)
G/G/P/G/D/K 0.04% (n=1)
R/G/A/G/D/E 0.04% (n=1)
R/G/S/G/A/R 0.04% (n=1)
S/G/Q/G/D/Q 0.04% (n=1)
R/G/A/G/D/K 0.04% (n=1)
S/G/L/G/D/Q 0.04% (n=1)
Q/G/P/G/D/E 0.04% (n=1)
R/G/A/G/D/G 0.04% (n=1)
T/G/P/G/D/N 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 3a (antibodies: [AR3A])

R/G/P/G/D/E 28.48% (n=682)
R/G/P/G/D/K 16.33% (n=391)
S/G/P/G/D/E 14.45% (n=346)
S/G/P/G/D/R 13.40% (n=321)
S/G/P/G/D/K 13.07% (n=313)
R/G/P/G/D/D 2.05% (n=49)
R/G/P/G/D/Q 1.80% (n=43)
R/G/P/G/D/N 1.54% (n=37)
R/G/P/G/D/G 1.50% (n=36)
R/G/P/G/D/T 1.34% (n=32)
S/G/P/G/D/G 1.13% (n=27)
S/G/P/G/D/T 0.96% (n=23)
S/G/P/G/D/Q 0.67% (n=16)
R/G/P/G/D/R 0.46% (n=11)
S/G/P/G/D/N 0.42% (n=10)
S/G/P/G/D/D 0.42% (n=10)
R/G/P/G/D/A 0.38% (n=9)
S/G/P/G/D/A 0.25% (n=6)
R/G/S/G/D/K 0.08% (n=2)
S/G/P/S/D/E 0.08% (n=2)
S/G/P/G/D/S 0.08% (n=2)
R/G/P/G/D/H 0.08% (n=2)
R/G/P/D/D/N 0.04% (n=1)
G/G/P/G/D/N 0.04% (n=1)
W/G/S/G/D/K 0.04% (n=1)
S/G/P/S/D/K 0.04% (n=1)
G/G/P/G/D/E 0.04% (n=1)
R/G/P/S/D/G 0.04% (n=1)
R/G/S/G/D/G 0.04% (n=1)
R/G/P/G/G/E 0.04% (n=1)
R/G/P/G/E/N 0.04% (n=1)
R/G/P/S/D/T 0.04% (n=1)
R/G/P/G/N/T 0.04% (n=1)
R/G/P/S/E/L 0.04% (n=1)
R/G/P/G/E/Q 0.04% (n=1)
S/G/P/N/D/N 0.04% (n=1)
S/G/P/G/D/H 0.04% (n=1)
G/G/P/G/D/K 0.04% (n=1)
R/G/A/G/D/E 0.04% (n=1)
R/G/S/G/A/R 0.04% (n=1)
S/G/P/G/D/P 0.04% (n=1)
S/G/Q/G/D/Q 0.04% (n=1)
R/G/A/G/D/K 0.04% (n=1)
S/G/L/G/D/Q 0.04% (n=1)
Q/G/P/G/D/E 0.04% (n=1)
R/G/A/G/D/G 0.04% (n=1)
R/G/P/G/D/S 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 3b (antibodies: [AR3A])

S/G/P/G/D/T 65.23% (n=227)
S/G/P/G/D/N 15.52% (n=54)
S/G/P/G/D/K 6.03% (n=21)
S/G/P/G/D/D 4.31% (n=15)
S/G/P/G/D/S 3.16% (n=11)
R/G/P/G/D/N 0.86% (n=3)
S/G/P/G/D/A 0.86% (n=3)
T/G/P/G/D/T 0.86% (n=3)
S/G/P/G/D/P 0.86% (n=3)
S/G/P/G/D/E 0.57% (n=2)
S/G/P/G/D/R 0.57% (n=2)
R/G/P/G/D/T 0.29% (n=1)
R/G/P/G/D/D 0.29% (n=1)
S/G/P/G/D/G 0.29% (n=1)
T/G/P/G/D/N 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 4 (antibodies: [AR3A])

R/G/P/G/D/N 98.06% (n=202)
G/G/P/G/D/N 0.49% (n=1)
R/G/P/G/D/G 0.49% (n=1)
R/G/P/G/N/N 0.49% (n=1)
S/G/P/G/D/N 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 4a (antibodies: [AR3A])

R/G/P/G/D/N 99.24% (n=131)
G/G/P/G/D/N 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 4d (antibodies: [AR3A])

R/G/P/G/D/N 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 5 (antibodies: [AR3A])

R/G/P/G/D/N 92.11% (n=35)
S/G/P/G/D/N 7.89% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 6 (antibodies: [AR3A])

R/G/P/G/D/E 50.83% (n=183)
R/G/P/G/D/Q 29.72% (n=107)
R/G/P/G/D/A 3.61% (n=13)
R/G/P/G/D/G 2.78% (n=10)
R/G/P/G/D/S 2.78% (n=10)
R/G/P/G/D/T 2.50% (n=9)
R/G/P/G/D/R 2.22% (n=8)
R/G/P/G/D/D 1.67% (n=6)
R/G/P/G/D/K 0.56% (n=2)
R/G/P/G/D/H 0.56% (n=2)
R/G/P/G/D/Y 0.56% (n=2)
R/G/P/G/D/N 0.56% (n=2)
S/G/P/G/D/S 0.28% (n=1)
S/G/P/G/D/Q 0.28% (n=1)
S/G/P/G/D/A 0.28% (n=1)
R/G/P/G/D/M 0.28% (n=1)
R/G/A/G/D/Q 0.28% (n=1)
R/G/A/G/D/E 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Subtype 6a (antibodies: [AR3A])

R/G/P/G/D/E 88.71% (n=110)
R/G/P/G/D/G 4.84% (n=6)
R/G/P/G/D/D 4.03% (n=5)
R/G/P/G/D/Q 0.81% (n=1)
R/G/P/G/D/A 0.81% (n=1)
R/G/P/G/D/K 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,523,525,530,535,540 in HCV Genotype 7 (antibodies: [AR3A])

R/G/P/G/D/N 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 1 (antibodies: [AR3C])

R/P/G/D/N 74.38% (n=7542)
S/P/G/D/N 23.62% (n=2395)
S/P/G/D/T 0.95% (n=96)
R/P/G/G/N 0.10% (n=10)
S/P/G/D/D 0.10% (n=10)
R/P/G/D/K 0.08% (n=8)
R/A/G/D/N 0.07% (n=7)
S/S/G/D/N 0.05% (n=5)
R/P/G/D/T 0.04% (n=4)
G/P/G/D/N 0.04% (n=4)
R/L/G/D/N 0.04% (n=4)
R/P/G/D/D 0.03% (n=3)
C/P/G/D/N 0.03% (n=3)
R/P/G/D/S 0.03% (n=3)
T/P/G/D/N 0.03% (n=3)
R/R/G/D/N 0.03% (n=3)
R/P/G/N/N 0.03% (n=3)
S/P/G/N/N 0.02% (n=2)
S/P/G/Y/N 0.02% (n=2)
S/P/G/D/K 0.02% (n=2)
S/P/G/G/N 0.02% (n=2)
R/P/V/D/N 0.02% (n=2)
Q/P/G/D/N 0.02% (n=2)
S/A/G/D/N 0.02% (n=2)
N/P/G/D/N 0.02% (n=2)
R/A/G/G/N 0.02% (n=2)
L/P/G/D/N 0.02% (n=2)
R/P/S/D/N 0.02% (n=2)
R/S/G/D/N 0.02% (n=2)
R/P/G/V/N 0.01% (n=1)
R/P/C/G/N 0.01% (n=1)
S/L/G/D/N 0.01% (n=1)
R/P/G/A/N 0.01% (n=1)
S/P/G/D/I 0.01% (n=1)
H/P/G/D/N 0.01% (n=1)
R/P/G/D/Y 0.01% (n=1)
R/P/R/D/N 0.01% (n=1)
R/P/R/D/K 0.01% (n=1)
R/P/G/C/N 0.01% (n=1)
R/P/E/D/N 0.01% (n=1)
E/P/G/D/N 0.01% (n=1)
K/P/G/D/N 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 1a (antibodies: [AR3C])

R/P/G/D/N 65.03% (n=4716)
S/P/G/D/N 32.71% (n=2372)
S/P/G/D/T 1.32% (n=96)
S/P/G/D/D 0.14% (n=10)
R/A/G/D/N 0.08% (n=6)
S/S/G/D/N 0.07% (n=5)
R/P/G/G/N 0.06% (n=4)
R/L/G/D/N 0.06% (n=4)
C/P/G/D/N 0.04% (n=3)
T/P/G/D/N 0.04% (n=3)
S/P/G/N/N 0.03% (n=2)
S/P/G/Y/N 0.03% (n=2)
S/P/G/D/K 0.03% (n=2)
S/P/G/G/N 0.03% (n=2)
R/P/V/D/N 0.03% (n=2)
Q/P/G/D/N 0.03% (n=2)
S/A/G/D/N 0.03% (n=2)
N/P/G/D/N 0.03% (n=2)
R/A/G/G/N 0.03% (n=2)
L/P/G/D/N 0.03% (n=2)
R/P/S/D/N 0.03% (n=2)
R/P/G/V/N 0.01% (n=1)
R/P/C/G/N 0.01% (n=1)
R/P/G/D/D 0.01% (n=1)
R/P/G/D/T 0.01% (n=1)
G/P/G/D/N 0.01% (n=1)
S/L/G/D/N 0.01% (n=1)
R/P/G/A/N 0.01% (n=1)
R/P/G/D/S 0.01% (n=1)
S/P/G/D/I 0.01% (n=1)
H/P/G/D/N 0.01% (n=1)
R/P/G/D/Y 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 1b (antibodies: [AR3C])

R/P/G/D/N 97.90% (n=2794)
S/P/G/D/N 0.74% (n=21)
R/P/G/D/K 0.28% (n=8)
R/P/G/G/N 0.21% (n=6)
R/R/G/D/N 0.11% (n=3)
R/P/G/N/N 0.11% (n=3)
G/P/G/D/N 0.11% (n=3)
R/P/G/D/T 0.11% (n=3)
R/P/G/D/S 0.07% (n=2)
R/S/G/D/N 0.07% (n=2)
R/P/G/D/D 0.07% (n=2)
R/P/R/D/N 0.04% (n=1)
R/P/R/D/K 0.04% (n=1)
R/P/G/C/N 0.04% (n=1)
R/P/E/D/N 0.04% (n=1)
R/A/G/D/N 0.04% (n=1)
E/P/G/D/N 0.04% (n=1)
K/P/G/D/N 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 2 (antibodies: [AR3C])

R/P/G/D/N 97.16% (n=513)
R/P/E/D/N 1.33% (n=7)
S/P/G/D/N 0.38% (n=2)
R/P/G/N/N 0.19% (n=1)
R/P/G/D/K 0.19% (n=1)
R/P/G/D/G 0.19% (n=1)
R/P/R/D/N 0.19% (n=1)
R/P/G/D/S 0.19% (n=1)
R/A/G/D/N 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 2a (antibodies: [AR3C])

R/P/G/D/N 85.53% (n=65)
R/P/E/D/N 7.89% (n=6)
S/P/G/D/N 2.63% (n=2)
R/P/G/N/N 1.32% (n=1)
R/P/G/D/K 1.32% (n=1)
R/P/G/D/G 1.32% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 2b (antibodies: [AR3C])

R/P/G/D/N 99.15% (n=348)
R/P/R/D/N 0.28% (n=1)
R/P/G/D/S 0.28% (n=1)
R/A/G/D/N 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 2c (antibodies: [AR3C])

R/P/G/D/N 98.44% (n=63)
R/P/E/D/N 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 3 (antibodies: [AR3C])

R/P/G/D/E 24.84% (n=686)
R/P/G/D/K 14.23% (n=393)
S/P/G/D/E 12.64% (n=349)
S/P/G/D/K 12.09% (n=334)
S/P/G/D/R 11.69% (n=323)
S/P/G/D/T 9.05% (n=250)
S/P/G/D/N 2.35% (n=65)
R/P/G/D/D 1.81% (n=50)
R/P/G/D/Q 1.56% (n=43)
R/P/G/D/N 1.45% (n=40)
R/P/G/D/G 1.30% (n=36)
R/P/G/D/T 1.30% (n=36)
S/P/G/D/G 1.01% (n=28)
S/P/G/D/D 0.94% (n=26)
S/P/G/D/Q 0.58% (n=16)
S/P/G/D/S 0.47% (n=13)
R/P/G/D/R 0.40% (n=11)
R/P/G/D/A 0.36% (n=10)
S/P/G/D/A 0.33% (n=9)
R/P/G/D/S 0.25% (n=7)
S/P/G/D/P 0.14% (n=4)
T/P/G/D/T 0.11% (n=3)
R/S/G/D/K 0.07% (n=2)
S/P/S/D/E 0.07% (n=2)
R/P/G/D/H 0.07% (n=2)
R/P/D/D/N 0.04% (n=1)
G/P/G/D/N 0.04% (n=1)
W/S/G/D/K 0.04% (n=1)
S/P/S/D/K 0.04% (n=1)
G/P/G/D/E 0.04% (n=1)
R/P/S/D/G 0.04% (n=1)
R/S/G/D/G 0.04% (n=1)
R/P/G/G/E 0.04% (n=1)
R/P/G/E/N 0.04% (n=1)
R/P/S/D/T 0.04% (n=1)
R/P/G/N/T 0.04% (n=1)
R/P/S/E/L 0.04% (n=1)
R/P/G/E/Q 0.04% (n=1)
S/P/N/D/N 0.04% (n=1)
S/P/G/D/H 0.04% (n=1)
G/P/G/D/K 0.04% (n=1)
R/A/G/D/E 0.04% (n=1)
R/S/G/A/R 0.04% (n=1)
S/Q/G/D/Q 0.04% (n=1)
R/A/G/D/K 0.04% (n=1)
S/L/G/D/Q 0.04% (n=1)
Q/P/G/D/E 0.04% (n=1)
R/A/G/D/G 0.04% (n=1)
T/P/G/D/N 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 3a (antibodies: [AR3C])

R/P/G/D/E 28.48% (n=682)
R/P/G/D/K 16.33% (n=391)
S/P/G/D/E 14.45% (n=346)
S/P/G/D/R 13.40% (n=321)
S/P/G/D/K 13.07% (n=313)
R/P/G/D/D 2.05% (n=49)
R/P/G/D/Q 1.80% (n=43)
R/P/G/D/N 1.54% (n=37)
R/P/G/D/G 1.50% (n=36)
R/P/G/D/T 1.34% (n=32)
S/P/G/D/G 1.13% (n=27)
S/P/G/D/T 0.96% (n=23)
S/P/G/D/Q 0.67% (n=16)
R/P/G/D/R 0.46% (n=11)
S/P/G/D/N 0.42% (n=10)
S/P/G/D/D 0.42% (n=10)
R/P/G/D/A 0.38% (n=9)
S/P/G/D/A 0.25% (n=6)
R/S/G/D/K 0.08% (n=2)
S/P/S/D/E 0.08% (n=2)
S/P/G/D/S 0.08% (n=2)
R/P/G/D/H 0.08% (n=2)
R/P/D/D/N 0.04% (n=1)
G/P/G/D/N 0.04% (n=1)
W/S/G/D/K 0.04% (n=1)
S/P/S/D/K 0.04% (n=1)
G/P/G/D/E 0.04% (n=1)
R/P/S/D/G 0.04% (n=1)
R/S/G/D/G 0.04% (n=1)
R/P/G/G/E 0.04% (n=1)
R/P/G/E/N 0.04% (n=1)
R/P/S/D/T 0.04% (n=1)
R/P/G/N/T 0.04% (n=1)
R/P/S/E/L 0.04% (n=1)
R/P/G/E/Q 0.04% (n=1)
S/P/N/D/N 0.04% (n=1)
S/P/G/D/H 0.04% (n=1)
G/P/G/D/K 0.04% (n=1)
R/A/G/D/E 0.04% (n=1)
R/S/G/A/R 0.04% (n=1)
S/P/G/D/P 0.04% (n=1)
S/Q/G/D/Q 0.04% (n=1)
R/A/G/D/K 0.04% (n=1)
S/L/G/D/Q 0.04% (n=1)
Q/P/G/D/E 0.04% (n=1)
R/A/G/D/G 0.04% (n=1)
R/P/G/D/S 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 3b (antibodies: [AR3C])

S/P/G/D/T 65.04% (n=227)
S/P/G/D/N 15.76% (n=55)
S/P/G/D/K 6.02% (n=21)
S/P/G/D/D 4.30% (n=15)
S/P/G/D/S 3.15% (n=11)
R/P/G/D/N 0.86% (n=3)
S/P/G/D/A 0.86% (n=3)
T/P/G/D/T 0.86% (n=3)
S/P/G/D/P 0.86% (n=3)
S/P/G/D/E 0.57% (n=2)
S/P/G/D/R 0.57% (n=2)
R/P/G/D/T 0.29% (n=1)
R/P/G/D/D 0.29% (n=1)
S/P/G/D/G 0.29% (n=1)
T/P/G/D/N 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 4 (antibodies: [AR3C])

R/P/G/D/N 98.06% (n=202)
G/P/G/D/N 0.49% (n=1)
R/P/G/D/G 0.49% (n=1)
R/P/G/N/N 0.49% (n=1)
S/P/G/D/N 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 4a (antibodies: [AR3C])

R/P/G/D/N 99.24% (n=131)
G/P/G/D/N 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 4d (antibodies: [AR3C])

R/P/G/D/N 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 5 (antibodies: [AR3C])

R/P/G/D/N 92.11% (n=35)
S/P/G/D/N 7.89% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 6 (antibodies: [AR3C])

R/P/G/D/E 50.83% (n=183)
R/P/G/D/Q 29.72% (n=107)
R/P/G/D/A 3.61% (n=13)
R/P/G/D/G 2.78% (n=10)
R/P/G/D/S 2.78% (n=10)
R/P/G/D/T 2.50% (n=9)
R/P/G/D/R 2.22% (n=8)
R/P/G/D/D 1.67% (n=6)
R/P/G/D/K 0.56% (n=2)
R/P/G/D/H 0.56% (n=2)
R/P/G/D/Y 0.56% (n=2)
R/P/G/D/N 0.56% (n=2)
S/P/G/D/S 0.28% (n=1)
S/P/G/D/Q 0.28% (n=1)
S/P/G/D/A 0.28% (n=1)
R/P/G/D/M 0.28% (n=1)
R/A/G/D/Q 0.28% (n=1)
R/A/G/D/E 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Subtype 6a (antibodies: [AR3C])

R/P/G/D/E 88.71% (n=110)
R/P/G/D/G 4.84% (n=6)
R/P/G/D/D 4.03% (n=5)
R/P/G/D/Q 0.81% (n=1)
R/P/G/D/A 0.81% (n=1)
R/P/G/D/K 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,525,530,535,540 in HCV Genotype 7 (antibodies: [AR3C])

R/P/G/D/N 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 424,530 in HCV Genotype 1 (antibodies: [AR3D])

R/G 75.04% (n=7652)
S/G 24.69% (n=2518)
G/G 0.04% (n=4)
C/G 0.03% (n=3)
T/G 0.03% (n=3)
R/V 0.02% (n=2)
Q/G 0.02% (n=2)
N/G 0.02% (n=2)
L/G 0.02% (n=2)
R/S 0.02% (n=2)
R/R 0.02% (n=2)
R/C 0.01% (n=1)
H/G 0.01% (n=1)
R/E 0.01% (n=1)
E/G 0.01% (n=1)
K/G 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 1a (antibodies: [AR3D])

R/G 65.35% (n=4742)
S/G 34.39% (n=2495)
C/G 0.04% (n=3)
T/G 0.04% (n=3)
R/V 0.03% (n=2)
Q/G 0.03% (n=2)
N/G 0.03% (n=2)
L/G 0.03% (n=2)
R/S 0.03% (n=2)
R/C 0.01% (n=1)
G/G 0.01% (n=1)
H/G 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 1b (antibodies: [AR3D])

R/G 99.00% (n=2878)
S/G 0.72% (n=21)
G/G 0.10% (n=3)
R/R 0.07% (n=2)
R/E 0.03% (n=1)
E/G 0.03% (n=1)
K/G 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 2 (antibodies: [AR3D])

R/G 98.11% (n=518)
R/E 1.33% (n=7)
S/G 0.38% (n=2)
R/R 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 2a (antibodies: [AR3D])

R/G 89.47% (n=68)
R/E 7.89% (n=6)
S/G 2.63% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 2b (antibodies: [AR3D])

R/G 99.72% (n=350)
R/R 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 2c (antibodies: [AR3D])

R/G 98.44% (n=63)
R/E 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 3 (antibodies: [AR3D])

S/G 51.24% (n=1425)
R/G 48.15% (n=1339)
T/G 0.14% (n=4)
G/G 0.11% (n=3)
S/S 0.11% (n=3)
R/S 0.11% (n=3)
R/D 0.04% (n=1)
W/G 0.04% (n=1)
S/N 0.04% (n=1)
Q/G 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 3a (antibodies: [AR3D])

R/G 54.62% (n=1318)
S/G 44.84% (n=1082)
G/G 0.12% (n=3)
S/S 0.12% (n=3)
R/S 0.12% (n=3)
R/D 0.04% (n=1)
W/G 0.04% (n=1)
S/N 0.04% (n=1)
Q/G 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 3b (antibodies: [AR3D])

S/G 97.43% (n=341)
R/G 1.43% (n=5)
T/G 1.14% (n=4)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 4 (antibodies: [AR3D])

R/G 99.15% (n=232)
G/G 0.43% (n=1)
S/G 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 4a (antibodies: [AR3D])

R/G 99.38% (n=159)
G/G 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 4d (antibodies: [AR3D])

R/G 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 5 (antibodies: [AR3D])

R/G 92.11% (n=35)
S/G 7.89% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 6 (antibodies: [AR3D])

R/G 99.17% (n=360)
S/G 0.83% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Subtype 6a (antibodies: [AR3D])

R/G 100.00% (n=125)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530 in HCV Genotype 7 (antibodies: [AR3D])

R/G 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 424,530,535 in HCV Genotype 1 (antibodies: [AR3B])

R/G/D 74.85% (n=7627)
S/G/D 24.65% (n=2512)
R/G/G 0.12% (n=12)
G/G/D 0.04% (n=4)
C/G/D 0.03% (n=3)
T/G/D 0.03% (n=3)
R/G/N 0.03% (n=3)
S/G/N 0.02% (n=2)
S/G/Y 0.02% (n=2)
S/G/G 0.02% (n=2)
R/V/D 0.02% (n=2)
Q/G/D 0.02% (n=2)
N/G/D 0.02% (n=2)
L/G/D 0.02% (n=2)
R/S/D 0.02% (n=2)
R/R/D 0.02% (n=2)
R/G/V 0.01% (n=1)
R/C/G 0.01% (n=1)
R/G/A 0.01% (n=1)
H/G/D 0.01% (n=1)
R/G/C 0.01% (n=1)
R/E/D 0.01% (n=1)
E/G/D 0.01% (n=1)
K/G/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 1a (antibodies: [AR3B])

R/G/D 65.23% (n=4731)
S/G/D 34.32% (n=2489)
R/G/G 0.08% (n=6)
C/G/D 0.04% (n=3)
T/G/D 0.04% (n=3)
S/G/N 0.03% (n=2)
S/G/Y 0.03% (n=2)
S/G/G 0.03% (n=2)
R/V/D 0.03% (n=2)
Q/G/D 0.03% (n=2)
N/G/D 0.03% (n=2)
L/G/D 0.03% (n=2)
R/S/D 0.03% (n=2)
R/G/V 0.01% (n=1)
R/C/G 0.01% (n=1)
G/G/D 0.01% (n=1)
R/G/A 0.01% (n=1)
H/G/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 1b (antibodies: [AR3B])

R/G/D 98.66% (n=2864)
S/G/D 0.72% (n=21)
R/G/G 0.21% (n=6)
R/G/N 0.10% (n=3)
G/G/D 0.10% (n=3)
R/R/D 0.07% (n=2)
R/G/C 0.03% (n=1)
R/E/D 0.03% (n=1)
E/G/D 0.03% (n=1)
K/G/D 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 2 (antibodies: [AR3B])

R/G/D 97.92% (n=517)
R/E/D 1.33% (n=7)
S/G/D 0.38% (n=2)
R/G/N 0.19% (n=1)
R/R/D 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 2a (antibodies: [AR3B])

R/G/D 88.16% (n=67)
R/E/D 7.89% (n=6)
S/G/D 2.63% (n=2)
R/G/N 1.32% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 2b (antibodies: [AR3B])

R/G/D 99.72% (n=350)
R/R/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 2c (antibodies: [AR3B])

R/G/D 98.44% (n=63)
R/E/D 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 3 (antibodies: [AR3B])

S/G/D 51.24% (n=1425)
R/G/D 47.97% (n=1334)
T/G/D 0.14% (n=4)
G/G/D 0.11% (n=3)
S/S/D 0.11% (n=3)
R/S/D 0.07% (n=2)
R/G/E 0.07% (n=2)
R/D/D 0.04% (n=1)
W/G/D 0.04% (n=1)
R/G/G 0.04% (n=1)
R/G/N 0.04% (n=1)
R/S/E 0.04% (n=1)
S/N/D 0.04% (n=1)
R/G/A 0.04% (n=1)
Q/G/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 3a (antibodies: [AR3B])

R/G/D 54.41% (n=1313)
S/G/D 44.84% (n=1082)
G/G/D 0.12% (n=3)
S/S/D 0.12% (n=3)
R/S/D 0.08% (n=2)
R/G/E 0.08% (n=2)
R/D/D 0.04% (n=1)
W/G/D 0.04% (n=1)
R/G/G 0.04% (n=1)
R/G/N 0.04% (n=1)
R/S/E 0.04% (n=1)
S/N/D 0.04% (n=1)
R/G/A 0.04% (n=1)
Q/G/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 3b (antibodies: [AR3B])

S/G/D 97.43% (n=341)
R/G/D 1.43% (n=5)
T/G/D 1.14% (n=4)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 4 (antibodies: [AR3B])

R/G/D 98.72% (n=231)
G/G/D 0.43% (n=1)
R/G/N 0.43% (n=1)
S/G/D 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 4a (antibodies: [AR3B])

R/G/D 99.38% (n=159)
G/G/D 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 4d (antibodies: [AR3B])

R/G/D 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 5 (antibodies: [AR3B])

R/G/D 92.11% (n=35)
S/G/D 7.89% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 6 (antibodies: [AR3B])

R/G/D 99.17% (n=360)
S/G/D 0.83% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Subtype 6a (antibodies: [AR3B])

R/G/D 100.00% (n=125)
---------------------------------------------------------------------------------------
Motifs for binding location set: 424,530,535 in HCV Genotype 7 (antibodies: [AR3B])

R/G/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 1 (antibodies: [HC-11])

TA/D/FL/FY/G/D 17.62% (n=1790)
TA/D/WI/FY/G/D 13.31% (n=1352)
TA/D/WL/FY/G/D 10.51% (n=1068)
TA/A/WL/FY/G/D 7.16% (n=727)
TA/A/WV/FY/G/D 6.72% (n=683)
TA/A/WI/FY/G/D 6.43% (n=653)
TA/E/WL/FY/G/D 5.18% (n=526)
TA/D/FI/FY/G/D 4.43% (n=450)
TA/D/WI/LY/G/D 4.06% (n=412)
TA/D/WV/FY/G/D 3.45% (n=351)
TA/A/WV/LY/G/D 2.78% (n=282)
TA/E/WV/LY/G/D 1.93% (n=196)
TA/D/WI/IY/G/D 1.52% (n=154)
TA/D/WV/LY/G/D 1.47% (n=149)
TA/E/FI/FY/G/D 0.99% (n=101)
TA/D/WL/LY/G/D 0.83% (n=84)
TS/D/FI/FY/G/D 0.81% (n=82)
TA/D/FF/FY/G/D 0.70% (n=71)
TA/D/FL/LY/G/D 0.68% (n=69)
TA/D/FI/FH/G/D 0.68% (n=69)
TA/D/FV/FY/G/D 0.62% (n=63)
TA/E/WL/VY/G/D 0.61% (n=62)
TA/A/WI/LY/G/D 0.57% (n=58)
TA/E/WV/FY/G/D 0.53% (n=54)
TA/A/WI/IY/G/D 0.38% (n=39)
TA/D/FI/IY/G/D 0.37% (n=38)
TA/D/WV/IY/G/D 0.34% (n=35)
TA/E/WL/IY/G/D 0.34% (n=35)
TA/E/WI/FY/G/D 0.31% (n=31)
TA/A/WV/IY/G/D 0.31% (n=31)
TA/E/WL/LY/G/D 0.29% (n=29)
TA/D/FI/LY/G/D 0.26% (n=26)
TA/D/WI/MY/G/D 0.24% (n=24)
TA/T/WL/FY/G/D 0.19% (n=19)
TA/E/FL/FY/G/D 0.18% (n=18)
TA/E/WI/LY/G/D 0.15% (n=15)
TA/D/WM/FY/G/D 0.15% (n=15)
TA/A/WM/FY/G/D 0.14% (n=14)
TA/D/FI/VY/G/D 0.09% (n=9)
TA/S/WL/FY/G/D 0.08% (n=8)
TA/S/WI/FY/G/D 0.07% (n=7)
TA/D/FF/VY/G/D 0.07% (n=7)
TA/A/WL/FH/G/D 0.06% (n=6)
TA/D/WL/VY/G/D 0.05% (n=5)
TA/D/GI/LY/G/D 0.05% (n=5)
TA/D/WL/IY/G/D 0.05% (n=5)
TA/G/WI/FY/G/D 0.05% (n=5)
TA/E/FF/FY/G/D 0.05% (n=5)
TA/D/SL/FY/G/D 0.05% (n=5)
TS/D/FL/FY/G/D 0.05% (n=5)
TA/D/FL/FY/G/G 0.05% (n=5)
TA/D/WI/VY/G/D 0.04% (n=4)
TA/G/FL/FY/G/D 0.04% (n=4)
TA/D/FF/IY/G/D 0.04% (n=4)
TA/A/GV/FY/G/D 0.03% (n=3)
TA/D/WL/SY/G/D 0.03% (n=3)
TA/D/WL/MY/G/D 0.03% (n=3)
TA/E/WM/FY/G/D 0.03% (n=3)
TA/A/WI/FH/G/D 0.03% (n=3)
TA/A/WL/FS/G/D 0.03% (n=3)
TA/A/WL/LY/G/D 0.03% (n=3)
TA/D/FL/IY/G/D 0.03% (n=3)
TA/E/WI/IY/G/D 0.03% (n=3)
TA/A/WF/FY/G/D 0.03% (n=3)
TA/E/FM/FY/G/D 0.03% (n=3)
AA/D/WV/FY/G/D 0.03% (n=3)
TA/D/LL/FY/G/D 0.03% (n=3)
TA/D/FP/FY/G/D 0.03% (n=3)
TA/D/FL/SY/G/D 0.03% (n=3)
TA/D/FL/FA/G/D 0.03% (n=3)
TA/A/WG/FY/G/D 0.02% (n=2)
MA/A/WV/FY/G/D 0.02% (n=2)
TA/D/WL/F*/G/D 0.02% (n=2)
TA/D/FM/LY/G/D 0.02% (n=2)
TA/A/WL/IY/G/D 0.02% (n=2)
TA/S/WV/FY/G/D 0.02% (n=2)
TA/D/RI/FY/G/D 0.02% (n=2)
TA/D/WI/FH/G/D 0.02% (n=2)
TA/D/WV/FY/G/Y 0.02% (n=2)
TA/V/WV/LY/G/D 0.02% (n=2)
TA/D/FL/FS/G/D 0.02% (n=2)
TA/D/FI/MY/G/D 0.02% (n=2)
TA/N/WL/FY/G/D 0.02% (n=2)
TA/S/WV/LY/G/D 0.02% (n=2)
TA/E/WV/IY/G/D 0.02% (n=2)
TS/D/WI/FY/G/D 0.02% (n=2)
AA/D/WV/LY/G/D 0.02% (n=2)
TA/D/WM/LY/G/D 0.02% (n=2)
TV/D/WL/FY/G/D 0.02% (n=2)
TA/D/WL/FH/G/D 0.02% (n=2)
TA/E/FV/IY/G/D 0.02% (n=2)
TA/A/WM/FY/G/G 0.02% (n=2)
TA/D/FI/FY/G/G 0.02% (n=2)
TA/E/FI/FC/G/D 0.02% (n=2)
TA/E/WL/VY/S/D 0.02% (n=2)
TA/A/WI/MY/G/D 0.02% (n=2)
MA/D/WV/LY/G/D 0.02% (n=2)
TA/A/WL/FN/G/D 0.02% (n=2)
TA/D/FL/FF/G/D 0.02% (n=2)
TA/D/FL/FY/G/N 0.02% (n=2)
TA/D/FI/SY/G/D 0.02% (n=2)
TA/D/FM/FY/G/D 0.02% (n=2)
TA/D/FV/IY/G/D 0.02% (n=2)
AA/D/FL/FY/G/D 0.02% (n=2)
TA/D/WL/LC/G/D 0.01% (n=1)
TA/D/WL/LY/G/N 0.01% (n=1)
AA/A/WV/FY/G/D 0.01% (n=1)
TA/D/WV/SY/G/D 0.01% (n=1)
TA/A/WI/FY/G/V 0.01% (n=1)
TA/A/WV/LY/C/G 0.01% (n=1)
TT/D/WL/FY/G/D 0.01% (n=1)
TA/D/WT/LY/G/D 0.01% (n=1)
TA/A/WM/IY/G/D 0.01% (n=1)
TA/A/WI/NY/G/D 0.01% (n=1)
TG/A/WI/IY/G/D 0.01% (n=1)
TA/D/WV/FY/G/N 0.01% (n=1)
TA/D/WI/LY/G/G 0.01% (n=1)
TA/D/WV/FY/V/D 0.01% (n=1)
TA/E/WL/FS/G/D 0.01% (n=1)
TA/A/FV/FY/G/D 0.01% (n=1)
TA/A/WI/IH/G/D 0.01% (n=1)
TA/T/WL/FH/G/D 0.01% (n=1)
TA/A/WI/VY/G/D 0.01% (n=1)
TA/T/WI/IY/G/D 0.01% (n=1)
TA/A/WI/FN/G/D 0.01% (n=1)
TA/V/WV/FY/G/D 0.01% (n=1)
TA/T/WL/IY/G/D 0.01% (n=1)
TA/T/WI/FS/G/D 0.01% (n=1)
TA/E/FI/LY/G/D 0.01% (n=1)
TS/A/WL/FY/G/D 0.01% (n=1)
TA/E/FV/LY/G/D 0.01% (n=1)
TA/D/CI/FY/G/D 0.01% (n=1)
SA/A/WL/FY/G/D 0.01% (n=1)
TV/D/WV/FY/G/D 0.01% (n=1)
TA/D/WV/FY/G/G 0.01% (n=1)
TA/A/WT/FY/G/D 0.01% (n=1)
TA/A/WI/FY/G/G 0.01% (n=1)
TA/A/RV/FY/G/D 0.01% (n=1)
TA/D/WL/FY/G/G 0.01% (n=1)
TA/G/WL/FY/G/D 0.01% (n=1)
TA/A/RL/FY/G/D 0.01% (n=1)
TA/D/WA/FY/G/D 0.01% (n=1)
TA/E/FI/FY/G/A 0.01% (n=1)
TA/E/LT/FY/G/D 0.01% (n=1)
TA/E/FI/FY/G/G 0.01% (n=1)
TA/E/FI/IY/G/D 0.01% (n=1)
TA/E/FT/FY/G/D 0.01% (n=1)
TA/E/FI/FH/G/D 0.01% (n=1)
TA/D/LI/FY/G/D 0.01% (n=1)
AA/D/WL/FY/G/D 0.01% (n=1)
TA/D/*V/FY/G/D 0.01% (n=1)
TA/A/*I/LY/G/D 0.01% (n=1)
TA/A/WL/PL/G/D 0.01% (n=1)
TV/E/WL/IY/G/D 0.01% (n=1)
TA/D/FV/LY/G/D 0.01% (n=1)
TS/D/WV/FY/G/D 0.01% (n=1)
TA/D/WV/FS/G/D 0.01% (n=1)
TA/E/WL/ST/G/D 0.01% (n=1)
TA/T/WI/FY/G/D 0.01% (n=1)
TA/A/WV/FY/V/D 0.01% (n=1)
TA/A/WV/FN/G/D 0.01% (n=1)
TA/A/WV/FF/G/D 0.01% (n=1)
TA/A/WV/FH/G/D 0.01% (n=1)
TA/A/WI/FC/G/D 0.01% (n=1)
TA/A/WA/VY/G/D 0.01% (n=1)
TA/A/FL/LY/G/D 0.01% (n=1)
TA/D/FV/FY/R/D 0.01% (n=1)
TA/D/FL/FN/G/D 0.01% (n=1)
TA/D/FI/FY/G/N 0.01% (n=1)
TP/D/FL/FY/G/D 0.01% (n=1)
TA/D/FL/FY/R/D 0.01% (n=1)
TA/D/VL/FY/G/D 0.01% (n=1)
TA/D/FL/FY/G/C 0.01% (n=1)
TA/D/FI/FY/E/D 0.01% (n=1)
TA/D/FT/FY/G/D 0.01% (n=1)
TA/D/FL/FH/G/D 0.01% (n=1)
TV/D/FI/FY/G/D 0.01% (n=1)
TS/E/WV/FY/G/D 0.01% (n=1)
TS/D/FV/FY/G/D 0.01% (n=1)
TV/D/FL/FY/G/D 0.01% (n=1)
TA/N/FL/FY/G/D 0.01% (n=1)
TT/D/FL/FY/G/D 0.01% (n=1)
TA/D/FL/FL/G/D 0.01% (n=1)
TS/D/WL/FY/G/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 1a (antibodies: [HC-11])

TA/D/WI/FY/G/D 18.67% (n=1352)
TA/D/WL/FY/G/D 14.50% (n=1050)
TA/A/WL/FY/G/D 10.01% (n=725)
TA/A/WV/FY/G/D 9.43% (n=683)
TA/A/WI/FY/G/D 9.02% (n=653)
TA/D/WI/LY/G/D 5.69% (n=412)
TA/D/WV/FY/G/D 4.79% (n=347)
TA/A/WV/LY/G/D 3.90% (n=282)
TA/E/WV/LY/G/D 2.71% (n=196)
TA/E/WL/FY/G/D 2.27% (n=164)
TA/D/WI/IY/G/D 2.13% (n=154)
TA/D/WV/LY/G/D 2.06% (n=149)
TA/E/FI/FY/G/D 1.38% (n=100)
TA/D/WL/LY/G/D 1.16% (n=84)
TA/D/FI/FH/G/D 0.94% (n=68)
TA/D/FL/LY/G/D 0.90% (n=65)
TA/E/WL/VY/G/D 0.86% (n=62)
TA/A/WI/LY/G/D 0.80% (n=58)
TA/E/WV/FY/G/D 0.72% (n=52)
TA/D/FI/FY/G/D 0.58% (n=42)
TA/A/WI/IY/G/D 0.54% (n=39)
TA/D/WV/IY/G/D 0.48% (n=35)
TA/E/WL/IY/G/D 0.47% (n=34)
TA/E/WI/FY/G/D 0.43% (n=31)
TA/A/WV/IY/G/D 0.43% (n=31)
TA/D/FV/FY/G/D 0.43% (n=31)
TA/E/WL/LY/G/D 0.39% (n=28)
TA/D/WI/MY/G/D 0.33% (n=24)
TA/T/WL/FY/G/D 0.26% (n=19)
TA/D/FI/LY/G/D 0.23% (n=17)
TA/E/WI/LY/G/D 0.21% (n=15)
TA/D/WM/FY/G/D 0.21% (n=15)
TA/A/WM/FY/G/D 0.19% (n=14)
TA/D/FL/FY/G/D 0.17% (n=12)
TA/S/WL/FY/G/D 0.11% (n=8)
TA/S/WI/FY/G/D 0.10% (n=7)
TA/A/WL/FH/G/D 0.08% (n=6)
TA/D/WL/VY/G/D 0.07% (n=5)
TA/D/GI/LY/G/D 0.07% (n=5)
TA/D/WL/IY/G/D 0.07% (n=5)
TA/G/WI/FY/G/D 0.07% (n=5)
TA/D/WI/VY/G/D 0.06% (n=4)
TA/A/GV/FY/G/D 0.04% (n=3)
TA/D/WL/SY/G/D 0.04% (n=3)
TA/D/WL/MY/G/D 0.04% (n=3)
TA/E/WM/FY/G/D 0.04% (n=3)
TA/A/WI/FH/G/D 0.04% (n=3)
TA/A/WL/FS/G/D 0.04% (n=3)
TA/A/WL/LY/G/D 0.04% (n=3)
TA/E/WI/IY/G/D 0.04% (n=3)
TA/A/WF/FY/G/D 0.04% (n=3)
AA/D/WV/FY/G/D 0.04% (n=3)
TA/A/WG/FY/G/D 0.03% (n=2)
MA/A/WV/FY/G/D 0.03% (n=2)
TA/D/WL/F*/G/D 0.03% (n=2)
TA/D/FM/LY/G/D 0.03% (n=2)
TA/A/WL/IY/G/D 0.03% (n=2)
TA/S/WV/FY/G/D 0.03% (n=2)
TA/D/RI/FY/G/D 0.03% (n=2)
TA/D/WI/FH/G/D 0.03% (n=2)
TA/D/WV/FY/G/Y 0.03% (n=2)
TA/V/WV/LY/G/D 0.03% (n=2)
TA/D/FL/FS/G/D 0.03% (n=2)
TA/D/FI/MY/G/D 0.03% (n=2)
TA/N/WL/FY/G/D 0.03% (n=2)
TA/S/WV/LY/G/D 0.03% (n=2)
TA/D/FI/IY/G/D 0.03% (n=2)
TA/D/FL/IY/G/D 0.03% (n=2)
TA/E/WV/IY/G/D 0.03% (n=2)
TS/D/WI/FY/G/D 0.03% (n=2)
AA/D/WV/LY/G/D 0.03% (n=2)
TA/D/WM/LY/G/D 0.03% (n=2)
TV/D/WL/FY/G/D 0.03% (n=2)
TA/D/WL/FH/G/D 0.03% (n=2)
TA/E/FV/IY/G/D 0.03% (n=2)
TA/A/WM/FY/G/G 0.03% (n=2)
TA/E/FM/FY/G/D 0.03% (n=2)
TA/E/FI/FC/G/D 0.03% (n=2)
TA/E/WL/VY/S/D 0.03% (n=2)
TA/A/WI/MY/G/D 0.03% (n=2)
MA/D/WV/LY/G/D 0.03% (n=2)
TA/A/WL/FN/G/D 0.03% (n=2)
TA/D/WL/LC/G/D 0.01% (n=1)
TA/D/WL/LY/G/N 0.01% (n=1)
AA/A/WV/FY/G/D 0.01% (n=1)
TA/D/WV/SY/G/D 0.01% (n=1)
TA/A/WI/FY/G/V 0.01% (n=1)
TA/A/WV/LY/C/G 0.01% (n=1)
TT/D/WL/FY/G/D 0.01% (n=1)
TA/D/WT/LY/G/D 0.01% (n=1)
TA/A/WM/IY/G/D 0.01% (n=1)
TA/A/WI/NY/G/D 0.01% (n=1)
TG/A/WI/IY/G/D 0.01% (n=1)
TA/D/WV/FY/G/N 0.01% (n=1)
TA/D/WI/LY/G/G 0.01% (n=1)
TA/D/WV/FY/V/D 0.01% (n=1)
TA/E/WL/FS/G/D 0.01% (n=1)
TA/A/FV/FY/G/D 0.01% (n=1)
TA/A/WI/IH/G/D 0.01% (n=1)
TA/T/WL/FH/G/D 0.01% (n=1)
TA/A/WI/VY/G/D 0.01% (n=1)
TA/T/WI/IY/G/D 0.01% (n=1)
TA/A/WI/FN/G/D 0.01% (n=1)
TA/V/WV/FY/G/D 0.01% (n=1)
TA/T/WL/IY/G/D 0.01% (n=1)
TA/T/WI/FS/G/D 0.01% (n=1)
TA/E/FI/LY/G/D 0.01% (n=1)
TS/A/WL/FY/G/D 0.01% (n=1)
TA/E/FV/LY/G/D 0.01% (n=1)
TA/D/CI/FY/G/D 0.01% (n=1)
SA/A/WL/FY/G/D 0.01% (n=1)
TV/D/WV/FY/G/D 0.01% (n=1)
TA/D/WV/FY/G/G 0.01% (n=1)
TA/A/WT/FY/G/D 0.01% (n=1)
TA/A/WI/FY/G/G 0.01% (n=1)
TA/A/RV/FY/G/D 0.01% (n=1)
TA/D/WL/FY/G/G 0.01% (n=1)
TA/G/WL/FY/G/D 0.01% (n=1)
TA/A/RL/FY/G/D 0.01% (n=1)
TA/D/WA/FY/G/D 0.01% (n=1)
TA/E/FI/FY/G/A 0.01% (n=1)
TA/D/FI/FY/G/G 0.01% (n=1)
TA/E/LT/FY/G/D 0.01% (n=1)
TA/E/FI/FY/G/G 0.01% (n=1)
TA/E/FI/IY/G/D 0.01% (n=1)
TA/E/FT/FY/G/D 0.01% (n=1)
TA/E/FI/FH/G/D 0.01% (n=1)
TA/D/LI/FY/G/D 0.01% (n=1)
AA/D/WL/FY/G/D 0.01% (n=1)
TA/D/*V/FY/G/D 0.01% (n=1)
TA/A/*I/LY/G/D 0.01% (n=1)
TA/A/WL/PL/G/D 0.01% (n=1)
TV/E/WL/IY/G/D 0.01% (n=1)
TA/D/FV/LY/G/D 0.01% (n=1)
TS/D/WV/FY/G/D 0.01% (n=1)
TA/D/WV/FS/G/D 0.01% (n=1)
TA/E/WL/ST/G/D 0.01% (n=1)
TA/T/WI/FY/G/D 0.01% (n=1)
TA/A/WV/FY/V/D 0.01% (n=1)
TA/A/WV/FN/G/D 0.01% (n=1)
TA/A/WV/FF/G/D 0.01% (n=1)
TA/A/WV/FH/G/D 0.01% (n=1)
TA/A/WI/FC/G/D 0.01% (n=1)
TA/A/WA/VY/G/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 1b (antibodies: [HC-11])

TA/D/FL/FY/G/D 61.24% (n=1768)
TA/D/FI/FY/G/D 13.99% (n=404)
TA/E/WL/FY/G/D 12.54% (n=362)
TS/D/FI/FY/G/D 2.84% (n=82)
TA/D/FF/FY/G/D 2.46% (n=71)
TA/D/FI/IY/G/D 1.21% (n=35)
TA/D/FV/FY/G/D 1.11% (n=32)
TA/E/FL/FY/G/D 0.62% (n=18)
TA/D/WL/FY/G/D 0.59% (n=17)
TA/D/FI/VY/G/D 0.28% (n=8)
TA/D/FF/VY/G/D 0.24% (n=7)
TA/D/FI/LY/G/D 0.24% (n=7)
TA/E/FF/FY/G/D 0.17% (n=5)
TA/D/SL/FY/G/D 0.17% (n=5)
TA/D/FL/FY/G/G 0.17% (n=5)
TA/G/FL/FY/G/D 0.14% (n=4)
TA/D/FF/IY/G/D 0.14% (n=4)
TS/D/FL/FY/G/D 0.14% (n=4)
TA/D/LL/FY/G/D 0.10% (n=3)
TA/D/FP/FY/G/D 0.10% (n=3)
TA/D/FL/SY/G/D 0.10% (n=3)
TA/D/FL/FF/G/D 0.07% (n=2)
TA/D/FL/FY/G/N 0.07% (n=2)
TA/E/WV/FY/G/D 0.07% (n=2)
TA/D/WV/FY/G/D 0.07% (n=2)
TA/D/FI/SY/G/D 0.07% (n=2)
TA/D/FM/FY/G/D 0.07% (n=2)
TA/D/FV/IY/G/D 0.07% (n=2)
AA/D/FL/FY/G/D 0.07% (n=2)
TA/A/FL/LY/G/D 0.03% (n=1)
TA/D/FL/IY/G/D 0.03% (n=1)
TA/D/FV/FY/R/D 0.03% (n=1)
TA/D/FL/FN/G/D 0.03% (n=1)
TA/D/FI/FY/G/N 0.03% (n=1)
TP/D/FL/FY/G/D 0.03% (n=1)
TA/D/FL/FY/R/D 0.03% (n=1)
TA/D/VL/FY/G/D 0.03% (n=1)
TA/D/FL/FY/G/C 0.03% (n=1)
TA/E/WL/IY/G/D 0.03% (n=1)
TA/D/FI/FH/G/D 0.03% (n=1)
TA/D/FL/LY/G/D 0.03% (n=1)
TA/D/FI/FY/E/D 0.03% (n=1)
TA/D/FT/FY/G/D 0.03% (n=1)
TA/E/FM/FY/G/D 0.03% (n=1)
TA/D/FL/FH/G/D 0.03% (n=1)
TV/D/FI/FY/G/D 0.03% (n=1)
TS/E/WV/FY/G/D 0.03% (n=1)
TS/D/FV/FY/G/D 0.03% (n=1)
TA/D/FI/FY/G/G 0.03% (n=1)
TA/E/FI/FY/G/D 0.03% (n=1)
TV/D/FL/FY/G/D 0.03% (n=1)
TA/N/FL/FY/G/D 0.03% (n=1)
TT/D/FL/FY/G/D 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 2 (antibodies: [HC-11])

TA/D/FI/FY/G/D 70.80% (n=371)
TA/D/FL/FY/G/D 19.47% (n=102)
TA/D/FF/FY/G/D 1.91% (n=10)
TA/D/FM/FY/G/D 1.34% (n=7)
TA/D/FV/FY/G/D 0.95% (n=5)
TA/E/FL/FY/G/D 0.76% (n=4)
TA/D/FI/FF/E/D 0.76% (n=4)
TA/K/FV/FY/G/D 0.38% (n=2)
TA/D/FI/FY/E/D 0.38% (n=2)
TA/D/CL/FY/G/D 0.38% (n=2)
TA/D/FI/IY/G/N 0.19% (n=1)
HP/T/FI/VY/G/D 0.19% (n=1)
TA/D/FL/FR/G/D 0.19% (n=1)
TA/D/FL/FY/R/D 0.19% (n=1)
TA/D/FI/VY/G/D 0.19% (n=1)
TA/D/FF/LY/G/D 0.19% (n=1)
TA/D/FV/LY/G/D 0.19% (n=1)
TA/D/FI/IY/G/D 0.19% (n=1)
TA/A/FL/FY/G/D 0.19% (n=1)
TA/D/FL/FY/E/D 0.19% (n=1)
TA/D/WL/FY/G/D 0.19% (n=1)
TA/A/WV/FY/G/D 0.19% (n=1)
IA/D/FI/FY/G/D 0.19% (n=1)
TA/D/FI/FH/G/D 0.19% (n=1)
TA/D/FI/LY/G/D 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 2a (antibodies: [HC-11])

TA/D/FL/FY/G/D 46.05% (n=35)
TA/D/FI/FY/G/D 31.58% (n=24)
TA/D/FI/FF/E/D 5.26% (n=4)
TA/E/FL/FY/G/D 2.63% (n=2)
TA/K/FV/FY/G/D 2.63% (n=2)
TA/D/FV/FY/G/D 2.63% (n=2)
TA/D/FI/FY/E/D 2.63% (n=2)
TA/D/FF/FY/G/D 1.32% (n=1)
TA/D/FI/IY/G/N 1.32% (n=1)
TA/D/FM/FY/G/D 1.32% (n=1)
HP/T/FI/VY/G/D 1.32% (n=1)
TA/D/FL/FR/G/D 1.32% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 2b (antibodies: [HC-11])

TA/D/FI/FY/G/D 83.95% (n=293)
TA/D/FL/FY/G/D 11.46% (n=40)
TA/D/FM/FY/G/D 1.72% (n=6)
TA/D/FF/FY/G/D 0.86% (n=3)
TA/D/CL/FY/G/D 0.57% (n=2)
TA/D/FL/FY/R/D 0.29% (n=1)
TA/D/FI/VY/G/D 0.29% (n=1)
TA/D/FF/LY/G/D 0.29% (n=1)
TA/D/FV/FY/G/D 0.29% (n=1)
TA/D/FV/LY/G/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 2c (antibodies: [HC-11])

TA/D/FI/FY/G/D 56.45% (n=35)
TA/D/FL/FY/G/D 20.97% (n=13)
TA/D/FF/FY/G/D 8.06% (n=5)
TA/E/FL/FY/G/D 3.23% (n=2)
TA/D/FV/FY/G/D 1.61% (n=1)
TA/D/FI/IY/G/D 1.61% (n=1)
TA/A/FL/FY/G/D 1.61% (n=1)
TA/D/FL/FY/E/D 1.61% (n=1)
TA/D/WL/FY/G/D 1.61% (n=1)
TA/A/WV/FY/G/D 1.61% (n=1)
IA/D/FI/FY/G/D 1.61% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 3 (antibodies: [HC-11])

TA/D/FI/FY/G/D 30.13% (n=827)
TA/D/FI/IY/G/D 23.02% (n=632)
TA/E/FI/FY/G/D 22.11% (n=607)
TA/E/FL/FY/G/D 10.89% (n=299)
TA/D/FL/FY/G/D 2.19% (n=60)
TA/D/FI/MY/G/D 1.71% (n=47)
TA/D/FI/LY/G/D 1.42% (n=39)
TA/E/FI/LY/G/D 1.06% (n=29)
TA/D/FI/FH/G/D 1.02% (n=28)
TA/E/FI/IY/G/D 0.95% (n=26)
TA/E/FV/FY/G/D 0.55% (n=15)
TA/D/FI/VY/G/D 0.40% (n=11)
TS/D/FI/FY/G/D 0.33% (n=9)
TA/D/FV/FY/G/D 0.26% (n=7)
TA/E/FI/FH/G/D 0.22% (n=6)
TA/D/FI/FS/G/D 0.22% (n=6)
TA/E/FF/FY/G/D 0.18% (n=5)
TA/D/FL/LY/G/D 0.18% (n=5)
TA/D/FI/FN/G/D 0.18% (n=5)
TA/E/FL/IY/G/D 0.15% (n=4)
TA/A/FI/MY/G/D 0.15% (n=4)
TS/D/FI/IY/G/D 0.15% (n=4)
TA/E/FV/IY/G/D 0.15% (n=4)
TA/E/FI/VY/G/D 0.15% (n=4)
TA/E/FI/FN/G/D 0.11% (n=3)
TA/E/FM/FY/G/D 0.11% (n=3)
TA/T/FL/FY/G/D 0.11% (n=3)
AA/E/FI/FY/G/D 0.07% (n=2)
AA/D/FI/FY/G/D 0.07% (n=2)
TA/A/FI/IY/G/D 0.07% (n=2)
TV/E/FI/FY/G/D 0.07% (n=2)
TA/E/FL/FY/S/D 0.07% (n=2)
TA/D/FM/FY/G/D 0.07% (n=2)
TA/E/FI/MY/G/D 0.07% (n=2)
TA/T/FI/FY/G/D 0.07% (n=2)
TA/A/FI/FY/G/D 0.07% (n=2)
TA/E/FI/FS/G/D 0.07% (n=2)
TA/D/FI/FR/G/D 0.04% (n=1)
TV/D/FI/FY/G/D 0.04% (n=1)
TA/E/FI/FY/D/D 0.04% (n=1)
TA/E/FM/FN/G/D 0.04% (n=1)
TA/D/SI/IY/G/D 0.04% (n=1)
TA/D/FI/IY/S/D 0.04% (n=1)
TA/E/FI/FY/S/D 0.04% (n=1)
TA/G/FI/FY/G/D 0.04% (n=1)
AA/D/FI/IY/G/D 0.04% (n=1)
TA/D/LI/FY/G/D 0.04% (n=1)
TA/D/FI/FY/G/G 0.04% (n=1)
AA/E/FL/FY/G/D 0.04% (n=1)
TS/D/FI/DY/G/E 0.04% (n=1)
TS/D/FT/FY/G/D 0.04% (n=1)
TA/D/FI/FH/S/D 0.04% (n=1)
TS/D/FI/FY/G/N 0.04% (n=1)
TA/D/FI/FY/S/E 0.04% (n=1)
TA/D/FI/FY/G/E 0.04% (n=1)
TA/D/FI/FY/N/D 0.04% (n=1)
TA/E/FL/MY/G/D 0.04% (n=1)
TA/D/SI/FY/G/D 0.04% (n=1)
TA/E/S*/FI/G/A 0.04% (n=1)
TA/D/FV/LY/G/D 0.04% (n=1)
TA/D/FL/IY/G/D 0.04% (n=1)
TA/E/FI/FF/G/D 0.04% (n=1)
TA/A/FV/FY/G/D 0.04% (n=1)
TA/E/FL/FH/G/D 0.04% (n=1)
TA/D/FL/VY/G/D 0.04% (n=1)
TA/E/FM/FH/G/D 0.04% (n=1)
TS/D/FI/FH/G/D 0.04% (n=1)
TS/E/FI/FY/G/D 0.04% (n=1)
TA/D/FM/LY/G/D 0.04% (n=1)
TA/D/FL/FS/G/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 3a (antibodies: [HC-11])

TA/D/FI/FY/G/D 31.88% (n=759)
TA/E/FI/FY/G/D 25.03% (n=596)
TA/D/FI/IY/G/D 18.10% (n=431)
TA/E/FL/FY/G/D 12.52% (n=298)
TA/D/FL/FY/G/D 2.39% (n=57)
TA/D/FI/FH/G/D 1.18% (n=28)
TA/E/FI/LY/G/D 1.13% (n=27)
TA/E/FI/IY/G/D 0.92% (n=22)
TA/D/FI/LY/G/D 0.84% (n=20)
TA/E/FV/FY/G/D 0.55% (n=13)
TS/D/FI/FY/G/D 0.38% (n=9)
TA/D/FI/VY/G/D 0.29% (n=7)
TA/E/FF/FY/G/D 0.21% (n=5)
TA/D/FL/LY/G/D 0.21% (n=5)
TA/D/FV/FY/G/D 0.21% (n=5)
TA/E/FI/FH/G/D 0.21% (n=5)
TA/D/FI/FN/G/D 0.21% (n=5)
TA/E/FL/IY/G/D 0.17% (n=4)
TA/A/FI/MY/G/D 0.17% (n=4)
TS/D/FI/IY/G/D 0.17% (n=4)
TA/D/FI/MY/G/D 0.17% (n=4)
TA/E/FV/IY/G/D 0.17% (n=4)
TA/D/FI/FS/G/D 0.17% (n=4)
TA/E/FI/FN/G/D 0.13% (n=3)
TA/E/FM/FY/G/D 0.13% (n=3)
TA/E/FI/VY/G/D 0.13% (n=3)
TA/T/FL/FY/G/D 0.13% (n=3)
AA/E/FI/FY/G/D 0.08% (n=2)
AA/D/FI/FY/G/D 0.08% (n=2)
TA/A/FI/IY/G/D 0.08% (n=2)
TV/E/FI/FY/G/D 0.08% (n=2)
TA/E/FL/FY/S/D 0.08% (n=2)
TA/D/FM/FY/G/D 0.08% (n=2)
TA/E/FI/MY/G/D 0.08% (n=2)
TA/T/FI/FY/G/D 0.08% (n=2)
TA/A/FI/FY/G/D 0.08% (n=2)
TA/E/FI/FS/G/D 0.08% (n=2)
TA/D/FI/FR/G/D 0.04% (n=1)
TV/D/FI/FY/G/D 0.04% (n=1)
TA/E/FI/FY/D/D 0.04% (n=1)
TA/E/FM/FN/G/D 0.04% (n=1)
TA/D/SI/IY/G/D 0.04% (n=1)
TA/D/FI/IY/S/D 0.04% (n=1)
TA/E/FI/FY/S/D 0.04% (n=1)
TA/G/FI/FY/G/D 0.04% (n=1)
AA/D/FI/IY/G/D 0.04% (n=1)
TA/D/LI/FY/G/D 0.04% (n=1)
TA/D/FI/FY/G/G 0.04% (n=1)
AA/E/FL/FY/G/D 0.04% (n=1)
TS/D/FI/DY/G/E 0.04% (n=1)
TS/D/FT/FY/G/D 0.04% (n=1)
TA/D/FI/FH/S/D 0.04% (n=1)
TS/D/FI/FY/G/N 0.04% (n=1)
TA/D/FI/FY/S/E 0.04% (n=1)
TA/D/FI/FY/G/E 0.04% (n=1)
TA/D/FI/FY/N/D 0.04% (n=1)
TA/E/FL/MY/G/D 0.04% (n=1)
TA/D/SI/FY/G/D 0.04% (n=1)
TA/E/S*/FI/G/A 0.04% (n=1)
TA/D/FV/LY/G/D 0.04% (n=1)
TA/D/FL/IY/G/D 0.04% (n=1)
TA/E/FI/FF/G/D 0.04% (n=1)
TA/A/FV/FY/G/D 0.04% (n=1)
TA/E/FL/FH/G/D 0.04% (n=1)
TA/D/FL/VY/G/D 0.04% (n=1)
TA/E/FM/FH/G/D 0.04% (n=1)
TS/D/FI/FH/G/D 0.04% (n=1)
TS/E/FI/FY/G/D 0.04% (n=1)
TA/D/FM/LY/G/D 0.04% (n=1)
TA/D/FL/FS/G/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 3b (antibodies: [HC-11])

TA/D/FI/IY/G/D 57.23% (n=198)
TA/D/FI/FY/G/D 17.34% (n=60)
TA/D/FI/MY/G/D 11.56% (n=40)
TA/D/FI/LY/G/D 4.91% (n=17)
TA/E/FI/FY/G/D 3.18% (n=11)
TA/D/FI/VY/G/D 1.16% (n=4)
TA/E/FI/IY/G/D 1.16% (n=4)
TA/D/FI/FS/G/D 0.58% (n=2)
TA/E/FV/FY/G/D 0.58% (n=2)
TA/E/FI/LY/G/D 0.58% (n=2)
TA/D/FV/FY/G/D 0.58% (n=2)
TA/D/FL/FY/G/D 0.29% (n=1)
TA/E/FL/FY/G/D 0.29% (n=1)
TA/E/FI/FH/G/D 0.29% (n=1)
TA/E/FI/VY/G/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 4 (antibodies: [HC-11])

TA/D/FL/FY/G/D 77.16% (n=179)
TA/D/FI/FY/G/D 8.19% (n=19)
TA/D/FI/LY/G/D 3.02% (n=7)
TA/D/FI/IY/G/D 1.29% (n=3)
TS/D/FI/LY/G/D 1.29% (n=3)
TA/D/WL/FY/G/D 1.29% (n=3)
TS/D/FL/FY/G/D 0.86% (n=2)
TA/D/FF/FY/G/D 0.86% (n=2)
TA/D/FV/FY/G/D 0.86% (n=2)
TA/E/FL/FY/G/D 0.43% (n=1)
TA/D/LI/FY/G/D 0.43% (n=1)
TA/D/FM/FY/G/D 0.43% (n=1)
TS/D/FL/LY/G/D 0.43% (n=1)
TA/D/FI/MY/G/D 0.43% (n=1)
TS/D/FI/FY/G/N 0.43% (n=1)
TS/D/FL/IY/G/D 0.43% (n=1)
TA/D/WA/FY/G/D 0.43% (n=1)
TA/D/WV/FY/G/D 0.43% (n=1)
TA/D/WF/FY/G/D 0.43% (n=1)
TS/D/FI/FY/G/D 0.43% (n=1)
TS/D/WL/FY/G/D 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 4a (antibodies: [HC-11])

TA/D/FL/FY/G/D 96.88% (n=155)
TS/D/FL/FY/G/D 0.63% (n=1)
TA/D/FF/FY/G/D 0.63% (n=1)
TA/D/FI/FY/G/D 0.63% (n=1)
TA/D/FI/LY/G/D 0.63% (n=1)
TA/E/FL/FY/G/D 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 4d (antibodies: [HC-11])

TA/D/FL/FY/G/D 53.85% (n=7)
TA/D/FI/FY/G/D 30.77% (n=4)
TA/D/LI/FY/G/D 7.69% (n=1)
TA/D/FI/LY/G/D 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 5 (antibodies: [HC-11])

TA/D/FI/MY/G/D 34.21% (n=13)
TA/D/FI/IY/G/D 18.42% (n=7)
TA/D/FI/LY/G/D 13.16% (n=5)
TA/D/FI/FY/G/D 10.53% (n=4)
TA/D/FV/LY/G/D 7.89% (n=3)
TA/D/FL/FY/G/D 5.26% (n=2)
TA/D/FI/VY/G/D 2.63% (n=1)
TA/D/FL/LY/G/D 2.63% (n=1)
TA/E/FI/FY/G/D 2.63% (n=1)
TA/D/FF/FY/G/D 2.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 6 (antibodies: [HC-11])

TA/D/FI/FY/G/D 51.71% (n=181)
TA/D/FL/FY/G/D 15.14% (n=53)
TA/D/FV/FY/G/D 8.00% (n=28)
TA/D/FI/LY/G/D 6.00% (n=21)
TA/D/FM/FY/G/D 2.86% (n=10)
TA/D/FI/IY/G/D 2.86% (n=10)
TA/D/FF/FY/G/D 2.00% (n=7)
TA/E/FI/FY/G/D 2.00% (n=7)
TA/D/FL/LY/G/D 1.71% (n=6)
TA/D/FI/MY/G/D 1.43% (n=5)
TA/D/FL/IY/G/D 1.14% (n=4)
TA/D/FI/FS/G/D 0.86% (n=3)
TA/E/FL/FY/G/D 0.57% (n=2)
TA/D/FI/FA/G/D 0.57% (n=2)
TA/D/WL/FY/G/D 0.57% (n=2)
TA/A/FI/FY/G/D 0.29% (n=1)
TA/D/FV/IY/G/D 0.29% (n=1)
TA/D/FR/FY/G/D 0.29% (n=1)
TA/D/FI/VY/G/D 0.29% (n=1)
TA/E/FF/FY/G/D 0.29% (n=1)
TA/D/FL/FN/G/D 0.29% (n=1)
TA/D/FL/FA/G/D 0.29% (n=1)
TA/D/FL/FT/G/D 0.29% (n=1)
TA/E/WL/LY/G/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Subtype 6a (antibodies: [HC-11])

TA/D/FI/FY/G/D 66.13% (n=82)
TA/D/FV/FY/G/D 18.55% (n=23)
TA/D/FL/FY/G/D 6.45% (n=8)
TA/D/FM/FY/G/D 3.23% (n=4)
TA/A/FI/FY/G/D 0.81% (n=1)
TA/D/FI/LY/G/D 0.81% (n=1)
TA/D/FI/MY/G/D 0.81% (n=1)
TA/D/FF/FY/G/D 0.81% (n=1)
TA/D/FV/IY/G/D 0.81% (n=1)
TA/D/FR/FY/G/D 0.81% (n=1)
TA/D/FI/IY/G/D 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,426,431,437,438,442,443,530,535 in HCV Genotype 7 (antibodies: [HC-11])

TA/D/FI/FY/G/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 1 (antibodies: [HC-1])

T/N/G/WG/D 98.78% (n=10062)
T/S/G/WG/D 0.25% (n=25)
T/N/G/WG/G 0.12% (n=12)
T/N/A/WG/D 0.11% (n=11)
A/N/G/WG/D 0.09% (n=9)
T/N/G/RG/D 0.06% (n=6)
T/N/G/WG/N 0.05% (n=5)
T/D/G/WG/D 0.05% (n=5)
T/N/G/SG/D 0.05% (n=5)
M/N/G/WG/D 0.04% (n=4)
T/N/G/FG/D 0.04% (n=4)
T/T/G/WG/D 0.04% (n=4)
T/K/G/WG/D 0.03% (n=3)
T/N/G/WG/Y 0.02% (n=2)
T/N/G/*G/D 0.02% (n=2)
T/N/G/WV/D 0.02% (n=2)
T/N/G/LG/G 0.02% (n=2)
T/N/G/WS/D 0.02% (n=2)
T/R/G/WG/D 0.02% (n=2)
T/N/R/WG/D 0.02% (n=2)
T/N/G/WG/V 0.01% (n=1)
T/N/G/WC/G 0.01% (n=1)
T/T/A/WG/D 0.01% (n=1)
T/N/G/CG/D 0.01% (n=1)
S/N/G/WG/D 0.01% (n=1)
T/N/G/WG/A 0.01% (n=1)
T/N/D/WG/D 0.01% (n=1)
T/N/S/WG/D 0.01% (n=1)
T/A/G/WG/D 0.01% (n=1)
T/D/G/RG/D 0.01% (n=1)
T/N/G/WR/D 0.01% (n=1)
T/N/G/GR/D 0.01% (n=1)
T/N/G/WG/C 0.01% (n=1)
T/N/G/WE/D 0.01% (n=1)
T/Y/G/WG/D 0.01% (n=1)
T/N/G/LG/D 0.01% (n=1)
T/N/E/WG/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 1a (antibodies: [HC-1])

T/N/G/WG/D 98.92% (n=7174)
T/S/G/WG/D 0.18% (n=13)
T/N/A/WG/D 0.15% (n=11)
A/N/G/WG/D 0.10% (n=7)
T/N/G/WG/G 0.08% (n=6)
M/N/G/WG/D 0.06% (n=4)
T/N/G/FG/D 0.06% (n=4)
T/T/G/WG/D 0.06% (n=4)
T/N/G/RG/D 0.06% (n=4)
T/D/G/WG/D 0.04% (n=3)
T/N/G/WG/N 0.03% (n=2)
T/N/G/WG/Y 0.03% (n=2)
T/N/G/*G/D 0.03% (n=2)
T/N/G/WV/D 0.03% (n=2)
T/N/G/LG/G 0.03% (n=2)
T/N/G/WS/D 0.03% (n=2)
T/K/G/WG/D 0.01% (n=1)
T/N/G/WG/V 0.01% (n=1)
T/N/G/WC/G 0.01% (n=1)
T/T/A/WG/D 0.01% (n=1)
T/N/G/CG/D 0.01% (n=1)
S/N/G/WG/D 0.01% (n=1)
T/N/G/WG/A 0.01% (n=1)
T/N/D/WG/D 0.01% (n=1)
T/N/S/WG/D 0.01% (n=1)
T/A/G/WG/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 1b (antibodies: [HC-1])

T/N/G/WG/D 98.66% (n=2861)
T/S/G/WG/D 0.34% (n=10)
T/N/G/WG/G 0.21% (n=6)
T/N/G/WG/N 0.10% (n=3)
T/D/G/WG/D 0.07% (n=2)
T/K/G/WG/D 0.07% (n=2)
T/R/G/WG/D 0.07% (n=2)
T/N/R/WG/D 0.07% (n=2)
T/N/G/RG/D 0.07% (n=2)
A/N/G/WG/D 0.07% (n=2)
T/D/G/RG/D 0.03% (n=1)
T/N/G/WR/D 0.03% (n=1)
T/N/G/GR/D 0.03% (n=1)
T/N/G/WG/C 0.03% (n=1)
T/N/G/WE/D 0.03% (n=1)
T/Y/G/WG/D 0.03% (n=1)
T/N/G/LG/D 0.03% (n=1)
T/N/E/WG/D 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 2 (antibodies: [HC-1])

T/N/G/WG/D 97.73% (n=516)
T/N/G/GE/D 0.95% (n=5)
T/N/G/WE/D 0.38% (n=2)
T/N/G/WG/N 0.19% (n=1)
H/T/G/WG/D 0.19% (n=1)
T/K/G/WG/D 0.19% (n=1)
T/N/G/WR/D 0.19% (n=1)
I/N/G/WG/D 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 2a (antibodies: [HC-1])

T/N/G/WG/D 89.47% (n=68)
T/N/G/GE/D 6.58% (n=5)
T/N/G/WG/N 1.32% (n=1)
T/N/G/WE/D 1.32% (n=1)
H/T/G/WG/D 1.32% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 2b (antibodies: [HC-1])

T/N/G/WG/D 99.43% (n=349)
T/K/G/WG/D 0.28% (n=1)
T/N/G/WR/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 2c (antibodies: [HC-1])

T/N/G/WG/D 96.88% (n=62)
T/N/G/WE/D 1.56% (n=1)
I/N/G/WG/D 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 3 (antibodies: [HC-1])

T/N/G/WG/D 85.14% (n=2355)
T/N/G/FG/D 8.89% (n=246)
T/S/G/FG/D 4.52% (n=125)
A/N/G/WG/D 0.22% (n=6)
T/N/R/WG/D 0.14% (n=4)
T/N/G/WS/D 0.14% (n=4)
T/N/G/RG/D 0.11% (n=3)
T/N/G/LG/D 0.11% (n=3)
T/D/G/WG/D 0.07% (n=2)
T/N/G/WG/E 0.07% (n=2)
T/N/G/GG/D 0.07% (n=2)
T/H/G/WG/D 0.07% (n=2)
T/N/G/WD/D 0.04% (n=1)
T/T/G/WG/D 0.04% (n=1)
T/S/G/WG/D 0.04% (n=1)
T/N/G/WG/G 0.04% (n=1)
T/N/E/WG/D 0.04% (n=1)
T/N/G/LS/D 0.04% (n=1)
T/N/G/LG/N 0.04% (n=1)
T/N/G/KS/E 0.04% (n=1)
T/N/G/SN/D 0.04% (n=1)
T/N/G/WG/A 0.04% (n=1)
T/N/G/YG/D 0.04% (n=1)
T/T/G/FG/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 3a (antibodies: [HC-1])

T/N/G/WG/D 98.00% (n=2350)
T/N/G/FG/D 0.38% (n=9)
A/N/G/WG/D 0.25% (n=6)
T/N/R/WG/D 0.17% (n=4)
T/N/G/WS/D 0.17% (n=4)
T/N/G/RG/D 0.13% (n=3)
T/N/G/LG/D 0.13% (n=3)
T/D/G/WG/D 0.08% (n=2)
T/N/G/WG/E 0.08% (n=2)
T/N/G/GG/D 0.08% (n=2)
T/H/G/WG/D 0.08% (n=2)
T/N/G/WD/D 0.04% (n=1)
T/T/G/WG/D 0.04% (n=1)
T/S/G/WG/D 0.04% (n=1)
T/N/G/WG/G 0.04% (n=1)
T/N/E/WG/D 0.04% (n=1)
T/N/G/LS/D 0.04% (n=1)
T/N/G/LG/N 0.04% (n=1)
T/N/G/KS/E 0.04% (n=1)
T/N/G/SN/D 0.04% (n=1)
T/N/G/WG/A 0.04% (n=1)
T/N/G/YG/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 3b (antibodies: [HC-1])

T/N/G/FG/D 64.00% (n=224)
T/S/G/FG/D 35.71% (n=125)
T/T/G/FG/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 4 (antibodies: [HC-1])

T/N/G/WG/D 98.29% (n=230)
T/N/G/LG/D 0.43% (n=1)
T/S/G/WG/D 0.43% (n=1)
T/N/G/FG/D 0.43% (n=1)
T/N/G/WG/N 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 4a (antibodies: [HC-1])

T/N/G/WG/D 99.38% (n=159)
T/N/G/LG/D 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 4d (antibodies: [HC-1])

T/N/G/WG/D 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 5 (antibodies: [HC-1])

T/N/G/WG/D 100.00% (n=38)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 6 (antibodies: [HC-1])

T/N/G/WG/D 97.51% (n=353)
T/N/G/FG/D 1.10% (n=4)
T/S/G/WG/D 0.83% (n=3)
T/N/E/WG/D 0.28% (n=1)
T/N/G/LG/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Subtype 6a (antibodies: [HC-1])

T/N/G/WG/D 99.19% (n=123)
T/N/E/WG/D 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,428,436,529,530,535 in HCV Genotype 7 (antibodies: [HC-1])

T/N/G/WG/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 437,438,441,442 in HCV Genotype 1 (antibodies: [mAb#8])

FL/LF 23.30% (n=5342)
WL/LF 15.88% (n=3641)
WI/LF 14.40% (n=3302)
WV/LF 13.03% (n=2987)
FI/LF 12.00% (n=2752)
WI/LL 5.16% (n=1182)
WV/LL 4.45% (n=1021)
WI/LI 2.78% (n=637)
FF/LF 1.94% (n=444)
WL/LL 1.45% (n=332)
FI/LL 0.87% (n=200)
FI/LI 0.69% (n=159)
WV/LI 0.67% (n=154)
WL/LI 0.50% (n=114)
FV/LF 0.45% (n=103)
WM/LF 0.42% (n=96)
FL/LL 0.36% (n=82)
WL/LV 0.31% (n=71)
WL/LM 0.14% (n=32)
WI/LM 0.12% (n=27)
FI/LV 0.12% (n=27)
FV/LI 0.10% (n=22)
FL/LI 0.08% (n=18)
FL/LS 0.04% (n=10)
LL/LF 0.04% (n=9)
WI/LV 0.03% (n=8)
SL/LF 0.03% (n=8)
FF/LV 0.03% (n=7)
FT/LF 0.03% (n=6)
FI/LM 0.03% (n=6)
WL/PF 0.02% (n=5)
GI/LL 0.02% (n=5)
*V/LF 0.02% (n=5)
FM/LF 0.02% (n=5)
FL/PF 0.02% (n=5)
FI/PF 0.02% (n=4)
FV/LL 0.02% (n=4)
WA/LF 0.02% (n=4)
FF/LI 0.02% (n=4)
FP/LF 0.02% (n=4)
RV/LF 0.01% (n=3)
WV/PF 0.01% (n=3)
GV/LF 0.01% (n=3)
WL/LS 0.01% (n=3)
WM/LL 0.01% (n=3)
WF/LF 0.01% (n=3)
LI/LF 0.01% (n=3)
FI/LS 0.01% (n=3)
SI/LF 0.01% (n=3)
*L/LF 0.01% (n=2)
WG/LF 0.01% (n=2)
FM/LL 0.01% (n=2)
WV/LH 0.01% (n=2)
WT/LF 0.01% (n=2)
RI/LF 0.01% (n=2)
VL/LF 0.01% (n=2)
WI/LP 0.00% (n=1)
*I/LF 0.00% (n=1)
RV/LL 0.00% (n=1)
WL/FS 0.00% (n=1)
WV/LS 0.00% (n=1)
WI/PS 0.00% (n=1)
WD/AF 0.00% (n=1)
RV/LI 0.00% (n=1)
WL/RA 0.00% (n=1)
WE/LF 0.00% (n=1)
WV/FL 0.00% (n=1)
CL/LF 0.00% (n=1)
WL/HF 0.00% (n=1)
WL/PL 0.00% (n=1)
WT/LL 0.00% (n=1)
WM/LI 0.00% (n=1)
WI/LN 0.00% (n=1)
WK/LI 0.00% (n=1)
WI/LT 0.00% (n=1)
LV/LL 0.00% (n=1)
YP/QH 0.00% (n=1)
CI/LF 0.00% (n=1)
RL/LF 0.00% (n=1)
LT/LF 0.00% (n=1)
*I/LI 0.00% (n=1)
WI/PI 0.00% (n=1)
*V/LL 0.00% (n=1)
WK/LL 0.00% (n=1)
WI/PL 0.00% (n=1)
WW/LF 0.00% (n=1)
*I/LL 0.00% (n=1)
WL/AP 0.00% (n=1)
WV/FF 0.00% (n=1)
WL/FL 0.00% (n=1)
WL/LP 0.00% (n=1)
GL/LF 0.00% (n=1)
WA/LL 0.00% (n=1)
WI/PF 0.00% (n=1)
WA/LV 0.00% (n=1)
WI/LS 0.00% (n=1)
FL/VF 0.00% (n=1)
FL/RF 0.00% (n=1)
IL/LF 0.00% (n=1)
FL/LV 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 1a (antibodies: [mAb#8])

WI/LF 24.13% (n=3289)
WL/LF 22.55% (n=3074)
WV/LF 21.81% (n=2973)
WI/LL 8.67% (n=1182)
WV/LL 7.47% (n=1018)
WI/LI 4.67% (n=637)
FI/LF 2.46% (n=335)
WL/LL 2.43% (n=331)
WV/LI 1.13% (n=154)
WL/LI 0.83% (n=113)
WM/LF 0.70% (n=96)
WL/LV 0.52% (n=71)
FL/LL 0.48% (n=66)
FI/LL 0.39% (n=53)
FV/LF 0.26% (n=35)
WL/LM 0.23% (n=32)
WI/LM 0.20% (n=27)
FL/LF 0.19% (n=26)
WI/LV 0.06% (n=8)
WL/PF 0.04% (n=5)
GI/LL 0.04% (n=5)
*V/LF 0.04% (n=5)
FV/LL 0.03% (n=4)
FT/LF 0.03% (n=4)
WA/LF 0.03% (n=4)
FI/LI 0.03% (n=4)
RV/LF 0.02% (n=3)
WV/PF 0.02% (n=3)
FI/PF 0.02% (n=3)
GV/LF 0.02% (n=3)
WL/LS 0.02% (n=3)
WM/LL 0.02% (n=3)
WF/LF 0.02% (n=3)
*L/LF 0.01% (n=2)
WG/LF 0.01% (n=2)
FM/LL 0.01% (n=2)
WV/LH 0.01% (n=2)
WT/LF 0.01% (n=2)
RI/LF 0.01% (n=2)
FI/LM 0.01% (n=2)
FL/LI 0.01% (n=2)
FV/LI 0.01% (n=2)
FM/LF 0.01% (n=2)
WI/LP 0.01% (n=1)
*I/LF 0.01% (n=1)
RV/LL 0.01% (n=1)
WL/FS 0.01% (n=1)
WV/LS 0.01% (n=1)
WI/PS 0.01% (n=1)
WD/AF 0.01% (n=1)
RV/LI 0.01% (n=1)
WL/RA 0.01% (n=1)
WE/LF 0.01% (n=1)
WV/FL 0.01% (n=1)
CL/LF 0.01% (n=1)
WL/HF 0.01% (n=1)
WL/PL 0.01% (n=1)
WT/LL 0.01% (n=1)
WM/LI 0.01% (n=1)
WI/LN 0.01% (n=1)
WK/LI 0.01% (n=1)
WI/LT 0.01% (n=1)
LV/LL 0.01% (n=1)
YP/QH 0.01% (n=1)
CI/LF 0.01% (n=1)
RL/LF 0.01% (n=1)
LT/LF 0.01% (n=1)
LI/LF 0.01% (n=1)
*I/LI 0.01% (n=1)
WI/PI 0.01% (n=1)
*V/LL 0.01% (n=1)
WK/LL 0.01% (n=1)
WI/PL 0.01% (n=1)
WW/LF 0.01% (n=1)
*I/LL 0.01% (n=1)
WL/AP 0.01% (n=1)
WV/FF 0.01% (n=1)
WL/FL 0.01% (n=1)
WL/LP 0.01% (n=1)
GL/LF 0.01% (n=1)
WA/LL 0.01% (n=1)
WI/PF 0.01% (n=1)
WA/LV 0.01% (n=1)
WI/LS 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 1b (antibodies: [mAb#8])

FL/LF 57.28% (n=5300)
FI/LF 26.07% (n=2412)
WL/LF 6.05% (n=560)
FF/LF 4.80% (n=444)
FI/LI 1.66% (n=154)
FI/LL 1.57% (n=145)
FV/LF 0.73% (n=68)
FI/LV 0.28% (n=26)
FV/LI 0.22% (n=20)
FL/LI 0.17% (n=16)
FL/LL 0.14% (n=13)
WI/LF 0.13% (n=12)
FL/LS 0.11% (n=10)
LL/LF 0.10% (n=9)
SL/LF 0.09% (n=8)
WV/LF 0.09% (n=8)
FF/LV 0.08% (n=7)
FL/PF 0.05% (n=5)
FF/LI 0.04% (n=4)
FI/LM 0.04% (n=4)
FP/LF 0.04% (n=4)
FI/LS 0.03% (n=3)
WV/LL 0.03% (n=3)
FM/LF 0.03% (n=3)
SI/LF 0.03% (n=3)
VL/LF 0.02% (n=2)
FT/LF 0.02% (n=2)
LI/LF 0.02% (n=2)
FL/VF 0.01% (n=1)
FL/RF 0.01% (n=1)
WL/LI 0.01% (n=1)
IL/LF 0.01% (n=1)
FL/LV 0.01% (n=1)
FI/PF 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 2 (antibodies: [mAb#8])

FI/LF 64.29% (n=864)
FL/LF 24.26% (n=326)
FV/LF 3.72% (n=50)
WL/LF 3.35% (n=45)
FF/LF 1.04% (n=14)
FM/LF 0.82% (n=11)
WI/LF 0.67% (n=9)
SI/LF 0.30% (n=4)
FI/LL 0.22% (n=3)
FI/LI 0.15% (n=2)
FI/LV 0.15% (n=2)
CL/LF 0.15% (n=2)
LI/LF 0.15% (n=2)
FL/PF 0.07% (n=1)
WL/LV 0.07% (n=1)
WL/LL 0.07% (n=1)
FF/LL 0.07% (n=1)
FV/LL 0.07% (n=1)
WV/LF 0.07% (n=1)
II/LF 0.07% (n=1)
FP/LF 0.07% (n=1)
LL/LF 0.07% (n=1)
FL/LS 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 2a (antibodies: [mAb#8])

FL/LF 53.68% (n=153)
FI/LF 24.91% (n=71)
FV/LF 16.14% (n=46)
FF/LF 1.75% (n=5)
FM/LF 1.75% (n=5)
FI/LI 0.35% (n=1)
FL/PF 0.35% (n=1)
WL/LF 0.35% (n=1)
FI/LL 0.35% (n=1)
FI/LV 0.35% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 2b (antibodies: [mAb#8])

FI/LF 75.16% (n=348)
FL/LF 9.72% (n=45)
WL/LF 9.29% (n=43)
WI/LF 1.94% (n=9)
FM/LF 1.30% (n=6)
FF/LF 0.65% (n=3)
CL/LF 0.43% (n=2)
FI/LV 0.22% (n=1)
WL/LV 0.22% (n=1)
WL/LL 0.22% (n=1)
LI/LF 0.22% (n=1)
FF/LL 0.22% (n=1)
FV/LF 0.22% (n=1)
FV/LL 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 2c (antibodies: [mAb#8])

FI/LF 92.07% (n=418)
FL/LF 4.41% (n=20)
FF/LF 1.10% (n=5)
SI/LF 0.88% (n=4)
FV/LF 0.22% (n=1)
FI/LI 0.22% (n=1)
WL/LF 0.22% (n=1)
WV/LF 0.22% (n=1)
FI/LL 0.22% (n=1)
LI/LF 0.22% (n=1)
II/LF 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 3 (antibodies: [mAb#8])

FI/LF 58.81% (n=2280)
FI/LI 18.31% (n=710)
FL/LF 14.81% (n=574)
FI/LL 3.30% (n=128)
FI/LM 2.45% (n=95)
FV/LF 0.67% (n=26)
FI/LV 0.44% (n=17)
FM/LF 0.18% (n=7)
FL/LL 0.15% (n=6)
FL/LI 0.13% (n=5)
FF/LF 0.13% (n=5)
FV/LI 0.10% (n=4)
LI/LF 0.08% (n=3)
SI/LF 0.05% (n=2)
FI/MF 0.03% (n=1)
FI/LS 0.03% (n=1)
SI/LM 0.03% (n=1)
SI/LL 0.03% (n=1)
SI/LI 0.03% (n=1)
FI/SF 0.03% (n=1)
FI/FD 0.03% (n=1)
FT/LF 0.03% (n=1)
FL/LM 0.03% (n=1)
FI/CF 0.03% (n=1)
S*/CF 0.03% (n=1)
SL/LI 0.03% (n=1)
FV/LL 0.03% (n=1)
FL/LV 0.03% (n=1)
FM/LL 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 3a (antibodies: [mAb#8])

FI/LF 66.15% (n=2171)
FI/LI 14.53% (n=477)
FL/LF 12.13% (n=398)
FI/LL 3.23% (n=106)
FI/LM 1.52% (n=50)
FV/LF 0.64% (n=21)
FI/LV 0.37% (n=12)
FM/LF 0.21% (n=7)
FL/LL 0.18% (n=6)
FL/LI 0.15% (n=5)
FF/LF 0.15% (n=5)
FV/LI 0.12% (n=4)
LI/LF 0.09% (n=3)
SI/LF 0.06% (n=2)
FI/MF 0.03% (n=1)
FI/LS 0.03% (n=1)
SI/LM 0.03% (n=1)
SI/LL 0.03% (n=1)
SI/LI 0.03% (n=1)
FI/SF 0.03% (n=1)
FI/FD 0.03% (n=1)
FT/LF 0.03% (n=1)
FL/LM 0.03% (n=1)
FI/CF 0.03% (n=1)
S*/CF 0.03% (n=1)
SL/LI 0.03% (n=1)
FV/LL 0.03% (n=1)
FL/LV 0.03% (n=1)
FM/LL 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 3b (antibodies: [mAb#8])

FI/LI 57.50% (n=230)
FI/LF 24.00% (n=96)
FI/LM 10.50% (n=42)
FI/LL 5.00% (n=20)
FI/LV 1.25% (n=5)
FV/LF 1.25% (n=5)
FL/LF 0.50% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 4 (antibodies: [mAb#8])

FI/LF 48.69% (n=372)
FL/LF 45.29% (n=346)
FI/LL 3.01% (n=23)
FF/LF 0.65% (n=5)
WL/LF 0.52% (n=4)
FI/LI 0.39% (n=3)
FL/LL 0.26% (n=2)
FV/LF 0.26% (n=2)
LI/LF 0.13% (n=1)
FM/LF 0.13% (n=1)
FI/LM 0.13% (n=1)
FL/LI 0.13% (n=1)
WA/LF 0.13% (n=1)
WV/LF 0.13% (n=1)
WF/LF 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 4a (antibodies: [mAb#8])

FL/LF 98.15% (n=159)
FF/LF 0.62% (n=1)
FI/LF 0.62% (n=1)
FI/LL 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 4d (antibodies: [mAb#8])

FI/LF 65.31% (n=354)
FL/LF 31.18% (n=169)
FI/LL 2.58% (n=14)
FF/LF 0.55% (n=3)
LI/LF 0.18% (n=1)
FL/LL 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 5 (antibodies: [mAb#8])

FI/LM 35.90% (n=14)
FI/LI 17.95% (n=7)
FI/LF 12.82% (n=5)
FI/LL 12.82% (n=5)
FV/LL 7.69% (n=3)
FL/LF 5.13% (n=2)
FI/LV 2.56% (n=1)
FL/LL 2.56% (n=1)
FF/LF 2.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 6 (antibodies: [mAb#8])

FI/LF 67.02% (n=378)
FL/LF 11.52% (n=65)
FV/LF 6.91% (n=39)
FI/LL 4.43% (n=25)
FM/LF 2.84% (n=16)
FI/LI 2.13% (n=12)
FF/LF 1.42% (n=8)
FL/LL 1.06% (n=6)
FI/LM 0.89% (n=5)
FL/LI 0.71% (n=4)
WL/LF 0.35% (n=2)
FV/LI 0.18% (n=1)
FR/LF 0.18% (n=1)
FI/LV 0.18% (n=1)
WL/LL 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Subtype 6a (antibodies: [mAb#8])

FI/LF 79.94% (n=259)
FV/LF 10.49% (n=34)
FL/LF 3.40% (n=11)
FM/LF 2.78% (n=9)
FI/LL 1.23% (n=4)
FI/LI 0.93% (n=3)
FI/LM 0.31% (n=1)
FF/LF 0.31% (n=1)
FV/LI 0.31% (n=1)
FR/LF 0.31% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,438,441,442 in HCV Genotype 7 (antibodies: [mAb#8])

FI/LF 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 437,439,530,535 in HCV Genotype 1 (antibodies: [CBH-2])

W/A/G/D 70.45% (n=7180)
F/A/G/D 27.98% (n=2852)
W/T/G/D 0.48% (n=49)
W/V/G/D 0.17% (n=17)
F/T/G/D 0.14% (n=14)
F/S/G/D 0.11% (n=11)
G/A/G/D 0.08% (n=8)
F/A/G/G 0.08% (n=8)
W/A/G/G 0.06% (n=6)
L/A/G/D 0.05% (n=5)
S/A/G/D 0.05% (n=5)
R/A/G/D 0.03% (n=3)
F/A/G/N 0.03% (n=3)
F/V/G/D 0.03% (n=3)
W/T/G/Y 0.02% (n=2)
W/A/V/D 0.02% (n=2)
*/A/G/D 0.02% (n=2)
W/A/S/D 0.02% (n=2)
W/S/G/D 0.02% (n=2)
F/A/R/D 0.02% (n=2)
W/A/G/N 0.01% (n=1)
W/A/G/V 0.01% (n=1)
W/A/C/G 0.01% (n=1)
W/G/G/D 0.01% (n=1)
W/T/G/N 0.01% (n=1)
Y/A/G/D 0.01% (n=1)
W/R/G/D 0.01% (n=1)
C/A/G/D 0.01% (n=1)
R/V/G/D 0.01% (n=1)
F/A/G/A 0.01% (n=1)
F/G/G/D 0.01% (n=1)
F/P/G/D 0.01% (n=1)
V/A/G/D 0.01% (n=1)
F/A/G/C 0.01% (n=1)
F/K/G/D 0.01% (n=1)
F/A/E/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 1a (antibodies: [CBH-2])

W/A/G/D 93.59% (n=6786)
F/A/G/D 4.92% (n=357)
W/T/G/D 0.68% (n=49)
W/V/G/D 0.23% (n=17)
G/A/G/D 0.11% (n=8)
W/A/G/G 0.08% (n=6)
R/A/G/D 0.04% (n=3)
W/T/G/Y 0.03% (n=2)
W/A/V/D 0.03% (n=2)
F/A/G/G 0.03% (n=2)
L/A/G/D 0.03% (n=2)
*/A/G/D 0.03% (n=2)
W/A/S/D 0.03% (n=2)
W/S/G/D 0.03% (n=2)
W/A/G/N 0.01% (n=1)
W/A/G/V 0.01% (n=1)
W/A/C/G 0.01% (n=1)
W/G/G/D 0.01% (n=1)
W/T/G/N 0.01% (n=1)
Y/A/G/D 0.01% (n=1)
W/R/G/D 0.01% (n=1)
C/A/G/D 0.01% (n=1)
R/V/G/D 0.01% (n=1)
F/A/G/A 0.01% (n=1)
F/T/G/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 1b (antibodies: [CBH-2])

F/A/G/D 84.93% (n=2469)
W/A/G/D 13.31% (n=387)
F/T/G/D 0.45% (n=13)
F/S/G/D 0.38% (n=11)
F/A/G/G 0.21% (n=6)
S/A/G/D 0.17% (n=5)
F/A/G/N 0.10% (n=3)
L/A/G/D 0.10% (n=3)
F/A/R/D 0.07% (n=2)
F/V/G/D 0.07% (n=2)
F/G/G/D 0.03% (n=1)
F/P/G/D 0.03% (n=1)
V/A/G/D 0.03% (n=1)
F/A/G/C 0.03% (n=1)
F/K/G/D 0.03% (n=1)
F/A/E/D 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 2 (antibodies: [CBH-2])

F/A/G/D 93.01% (n=492)
F/T/G/D 2.27% (n=12)
F/A/E/D 1.32% (n=7)
F/S/G/D 1.13% (n=6)
F/V/G/D 0.57% (n=3)
C/S/G/D 0.38% (n=2)
W/A/G/D 0.38% (n=2)
F/S/G/N 0.19% (n=1)
F/C/G/D 0.19% (n=1)
F/R/G/D 0.19% (n=1)
F/H/G/D 0.19% (n=1)
F/A/R/D 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 2a (antibodies: [CBH-2])

F/A/G/D 80.52% (n=62)
F/A/E/D 7.79% (n=6)
F/T/G/D 5.19% (n=4)
F/V/G/D 2.60% (n=2)
F/S/G/N 1.30% (n=1)
F/C/G/D 1.30% (n=1)
F/R/G/D 1.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 2b (antibodies: [CBH-2])

F/A/G/D 95.73% (n=336)
F/T/G/D 1.71% (n=6)
F/S/G/D 1.14% (n=4)
C/S/G/D 0.57% (n=2)
F/H/G/D 0.28% (n=1)
F/A/R/D 0.28% (n=1)
F/V/G/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 2c (antibodies: [CBH-2])

F/A/G/D 92.19% (n=59)
W/A/G/D 3.13% (n=2)
F/S/G/D 1.56% (n=1)
F/T/G/D 1.56% (n=1)
F/A/E/D 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 3 (antibodies: [CBH-2])

F/A/G/D 98.51% (n=2719)
F/V/G/D 0.83% (n=23)
F/A/S/D 0.18% (n=5)
S/A/G/D 0.07% (n=2)
F/T/G/D 0.07% (n=2)
F/A/G/E 0.07% (n=2)
F/A/D/D 0.04% (n=1)
L/A/G/D 0.04% (n=1)
F/A/G/G 0.04% (n=1)
F/A/G/N 0.04% (n=1)
F/A/S/E 0.04% (n=1)
F/A/N/D 0.04% (n=1)
S/L/G/A 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 3a (antibodies: [CBH-2])

F/A/G/D 98.33% (n=2357)
F/V/G/D 0.96% (n=23)
F/A/S/D 0.21% (n=5)
S/A/G/D 0.08% (n=2)
F/A/G/E 0.08% (n=2)
F/A/D/D 0.04% (n=1)
F/T/G/D 0.04% (n=1)
L/A/G/D 0.04% (n=1)
F/A/G/G 0.04% (n=1)
F/A/G/N 0.04% (n=1)
F/A/S/E 0.04% (n=1)
F/A/N/D 0.04% (n=1)
S/L/G/A 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 3b (antibodies: [CBH-2])

F/A/G/D 99.71% (n=344)
F/T/G/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 4 (antibodies: [CBH-2])

F/A/G/D 95.28% (n=222)
W/A/G/D 3.00% (n=7)
F/T/G/D 0.43% (n=1)
L/A/G/D 0.43% (n=1)
F/V/G/D 0.43% (n=1)
F/A/G/N 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 4a (antibodies: [CBH-2])

F/A/G/D 99.38% (n=159)
F/T/G/D 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 4d (antibodies: [CBH-2])

F/A/G/D 92.31% (n=12)
L/A/G/D 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 5 (antibodies: [CBH-2])

F/A/G/D 100.00% (n=38)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 6 (antibodies: [CBH-2])

F/A/G/D 93.07% (n=336)
F/T/G/D 3.88% (n=14)
F/S/G/D 1.66% (n=6)
W/A/G/D 0.83% (n=3)
F/V/G/D 0.55% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Subtype 6a (antibodies: [CBH-2])

F/A/G/D 95.97% (n=119)
F/T/G/D 3.23% (n=4)
F/S/G/D 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 437,439,530,535 in HCV Genotype 7 (antibodies: [CBH-2])

F/A/G/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 441,442 in HCV Genotype 1 (antibodies: [HC84.1])

LF 81.75% (n=18768)
LL 12.37% (n=2839)
LI 4.85% (n=1113)
LV 0.50% (n=115)
LM 0.28% (n=65)
PF 0.08% (n=18)
LS 0.08% (n=18)
LP 0.01% (n=2)
LH 0.01% (n=2)
FL 0.01% (n=2)
PL 0.01% (n=2)
FS 0.00% (n=1)
PS 0.00% (n=1)
AF 0.00% (n=1)
RA 0.00% (n=1)
HF 0.00% (n=1)
LN 0.00% (n=1)
LT 0.00% (n=1)
QH 0.00% (n=1)
PI 0.00% (n=1)
AP 0.00% (n=1)
FF 0.00% (n=1)
VF 0.00% (n=1)
RF 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 1a (antibodies: [HC84.1])

LF 72.41% (n=9881)
LL 19.57% (n=2671)
LI 6.72% (n=917)
LV 0.59% (n=80)
LM 0.45% (n=61)
PF 0.09% (n=12)
LS 0.04% (n=5)
LP 0.01% (n=2)
LH 0.01% (n=2)
FL 0.01% (n=2)
PL 0.01% (n=2)
FS 0.01% (n=1)
PS 0.01% (n=1)
AF 0.01% (n=1)
RA 0.01% (n=1)
HF 0.01% (n=1)
LN 0.01% (n=1)
LT 0.01% (n=1)
QH 0.01% (n=1)
PI 0.01% (n=1)
AP 0.01% (n=1)
FF 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 1b (antibodies: [HC84.1])

LF 95.51% (n=8852)
LI 2.10% (n=195)
LL 1.75% (n=162)
LV 0.37% (n=34)
LS 0.14% (n=13)
PF 0.06% (n=6)
LM 0.04% (n=4)
VF 0.01% (n=1)
RF 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 2 (antibodies: [HC84.1])

LF 99.04% (n=1344)
LL 0.44% (n=6)
LV 0.22% (n=3)
LI 0.15% (n=2)
PF 0.07% (n=1)
LS 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 2a (antibodies: [HC84.1])

LF 98.65% (n=292)
LI 0.34% (n=1)
PF 0.34% (n=1)
LL 0.34% (n=1)
LV 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 2b (antibodies: [HC84.1])

LF 98.92% (n=458)
LL 0.65% (n=3)
LV 0.43% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 2c (antibodies: [HC84.1])

LF 99.56% (n=454)
LI 0.22% (n=1)
LL 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 3 (antibodies: [HC84.1])

LF 74.72% (n=2900)
LI 18.60% (n=722)
LL 3.56% (n=138)
LM 2.50% (n=97)
LV 0.46% (n=18)
CF 0.05% (n=2)
MF 0.03% (n=1)
LS 0.03% (n=1)
SF 0.03% (n=1)
FD 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 3a (antibodies: [HC84.1])

LF 79.45% (n=2609)
LI 14.89% (n=489)
LL 3.50% (n=115)
LM 1.58% (n=52)
LV 0.40% (n=13)
CF 0.06% (n=2)
MF 0.03% (n=1)
LS 0.03% (n=1)
SF 0.03% (n=1)
FD 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 3b (antibodies: [HC84.1])

LI 57.21% (n=230)
LF 25.87% (n=104)
LM 10.45% (n=42)
LL 5.22% (n=21)
LV 1.24% (n=5)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 4 (antibodies: [HC84.1])

LF 96.08% (n=735)
LL 3.27% (n=25)
LI 0.52% (n=4)
LM 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 4a (antibodies: [HC84.1])

LF 99.38% (n=161)
LL 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 4d (antibodies: [HC84.1])

LF 97.23% (n=527)
LL 2.77% (n=15)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 5 (antibodies: [HC84.1])

LM 35.90% (n=14)
LL 23.08% (n=9)
LF 20.51% (n=8)
LI 17.95% (n=7)
LV 2.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 6 (antibodies: [HC84.1])

LF 90.47% (n=522)
LL 5.55% (n=32)
LI 2.95% (n=17)
LM 0.87% (n=5)
LV 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Subtype 6a (antibodies: [HC84.1])

LF 97.30% (n=324)
LI 1.20% (n=4)
LL 1.20% (n=4)
LM 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442 in HCV Genotype 7 (antibodies: [HC84.1])

LF 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 1 (antibodies: [HC84.20])

LFY/Y/W 79.48% (n=6360)
LLY/Y/W 13.98% (n=1119)
LIY/Y/W 2.55% (n=204)
LFY/H/W 1.10% (n=88)
LVY/Y/W 1.09% (n=87)
LFH/Y/W 1.04% (n=83)
LMY/Y/W 0.12% (n=10)
LFS/Y/W 0.07% (n=6)
LFN/Y/W 0.07% (n=6)
PFY/Y/W 0.05% (n=4)
LFC/Y/W 0.04% (n=3)
LFF/Y/W 0.04% (n=3)
LSY/Y/W 0.04% (n=3)
LFA/Y/W 0.04% (n=3)
LFY/Y/R 0.02% (n=2)
LFY/R/W 0.02% (n=2)
LFY/S/W 0.02% (n=2)
HFY/Y/W 0.01% (n=1)
PLY/Y/W 0.01% (n=1)
LNY/Y/W 0.01% (n=1)
PFS/Y/W 0.01% (n=1)
LIH/Y/W 0.01% (n=1)
QH*/Y/W 0.01% (n=1)
LFY/Y/G 0.01% (n=1)
LFH/H/W 0.01% (n=1)
LFY/C/W 0.01% (n=1)
APL/Y/W 0.01% (n=1)
LFY/Y/T 0.01% (n=1)
FFY/Y/W 0.01% (n=1)
LST/Y/W 0.01% (n=1)
LFY/Y/* 0.01% (n=1)
LIY/*/W 0.01% (n=1)
VFY/Y/W 0.01% (n=1)
LFL/Y/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 1a (antibodies: [HC84.20])

LFY/Y/W 74.59% (n=4593)
LLY/Y/W 17.98% (n=1107)
LIY/Y/W 2.76% (n=170)
LFY/H/W 1.40% (n=86)
LFH/Y/W 1.33% (n=82)
LVY/Y/W 1.20% (n=74)
LMY/Y/W 0.16% (n=10)
LFS/Y/W 0.10% (n=6)
PFY/Y/W 0.06% (n=4)
LFN/Y/W 0.06% (n=4)
LFC/Y/W 0.05% (n=3)
LFY/Y/R 0.03% (n=2)
LFY/R/W 0.03% (n=2)
HFY/Y/W 0.02% (n=1)
PLY/Y/W 0.02% (n=1)
LNY/Y/W 0.02% (n=1)
PFS/Y/W 0.02% (n=1)
LIH/Y/W 0.02% (n=1)
QH*/Y/W 0.02% (n=1)
LFY/Y/G 0.02% (n=1)
LFH/H/W 0.02% (n=1)
LFY/C/W 0.02% (n=1)
APL/Y/W 0.02% (n=1)
LFY/Y/T 0.02% (n=1)
FFY/Y/W 0.02% (n=1)
LST/Y/W 0.02% (n=1)
LFF/Y/W 0.02% (n=1)
LFY/Y/* 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 1b (antibodies: [HC84.20])

LFY/Y/W 96.25% (n=1746)
LIY/Y/W 1.82% (n=33)
LVY/Y/W 0.66% (n=12)
LLY/Y/W 0.50% (n=9)
LSY/Y/W 0.17% (n=3)
LFF/Y/W 0.11% (n=2)
LFY/H/W 0.11% (n=2)
LFN/Y/W 0.11% (n=2)
LFY/S/W 0.11% (n=2)
LIY/*/W 0.06% (n=1)
VFY/Y/W 0.06% (n=1)
LFH/Y/W 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 2 (antibodies: [HC84.20])

LFY/Y/W 97.69% (n=465)
LLY/Y/W 0.63% (n=3)
LVY/Y/W 0.42% (n=2)
LIY/Y/W 0.21% (n=1)
LFY/Y/G 0.21% (n=1)
PFY/Y/W 0.21% (n=1)
LFR/Y/W 0.21% (n=1)
LFY/H/G 0.21% (n=1)
LFH/Y/W 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 2a (antibodies: [HC84.20])

LFY/Y/W 92.42% (n=61)
LIY/Y/W 1.52% (n=1)
LFY/Y/G 1.52% (n=1)
PFY/Y/W 1.52% (n=1)
LVY/Y/W 1.52% (n=1)
LFR/Y/W 1.52% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 2b (antibodies: [HC84.20])

LFY/Y/W 98.86% (n=347)
LLY/Y/W 0.57% (n=2)
LVY/Y/W 0.28% (n=1)
LFY/H/G 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 2c (antibodies: [HC84.20])

LFY/Y/W 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 3 (antibodies: [HC84.20])

LFY/Y/W 69.04% (n=1686)
LIY/Y/W 23.87% (n=583)
LLY/Y/W 2.42% (n=59)
LMY/Y/W 1.84% (n=45)
LFH/Y/W 1.39% (n=34)
LFN/Y/W 0.37% (n=9)
LVY/Y/W 0.33% (n=8)
LFS/Y/W 0.29% (n=7)
LFY/I/L 0.08% (n=2)
LFR/Y/W 0.04% (n=1)
LFY/Y/R 0.04% (n=1)
SFY/Y/W 0.04% (n=1)
LFY/Y/C 0.04% (n=1)
FDY/Y/W 0.04% (n=1)
CFY/Y/W 0.04% (n=1)
LFH/Y/* 0.04% (n=1)
CFI/Y/W 0.04% (n=1)
LFF/Y/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 3a (antibodies: [HC84.20])

LFY/Y/W 73.72% (n=1669)
LIY/Y/W 20.54% (n=465)
LLY/Y/W 2.25% (n=51)
LFH/Y/W 1.50% (n=34)
LMY/Y/W 0.44% (n=10)
LFN/Y/W 0.40% (n=9)
LVY/Y/W 0.35% (n=8)
LFS/Y/W 0.31% (n=7)
LFY/I/L 0.09% (n=2)
LFR/Y/W 0.04% (n=1)
LFY/Y/R 0.04% (n=1)
SFY/Y/W 0.04% (n=1)
LFY/Y/C 0.04% (n=1)
FDY/Y/W 0.04% (n=1)
CFY/Y/W 0.04% (n=1)
LFH/Y/* 0.04% (n=1)
CFI/Y/W 0.04% (n=1)
LFF/Y/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 3b (antibodies: [HC84.20])

LIY/Y/W 71.88% (n=115)
LMY/Y/W 20.00% (n=32)
LFY/Y/W 4.38% (n=7)
LLY/Y/W 3.75% (n=6)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 4 (antibodies: [HC84.20])

LFY/Y/W 91.75% (n=189)
LLY/Y/W 5.34% (n=11)
LIY/Y/W 1.94% (n=4)
LFY/I/V 0.49% (n=1)
LMY/Y/W 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 4a (antibodies: [HC84.20])

LFY/Y/W 98.48% (n=130)
LFY/I/V 0.76% (n=1)
LLY/Y/W 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 4d (antibodies: [HC84.20])

LFY/Y/W 92.31% (n=12)
LLY/Y/W 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 5 (antibodies: [HC84.20])

LMY/Y/W 35.14% (n=13)
LLY/Y/W 24.32% (n=9)
LFY/Y/W 18.92% (n=7)
LIY/Y/W 18.92% (n=7)
LVY/Y/W 2.70% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 6 (antibodies: [HC84.20])

LFY/Y/W 83.71% (n=185)
LLY/Y/W 8.60% (n=19)
LIY/Y/W 3.62% (n=8)
LMY/Y/W 1.36% (n=3)
LFA/Y/W 1.36% (n=3)
LFS/Y/W 0.45% (n=1)
LVY/Y/W 0.45% (n=1)
LFT/Y/W 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Subtype 6a (antibodies: [HC84.20])

LFY/Y/W 98.04% (n=100)
LLY/Y/W 0.98% (n=1)
LMY/Y/W 0.98% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,443,613,616 in HCV Genotype 7 (antibodies: [HC84.20])

LFY/Y/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 441,442,446,616 in HCV Genotype 1 (antibodies: [HC84.27])

LF/K/W 57.42% (n=4580)
LF/R/W 14.77% (n=1178)
LL/K/W 12.40% (n=989)
LF/N/W 4.76% (n=380)
LF/S/W 3.50% (n=279)
LI/K/W 2.09% (n=167)
LL/R/W 1.10% (n=88)
LV/K/W 1.00% (n=80)
LF/Q/W 0.99% (n=79)
LL/S/W 0.35% (n=28)
LI/R/W 0.25% (n=20)
LI/Q/W 0.18% (n=14)
LF/T/W 0.15% (n=12)
LF/G/W 0.13% (n=10)
LL/N/W 0.11% (n=9)
LM/K/W 0.10% (n=8)
LV/R/W 0.08% (n=6)
LF/P/W 0.08% (n=6)
LF/H/W 0.06% (n=5)
PF/K/W 0.05% (n=4)
LF/E/W 0.05% (n=4)
LL/Q/W 0.03% (n=2)
LI/E/W 0.03% (n=2)
LM/S/W 0.03% (n=2)
LS/K/W 0.03% (n=2)
LI/G/W 0.01% (n=1)
HF/K/W 0.01% (n=1)
PL/K/W 0.01% (n=1)
LN/Q/W 0.01% (n=1)
LL/G/W 0.01% (n=1)
LI/N/W 0.01% (n=1)
LF/K/R 0.01% (n=1)
QH/L/W 0.01% (n=1)
LI/S/W 0.01% (n=1)
LF/K/G 0.01% (n=1)
PF/R/W 0.01% (n=1)
LF/R/R 0.01% (n=1)
AP/K/W 0.01% (n=1)
LF/K/T 0.01% (n=1)
FF/K/W 0.01% (n=1)
LS/S/W 0.01% (n=1)
LV/Q/W 0.01% (n=1)
LF/K/* 0.01% (n=1)
LF/M/W 0.01% (n=1)
VF/K/W 0.01% (n=1)
LF/W/W 0.01% (n=1)
LF/A/W 0.01% (n=1)
LS/R/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 1a (antibodies: [HC84.27])

LF/K/W 56.35% (n=3468)
LL/K/W 15.88% (n=977)
LF/R/W 11.60% (n=714)
LF/N/W 5.57% (n=343)
LF/S/W 2.53% (n=156)
LI/K/W 2.18% (n=134)
LL/R/W 1.43% (n=88)
LF/Q/W 1.27% (n=78)
LV/K/W 1.10% (n=68)
LL/S/W 0.45% (n=28)
LI/R/W 0.29% (n=18)
LI/Q/W 0.23% (n=14)
LF/T/W 0.18% (n=11)
LL/N/W 0.15% (n=9)
LM/K/W 0.13% (n=8)
LF/G/W 0.08% (n=5)
LV/R/W 0.08% (n=5)
PF/K/W 0.06% (n=4)
LL/Q/W 0.03% (n=2)
LI/E/W 0.03% (n=2)
LM/S/W 0.03% (n=2)
LI/G/W 0.02% (n=1)
HF/K/W 0.02% (n=1)
PL/K/W 0.02% (n=1)
LN/Q/W 0.02% (n=1)
LL/G/W 0.02% (n=1)
LF/H/W 0.02% (n=1)
LI/N/W 0.02% (n=1)
LF/K/R 0.02% (n=1)
QH/L/W 0.02% (n=1)
LI/S/W 0.02% (n=1)
LF/K/G 0.02% (n=1)
LF/E/W 0.02% (n=1)
PF/R/W 0.02% (n=1)
LF/R/R 0.02% (n=1)
AP/K/W 0.02% (n=1)
LF/K/T 0.02% (n=1)
FF/K/W 0.02% (n=1)
LS/S/W 0.02% (n=1)
LV/Q/W 0.02% (n=1)
LF/K/* 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 1b (antibodies: [HC84.27])

LF/K/W 61.35% (n=1100)
LF/R/W 25.32% (n=454)
LF/S/W 6.75% (n=121)
LF/N/W 2.01% (n=36)
LI/K/W 1.78% (n=32)
LV/K/W 0.67% (n=12)
LL/K/W 0.50% (n=9)
LF/P/W 0.33% (n=6)
LF/G/W 0.28% (n=5)
LF/H/W 0.22% (n=4)
LF/E/W 0.17% (n=3)
LI/R/W 0.11% (n=2)
LS/K/W 0.11% (n=2)
LF/M/W 0.06% (n=1)
VF/K/W 0.06% (n=1)
LF/Q/W 0.06% (n=1)
LF/W/W 0.06% (n=1)
LF/T/W 0.06% (n=1)
LF/A/W 0.06% (n=1)
LS/R/W 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 2 (antibodies: [HC84.27])

LF/K/W 34.95% (n=166)
LF/N/W 26.32% (n=125)
LF/R/W 15.58% (n=74)
LF/S/W 15.16% (n=72)
LF/H/W 3.37% (n=16)
LF/Q/W 1.47% (n=7)
LF/T/W 0.84% (n=4)
LV/R/W 0.42% (n=2)
LL/K/W 0.42% (n=2)
LI/R/W 0.21% (n=1)
LF/A/G 0.21% (n=1)
PF/R/W 0.21% (n=1)
LF/K/G 0.21% (n=1)
LF/I/W 0.21% (n=1)
LF/D/W 0.21% (n=1)
LL/S/W 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 2a (antibodies: [HC84.27])

LF/R/W 46.97% (n=31)
LF/S/W 13.64% (n=9)
LF/K/W 12.12% (n=8)
LF/N/W 12.12% (n=8)
LF/H/W 6.06% (n=4)
LF/Q/W 3.03% (n=2)
LI/R/W 1.52% (n=1)
LF/A/G 1.52% (n=1)
PF/R/W 1.52% (n=1)
LV/R/W 1.52% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 2b (antibodies: [HC84.27])

LF/K/W 40.46% (n=142)
LF/N/W 30.77% (n=108)
LF/S/W 11.97% (n=42)
LF/R/W 9.69% (n=34)
LF/H/W 2.85% (n=10)
LF/Q/W 1.42% (n=5)
LF/T/W 1.14% (n=4)
LV/R/W 0.28% (n=1)
LF/K/G 0.28% (n=1)
LF/I/W 0.28% (n=1)
LF/D/W 0.28% (n=1)
LL/K/W 0.28% (n=1)
LL/S/W 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 2c (antibodies: [HC84.27])

LF/S/W 63.64% (n=14)
LF/N/W 22.73% (n=5)
LF/H/W 9.09% (n=2)
LF/R/W 4.55% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 3 (antibodies: [HC84.27])

LF/K/W 46.03% (n=1124)
LI/K/W 22.85% (n=558)
LF/R/W 22.36% (n=546)
LL/K/W 2.13% (n=52)
LF/N/W 1.56% (n=38)
LM/K/W 1.43% (n=35)
LI/R/W 0.86% (n=21)
LF/Q/W 0.37% (n=9)
LF/S/W 0.37% (n=9)
LF/E/W 0.29% (n=7)
LV/K/W 0.29% (n=7)
LL/R/W 0.25% (n=6)
LM/R/W 0.25% (n=6)
LM/S/W 0.16% (n=4)
LI/S/W 0.12% (n=3)
LF/K/L 0.08% (n=2)
LF/H/W 0.08% (n=2)
LF/A/W 0.04% (n=1)
LF/K/R 0.04% (n=1)
SF/R/W 0.04% (n=1)
LF/M/W 0.04% (n=1)
LF/R/C 0.04% (n=1)
FD/K/W 0.04% (n=1)
CF/K/W 0.04% (n=1)
LF/R/* 0.04% (n=1)
CF/S/W 0.04% (n=1)
LF/V/W 0.04% (n=1)
LV/R/W 0.04% (n=1)
LI/Q/W 0.04% (n=1)
LL/Q/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 3a (antibodies: [HC84.27])

LF/K/W 49.03% (n=1110)
LF/R/W 24.03% (n=544)
LI/K/W 19.61% (n=444)
LL/K/W 1.99% (n=45)
LF/N/W 1.63% (n=37)
LI/R/W 0.75% (n=17)
LF/Q/W 0.40% (n=9)
LF/S/W 0.40% (n=9)
LF/E/W 0.31% (n=7)
LV/K/W 0.31% (n=7)
LL/R/W 0.27% (n=6)
LM/S/W 0.18% (n=4)
LI/S/W 0.13% (n=3)
LM/K/W 0.13% (n=3)
LM/R/W 0.13% (n=3)
LF/K/L 0.09% (n=2)
LF/H/W 0.09% (n=2)
LF/A/W 0.04% (n=1)
LF/K/R 0.04% (n=1)
SF/R/W 0.04% (n=1)
LF/M/W 0.04% (n=1)
LF/R/C 0.04% (n=1)
FD/K/W 0.04% (n=1)
CF/K/W 0.04% (n=1)
LF/R/* 0.04% (n=1)
CF/S/W 0.04% (n=1)
LF/V/W 0.04% (n=1)
LV/R/W 0.04% (n=1)
LI/Q/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 3b (antibodies: [HC84.27])

LI/K/W 70.00% (n=112)
LM/K/W 19.38% (n=31)
LF/K/W 3.75% (n=6)
LL/K/W 3.13% (n=5)
LI/R/W 1.88% (n=3)
LF/R/W 0.63% (n=1)
LL/Q/W 0.63% (n=1)
LM/R/W 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 4 (antibodies: [HC84.27])

LF/K/W 69.76% (n=143)
LF/R/W 16.10% (n=33)
LL/K/W 4.88% (n=10)
LF/S/W 4.39% (n=9)
LI/K/W 1.95% (n=4)
LF/Q/V 0.49% (n=1)
LM/K/W 0.49% (n=1)
LL/Q/W 0.49% (n=1)
LF/A/W 0.49% (n=1)
LF/T/W 0.49% (n=1)
LF/N/W 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 4a (antibodies: [HC84.27])

LF/K/W 80.30% (n=106)
LF/R/W 15.15% (n=20)
LF/S/W 3.03% (n=4)
LF/Q/V 0.76% (n=1)
LL/K/W 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 4d (antibodies: [HC84.27])

LF/K/W 69.23% (n=9)
LF/R/W 23.08% (n=3)
LL/K/W 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 5 (antibodies: [HC84.27])

LM/K/W 27.03% (n=10)
LL/K/W 21.62% (n=8)
LI/K/W 16.22% (n=6)
LF/K/W 10.81% (n=4)
LF/R/W 5.41% (n=2)
LM/N/W 5.41% (n=2)
LV/K/W 2.70% (n=1)
LL/R/W 2.70% (n=1)
LM/R/W 2.70% (n=1)
LF/S/W 2.70% (n=1)
LI/R/W 2.70% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 6 (antibodies: [HC84.27])

LF/K/W 47.66% (n=102)
LF/R/W 23.83% (n=51)
LF/S/W 4.67% (n=10)
LF/N/W 4.67% (n=10)
LL/K/W 4.67% (n=10)
LI/K/W 3.27% (n=7)
LL/R/W 2.80% (n=6)
LM/K/W 1.40% (n=3)
LF/G/W 1.40% (n=3)
LF/H/W 1.40% (n=3)
LF/Q/W 0.93% (n=2)
LF/T/W 0.47% (n=1)
LF/P/W 0.47% (n=1)
LL/Q/W 0.47% (n=1)
LV/Q/W 0.47% (n=1)
LI/N/W 0.47% (n=1)
LL/N/W 0.47% (n=1)
LL/H/W 0.47% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Subtype 6a (antibodies: [HC84.27])

LF/K/W 60.20% (n=59)
LF/R/W 28.57% (n=28)
LF/S/W 4.08% (n=4)
LF/N/W 3.06% (n=3)
LF/T/W 1.02% (n=1)
LF/P/W 1.02% (n=1)
LL/K/W 1.02% (n=1)
LM/K/W 1.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,446,616 in HCV Genotype 7 (antibodies: [HC84.27])

LF/R/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 441,442,616 in HCV Genotype 1 (antibodies: [HC84.25, HC84.26])

LF/W 81.97% (n=6561)
LL/W 13.98% (n=1119)
LI/W 2.57% (n=206)
LV/W 1.09% (n=87)
LM/W 0.12% (n=10)
PF/W 0.06% (n=5)
LS/W 0.05% (n=4)
LF/R 0.02% (n=2)
HF/W 0.01% (n=1)
PL/W 0.01% (n=1)
LN/W 0.01% (n=1)
QH/W 0.01% (n=1)
LF/G 0.01% (n=1)
AP/W 0.01% (n=1)
LF/T 0.01% (n=1)
FF/W 0.01% (n=1)
LF/* 0.01% (n=1)
VF/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 1a (antibodies: [HC84.25, HC84.26])

LF/W 77.61% (n=4781)
LL/W 17.97% (n=1107)
LI/W 2.78% (n=171)
LV/W 1.20% (n=74)
LM/W 0.16% (n=10)
PF/W 0.08% (n=5)
LF/R 0.03% (n=2)
HF/W 0.02% (n=1)
PL/W 0.02% (n=1)
LN/W 0.02% (n=1)
QH/W 0.02% (n=1)
LF/G 0.02% (n=1)
AP/W 0.02% (n=1)
LF/T 0.02% (n=1)
FF/W 0.02% (n=1)
LS/W 0.02% (n=1)
LF/* 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 1b (antibodies: [HC84.25, HC84.26])

LF/W 96.75% (n=1755)
LI/W 1.87% (n=34)
LV/W 0.66% (n=12)
LL/W 0.50% (n=9)
LS/W 0.17% (n=3)
VF/W 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 2 (antibodies: [HC84.25, HC84.26])

LF/W 98.11% (n=468)
LL/W 0.63% (n=3)
LF/G 0.42% (n=2)
LV/W 0.42% (n=2)
LI/W 0.21% (n=1)
PF/W 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 2a (antibodies: [HC84.25, HC84.26])

LF/W 93.94% (n=62)
LI/W 1.52% (n=1)
LF/G 1.52% (n=1)
PF/W 1.52% (n=1)
LV/W 1.52% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 2b (antibodies: [HC84.25, HC84.26])

LF/W 98.86% (n=348)
LL/W 0.57% (n=2)
LV/W 0.28% (n=1)
LF/G 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 2c (antibodies: [HC84.25, HC84.26])

LF/W 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 3 (antibodies: [HC84.25, HC84.26])

LF/W 71.17% (n=1738)
LI/W 23.87% (n=583)
LL/W 2.42% (n=59)
LM/W 1.84% (n=45)
LV/W 0.33% (n=8)
LF/L 0.08% (n=2)
CF/W 0.08% (n=2)
LF/R 0.04% (n=1)
SF/W 0.04% (n=1)
LF/C 0.04% (n=1)
FD/W 0.04% (n=1)
LF/* 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 3a (antibodies: [HC84.25, HC84.26])

LF/W 76.02% (n=1721)
LI/W 20.54% (n=465)
LL/W 2.25% (n=51)
LM/W 0.44% (n=10)
LV/W 0.35% (n=8)
LF/L 0.09% (n=2)
CF/W 0.09% (n=2)
LF/R 0.04% (n=1)
SF/W 0.04% (n=1)
LF/C 0.04% (n=1)
FD/W 0.04% (n=1)
LF/* 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 3b (antibodies: [HC84.25, HC84.26])

LI/W 71.88% (n=115)
LM/W 20.00% (n=32)
LF/W 4.38% (n=7)
LL/W 3.75% (n=6)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 4 (antibodies: [HC84.25, HC84.26])

LF/W 91.75% (n=189)
LL/W 5.34% (n=11)
LI/W 1.94% (n=4)
LF/V 0.49% (n=1)
LM/W 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 4a (antibodies: [HC84.25, HC84.26])

LF/W 98.48% (n=130)
LF/V 0.76% (n=1)
LL/W 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 4d (antibodies: [HC84.25, HC84.26])

LF/W 92.31% (n=12)
LL/W 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 5 (antibodies: [HC84.25, HC84.26])

LM/W 35.14% (n=13)
LL/W 24.32% (n=9)
LF/W 18.92% (n=7)
LI/W 18.92% (n=7)
LV/W 2.70% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 6 (antibodies: [HC84.25, HC84.26])

LF/W 86.04% (n=191)
LL/W 8.56% (n=19)
LI/W 3.60% (n=8)
LM/W 1.35% (n=3)
LV/W 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Subtype 6a (antibodies: [HC84.25, HC84.26])

LF/W 98.04% (n=100)
LL/W 0.98% (n=1)
LM/W 0.98% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 441,442,616 in HCV Genotype 7 (antibodies: [HC84.25, HC84.26])

LF/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 442,443 in HCV Genotype 1 (antibodies: [HC84.24])

FY 81.17% (n=18634)
LY 12.36% (n=2838)
IY 4.84% (n=1112)
VY 0.50% (n=115)
FH 0.50% (n=114)
MY 0.28% (n=65)
SY 0.08% (n=19)
FN 0.05% (n=12)
FC 0.05% (n=11)
FS 0.04% (n=10)
FF 0.01% (n=3)
FA 0.01% (n=3)
PY 0.01% (n=2)
F* 0.01% (n=2)
FL 0.01% (n=2)
IH 0.01% (n=2)
HY 0.01% (n=2)
LH 0.01% (n=2)
LC 0.00% (n=1)
AS 0.00% (n=1)
LP 0.00% (n=1)
NY 0.00% (n=1)
TY 0.00% (n=1)
H* 0.00% (n=1)
PL 0.00% (n=1)
ST 0.00% (n=1)
LN 0.00% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 1a (antibodies: [HC84.24])

FY 71.51% (n=9758)
LY 19.57% (n=2670)
IY 6.71% (n=916)
FH 0.79% (n=108)
VY 0.59% (n=80)
MY 0.45% (n=61)
FS 0.07% (n=10)
FN 0.06% (n=8)
FC 0.05% (n=7)
SY 0.04% (n=6)
PY 0.01% (n=2)
F* 0.01% (n=2)
IH 0.01% (n=2)
HY 0.01% (n=2)
LH 0.01% (n=2)
LC 0.01% (n=1)
FL 0.01% (n=1)
AS 0.01% (n=1)
LP 0.01% (n=1)
NY 0.01% (n=1)
TY 0.01% (n=1)
H* 0.01% (n=1)
PL 0.01% (n=1)
ST 0.01% (n=1)
LN 0.01% (n=1)
FF 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 1b (antibodies: [HC84.24])

FY 95.43% (n=8845)
IY 2.10% (n=195)
LY 1.75% (n=162)
VY 0.37% (n=34)
SY 0.14% (n=13)
FH 0.06% (n=6)
FN 0.04% (n=4)
MY 0.04% (n=4)
FC 0.04% (n=4)
FF 0.02% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 2 (antibodies: [HC84.24])

FY 98.30% (n=1332)
LY 0.44% (n=6)
FH 0.37% (n=5)
FF 0.30% (n=4)
VY 0.22% (n=3)
IY 0.15% (n=2)
FR 0.07% (n=1)
FC 0.07% (n=1)
SY 0.07% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 2a (antibodies: [HC84.24])

FY 96.61% (n=285)
FF 1.36% (n=4)
FH 0.68% (n=2)
IY 0.34% (n=1)
LY 0.34% (n=1)
VY 0.34% (n=1)
FR 0.34% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 2b (antibodies: [HC84.24])

FY 98.92% (n=457)
LY 0.65% (n=3)
VY 0.43% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 2c (antibodies: [HC84.24])

FY 99.12% (n=452)
FC 0.22% (n=1)
IY 0.22% (n=1)
FH 0.22% (n=1)
LY 0.22% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 3 (antibodies: [HC84.24])

FY 71.44% (n=2772)
IY 18.61% (n=722)
LY 3.56% (n=138)
MY 2.50% (n=97)
FS 1.65% (n=64)
FH 1.34% (n=52)
VY 0.46% (n=18)
FN 0.28% (n=11)
FR 0.03% (n=1)
FC 0.03% (n=1)
SY 0.03% (n=1)
DY 0.03% (n=1)
FI 0.03% (n=1)
FF 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 3a (antibodies: [HC84.24])

FY 75.69% (n=2485)
IY 14.89% (n=489)
LY 3.50% (n=115)
FS 1.89% (n=62)
MY 1.58% (n=52)
FH 1.55% (n=51)
VY 0.40% (n=13)
FN 0.30% (n=10)
FR 0.03% (n=1)
FC 0.03% (n=1)
SY 0.03% (n=1)
DY 0.03% (n=1)
FI 0.03% (n=1)
FF 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 3b (antibodies: [HC84.24])

IY 57.21% (n=230)
FY 24.88% (n=100)
MY 10.45% (n=42)
LY 5.22% (n=21)
VY 1.24% (n=5)
FS 0.50% (n=2)
FN 0.25% (n=1)
FH 0.25% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 4 (antibodies: [HC84.24])

FY 95.95% (n=734)
LY 3.27% (n=25)
IY 0.52% (n=4)
FR 0.13% (n=1)
MY 0.13% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 4a (antibodies: [HC84.24])

FY 99.38% (n=161)
LY 0.62% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 4d (antibodies: [HC84.24])

FY 97.05% (n=526)
LY 2.77% (n=15)
FR 0.18% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 5 (antibodies: [HC84.24])

MY 35.90% (n=14)
LY 23.08% (n=9)
FY 20.51% (n=8)
IY 17.95% (n=7)
VY 2.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 6 (antibodies: [HC84.24])

FY 89.01% (n=510)
LY 5.58% (n=32)
IY 2.97% (n=17)
MY 0.87% (n=5)
FA 0.52% (n=3)
FS 0.52% (n=3)
VY 0.17% (n=1)
FN 0.17% (n=1)
FT 0.17% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Subtype 6a (antibodies: [HC84.24])

FY 97.30% (n=324)
IY 1.20% (n=4)
LY 1.20% (n=4)
MY 0.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 442,443 in HCV Genotype 7 (antibodies: [HC84.24])

FY 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 1 (antibodies: [MAb44])

G/P/N/W/Y 98.07% (n=8070)
G/P/T/W/H 1.00% (n=82)
G/P/T/W/Y 0.19% (n=16)
G/P/D/W/Y 0.13% (n=11)
G/A/N/W/Y 0.10% (n=8)
G/P/N/W/H 0.09% (n=7)
G/S/N/W/Y 0.07% (n=6)
G/L/N/W/Y 0.05% (n=4)
S/P/N/W/Y 0.04% (n=3)
D/P/N/W/Y 0.02% (n=2)
G/P/N/*/Y 0.02% (n=2)
G/P/N/R/Y 0.02% (n=2)
G/A/N/I/R 0.02% (n=2)
G/R/N/W/Y 0.02% (n=2)
G/P/S/W/Y 0.02% (n=2)
G/P/N/W/S 0.02% (n=2)
N/P/N/W/Y 0.01% (n=1)
R/P/N/W/Y 0.01% (n=1)
G/P/K/W/Y 0.01% (n=1)
G/P/N/W/C 0.01% (n=1)
G/P/Y/W/Y 0.01% (n=1)
G/P/N/K/Y 0.01% (n=1)
G/P/N/W/* 0.01% (n=1)
S/R/N/W/Y 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 1a (antibodies: [MAb44])

G/P/N/W/Y 97.74% (n=6191)
G/P/T/W/H 1.29% (n=82)
G/P/T/W/Y 0.22% (n=14)
G/P/D/W/Y 0.16% (n=10)
G/A/N/W/Y 0.13% (n=8)
G/S/N/W/Y 0.08% (n=5)
G/P/N/W/H 0.08% (n=5)
G/L/N/W/Y 0.06% (n=4)
D/P/N/W/Y 0.03% (n=2)
G/P/N/*/Y 0.03% (n=2)
G/P/N/R/Y 0.03% (n=2)
G/A/N/I/R 0.03% (n=2)
S/P/N/W/Y 0.03% (n=2)
N/P/N/W/Y 0.02% (n=1)
R/P/N/W/Y 0.02% (n=1)
G/P/K/W/Y 0.02% (n=1)
G/P/N/W/C 0.02% (n=1)
G/P/Y/W/Y 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 1b (antibodies: [MAb44])

G/P/N/W/Y 99.14% (n=1848)
G/R/N/W/Y 0.11% (n=2)
G/P/S/W/Y 0.11% (n=2)
G/P/N/W/H 0.11% (n=2)
G/P/N/W/S 0.11% (n=2)
G/P/T/W/Y 0.11% (n=2)
G/P/N/K/Y 0.05% (n=1)
G/S/N/W/Y 0.05% (n=1)
G/P/N/W/* 0.05% (n=1)
S/P/N/W/Y 0.05% (n=1)
G/P/D/W/Y 0.05% (n=1)
S/R/N/W/Y 0.05% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 2 (antibodies: [MAb44])

G/P/N/W/Y 98.11% (n=468)
E/P/N/W/Y 0.21% (n=1)
G/P/K/W/Y 0.21% (n=1)
G/P/G/W/Y 0.21% (n=1)
G/P/N/C/Y 0.21% (n=1)
G/P/N/W/H 0.21% (n=1)
G/P/N/R/Y 0.21% (n=1)
G/P/S/W/Y 0.21% (n=1)
G/A/N/W/Y 0.21% (n=1)
R/P/N/W/Y 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 2a (antibodies: [MAb44])

G/P/N/W/Y 95.45% (n=63)
E/P/N/W/Y 1.52% (n=1)
G/P/K/W/Y 1.52% (n=1)
G/P/G/W/Y 1.52% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 2b (antibodies: [MAb44])

G/P/N/W/Y 98.58% (n=347)
G/P/N/C/Y 0.28% (n=1)
G/P/N/W/H 0.28% (n=1)
G/P/N/R/Y 0.28% (n=1)
G/P/S/W/Y 0.28% (n=1)
G/A/N/W/Y 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 2c (antibodies: [MAb44])

G/P/N/W/Y 100.00% (n=22)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 3 (antibodies: [MAb44])

G/P/E/W/Y 40.86% (n=1003)
G/P/K/W/Y 25.99% (n=638)
G/P/R/W/Y 13.48% (n=331)
G/P/T/W/Y 8.59% (n=211)
G/P/G/W/Y 2.61% (n=64)
G/P/D/W/Y 2.44% (n=60)
G/P/Q/W/Y 2.12% (n=52)
G/P/N/W/Y 2.04% (n=50)
G/P/A/W/Y 0.57% (n=14)
G/P/S/W/Y 0.37% (n=9)
G/S/K/W/Y 0.12% (n=3)
G/P/H/W/Y 0.12% (n=3)
G/P/N/G/I 0.08% (n=2)
G/P/E/G/Y 0.04% (n=1)
G/S/G/W/Y 0.04% (n=1)
G/P/K/W/S 0.04% (n=1)
G/P/E/S/Y 0.04% (n=1)
G/P/E/C/Y 0.04% (n=1)
G/P/K/L/Y 0.04% (n=1)
G/A/E/W/Y 0.04% (n=1)
G/S/R/S/Y 0.04% (n=1)
G/S/R/E/Y 0.04% (n=1)
G/P/P/W/Y 0.04% (n=1)
G/Q/Q/W/Y 0.04% (n=1)
G/A/K/W/Y 0.04% (n=1)
G/L/Q/W/Y 0.04% (n=1)
G/A/G/W/Y 0.04% (n=1)
G/P/K/V/Y 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 3a (antibodies: [MAb44])

G/P/E/W/Y 43.83% (n=998)
G/P/K/W/Y 27.93% (n=636)
G/P/R/W/Y 14.54% (n=331)
G/P/G/W/Y 2.81% (n=64)
G/P/D/W/Y 2.59% (n=59)
G/P/Q/W/Y 2.28% (n=52)
G/P/T/W/Y 2.24% (n=51)
G/P/N/W/Y 2.15% (n=49)
G/P/A/W/Y 0.53% (n=12)
G/S/K/W/Y 0.13% (n=3)
G/P/H/W/Y 0.13% (n=3)
G/P/N/G/I 0.09% (n=2)
G/P/S/W/Y 0.09% (n=2)
G/P/E/G/Y 0.04% (n=1)
G/S/G/W/Y 0.04% (n=1)
G/P/K/W/S 0.04% (n=1)
G/P/E/S/Y 0.04% (n=1)
G/P/E/C/Y 0.04% (n=1)
G/P/K/L/Y 0.04% (n=1)
G/A/E/W/Y 0.04% (n=1)
G/S/R/S/Y 0.04% (n=1)
G/S/R/E/Y 0.04% (n=1)
G/P/P/W/Y 0.04% (n=1)
G/Q/Q/W/Y 0.04% (n=1)
G/A/K/W/Y 0.04% (n=1)
G/L/Q/W/Y 0.04% (n=1)
G/A/G/W/Y 0.04% (n=1)
G/P/K/V/Y 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 3b (antibodies: [MAb44])

G/P/T/W/Y 98.13% (n=157)
G/P/N/W/Y 0.63% (n=1)
G/P/A/W/Y 0.63% (n=1)
G/P/S/W/Y 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 4 (antibodies: [MAb44])

G/P/N/W/Y 99.03% (n=204)
G/P/N/W/I 0.49% (n=1)
G/P/G/W/Y 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 4a (antibodies: [MAb44])

G/P/N/W/Y 99.24% (n=131)
G/P/N/W/I 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 4d (antibodies: [MAb44])

G/P/N/W/Y 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 5 (antibodies: [MAb44])

G/P/N/W/Y 100.00% (n=37)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 6 (antibodies: [MAb44])

G/P/E/W/Y 59.55% (n=131)
G/P/Q/W/Y 13.64% (n=30)
G/P/A/W/Y 6.36% (n=14)
G/P/S/W/Y 5.00% (n=11)
G/P/G/W/Y 4.09% (n=9)
G/P/T/W/Y 4.09% (n=9)
G/P/R/W/Y 1.82% (n=4)
G/P/D/W/Y 0.91% (n=2)
G/P/H/W/Y 0.91% (n=2)
G/P/Y/W/Y 0.91% (n=2)
G/P/N/W/Y 0.91% (n=2)
G/P/K/W/Y 0.45% (n=1)
G/P/M/W/Y 0.45% (n=1)
G/A/Q/W/Y 0.45% (n=1)
G/A/E/W/Y 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Subtype 6a (antibodies: [MAb44])

G/P/E/W/Y 92.08% (n=93)
G/P/G/W/Y 4.95% (n=5)
G/P/Q/W/Y 0.99% (n=1)
G/P/A/W/Y 0.99% (n=1)
G/P/D/W/Y 0.99% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,525,540,549,613 in HCV Genotype 7 (antibodies: [MAb44])

G/P/N/W/Y 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 1 (antibodies: [1:7, A8])

G/TY/WG/D 91.85% (n=9381)
G/TF/WG/D 3.64% (n=372)
G/AY/WG/D 3.33% (n=340)
G/TH/WG/D 0.37% (n=38)
G/TY/WG/G 0.11% (n=11)
G/TY/RG/D 0.06% (n=6)
G/TY/WG/N 0.05% (n=5)
G/TC/WG/D 0.05% (n=5)
G/SY/WG/D 0.05% (n=5)
D/TY/WG/D 0.04% (n=4)
G/TF/SG/D 0.04% (n=4)
E/TY/WG/D 0.03% (n=3)
S/TY/WG/D 0.03% (n=3)
G/TY/WG/Y 0.02% (n=2)
G/TY/*G/D 0.02% (n=2)
G/TY/WV/D 0.02% (n=2)
G/TF/FG/D 0.02% (n=2)
G/TY/FG/D 0.02% (n=2)
G/IY/WG/D 0.02% (n=2)
G/YF/LG/G 0.02% (n=2)
G/TN/WG/D 0.02% (n=2)
G/TY/WS/D 0.02% (n=2)
G/TY/WG/V 0.01% (n=1)
G/TY/WC/G 0.01% (n=1)
C/TY/WG/D 0.01% (n=1)
E/TY/WG/G 0.01% (n=1)
G/TY/CG/D 0.01% (n=1)
N/TF/WG/D 0.01% (n=1)
R/TY/WG/D 0.01% (n=1)
G/TL/WG/D 0.01% (n=1)
G/TY/WG/E 0.01% (n=1)
G/TY/WG/A 0.01% (n=1)
G/TS/RG/D 0.01% (n=1)
G/KY/WG/D 0.01% (n=1)
G/TY/WR/D 0.01% (n=1)
G/TY/GR/D 0.01% (n=1)
G/TY/WG/C 0.01% (n=1)
G/TY/WE/D 0.01% (n=1)
S/SY/LG/D 0.01% (n=1)
G/TY/SG/D 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 1a (antibodies: [1:7, A8])

G/TY/WG/D 89.36% (n=6492)
G/TF/WG/D 4.74% (n=344)
G/AY/WG/D 4.68% (n=340)
G/TH/WG/D 0.48% (n=35)
G/TY/WG/G 0.07% (n=5)
G/TC/WG/D 0.06% (n=4)
G/SY/WG/D 0.06% (n=4)
G/TY/RG/D 0.06% (n=4)
E/TY/WG/D 0.04% (n=3)
D/TY/WG/D 0.03% (n=2)
G/TY/WG/N 0.03% (n=2)
G/TY/WG/Y 0.03% (n=2)
G/TY/*G/D 0.03% (n=2)
G/TY/WV/D 0.03% (n=2)
G/TF/FG/D 0.03% (n=2)
G/TY/FG/D 0.03% (n=2)
G/IY/WG/D 0.03% (n=2)
G/YF/LG/G 0.03% (n=2)
G/TN/WG/D 0.03% (n=2)
G/TY/WS/D 0.03% (n=2)
S/TY/WG/D 0.03% (n=2)
G/TY/WG/V 0.01% (n=1)
G/TY/WC/G 0.01% (n=1)
C/TY/WG/D 0.01% (n=1)
E/TY/WG/G 0.01% (n=1)
G/TY/CG/D 0.01% (n=1)
N/TF/WG/D 0.01% (n=1)
R/TY/WG/D 0.01% (n=1)
G/TL/WG/D 0.01% (n=1)
G/TY/WG/E 0.01% (n=1)
G/TY/WG/A 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 1b (antibodies: [1:7, A8])

G/TY/WG/D 98.15% (n=2860)
G/TF/WG/D 0.96% (n=28)
G/TY/WG/G 0.21% (n=6)
G/TY/WG/N 0.10% (n=3)
G/TH/WG/D 0.10% (n=3)
D/TY/WG/D 0.07% (n=2)
G/TY/RG/D 0.07% (n=2)
G/TS/RG/D 0.03% (n=1)
G/KY/WG/D 0.03% (n=1)
G/TY/WR/D 0.03% (n=1)
G/TY/GR/D 0.03% (n=1)
S/TY/WG/D 0.03% (n=1)
G/TY/WG/C 0.03% (n=1)
G/TC/WG/D 0.03% (n=1)
G/TY/WE/D 0.03% (n=1)
G/SY/WG/D 0.03% (n=1)
S/SY/LG/D 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 2 (antibodies: [1:7, A8])

G/TY/WG/D 97.54% (n=516)
G/PR/GE/D 0.57% (n=3)
E/TY/WG/D 0.19% (n=1)
G/TY/WG/N 0.19% (n=1)
G/TR/WE/D 0.19% (n=1)
G/TR/GE/D 0.19% (n=1)
G/PH/GE/D 0.19% (n=1)
G/TC/WR/D 0.19% (n=1)
G/TH/WG/D 0.19% (n=1)
G/TY/WE/D 0.19% (n=1)
G/AY/WG/D 0.19% (n=1)
R/TY/WG/D 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 2a (antibodies: [1:7, A8])

G/TY/WG/D 89.61% (n=69)
G/PR/GE/D 3.90% (n=3)
E/TY/WG/D 1.30% (n=1)
G/TY/WG/N 1.30% (n=1)
G/TR/WE/D 1.30% (n=1)
G/TR/GE/D 1.30% (n=1)
G/PH/GE/D 1.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 2b (antibodies: [1:7, A8])

G/TY/WG/D 99.43% (n=349)
G/TC/WR/D 0.28% (n=1)
G/TH/WG/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 2c (antibodies: [1:7, A8])

G/TY/WG/D 98.44% (n=63)
G/TY/WE/D 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 3 (antibodies: [1:7, A8])

G/TY/WG/D 82.90% (n=2293)
G/TY/FG/D 13.38% (n=370)
G/TF/WG/D 2.60% (n=72)
G/TY/WS/D 0.14% (n=4)
G/TY/RG/D 0.11% (n=3)
G/TY/LG/D 0.11% (n=3)
G/RY/WG/D 0.07% (n=2)
G/TH/WG/D 0.07% (n=2)
G/TY/WG/E 0.07% (n=2)
G/TY/GG/D 0.07% (n=2)
G/IY/WG/D 0.07% (n=2)
G/TY/WD/D 0.04% (n=1)
G/TC/WG/D 0.04% (n=1)
G/TF/WG/G 0.04% (n=1)
G/TY/LS/D 0.04% (n=1)
G/TY/LG/N 0.04% (n=1)
G/TY/KS/E 0.04% (n=1)
G/TY/SN/D 0.04% (n=1)
G/TY/WG/A 0.04% (n=1)
G/TL/WG/D 0.04% (n=1)
G/TY/YG/D 0.04% (n=1)
G/TC/FG/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 3a (antibodies: [1:7, A8])

G/TY/WG/D 95.41% (n=2289)
G/TF/WG/D 2.96% (n=71)
G/TY/FG/D 0.38% (n=9)
G/TY/WS/D 0.17% (n=4)
G/TY/RG/D 0.13% (n=3)
G/TY/LG/D 0.13% (n=3)
G/RY/WG/D 0.08% (n=2)
G/TH/WG/D 0.08% (n=2)
G/TY/WG/E 0.08% (n=2)
G/TY/GG/D 0.08% (n=2)
G/IY/WG/D 0.08% (n=2)
G/TY/WD/D 0.04% (n=1)
G/TC/WG/D 0.04% (n=1)
G/TF/WG/G 0.04% (n=1)
G/TY/LS/D 0.04% (n=1)
G/TY/LG/N 0.04% (n=1)
G/TY/KS/E 0.04% (n=1)
G/TY/SN/D 0.04% (n=1)
G/TY/WG/A 0.04% (n=1)
G/TL/WG/D 0.04% (n=1)
G/TY/YG/D 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 3b (antibodies: [1:7, A8])

G/TY/FG/D 99.71% (n=348)
G/TC/FG/D 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 4 (antibodies: [1:7, A8])

G/TY/WG/D 96.58% (n=226)
G/TH/WG/D 2.14% (n=5)
G/TY/LG/D 0.43% (n=1)
G/TY/FG/D 0.43% (n=1)
G/TY/WG/N 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 4a (antibodies: [1:7, A8])

G/TY/WG/D 96.88% (n=155)
G/TH/WG/D 2.50% (n=4)
G/TY/LG/D 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 4d (antibodies: [1:7, A8])

G/TY/WG/D 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 5 (antibodies: [1:7, A8])

G/TY/WG/D 94.74% (n=36)
G/SY/WG/D 5.26% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 6 (antibodies: [1:7, A8])

G/TY/WG/D 97.24% (n=352)
G/TY/FG/D 1.10% (n=4)
G/TF/WG/D 1.10% (n=4)
G/KY/WG/D 0.28% (n=1)
G/TY/LG/D 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Subtype 6a (antibodies: [1:7, A8])

G/TY/WG/D 100.00% (n=125)
---------------------------------------------------------------------------------------
Motifs for binding location set: 523,526,527,529,530,535 in HCV Genotype 7 (antibodies: [1:7, A8])

G/TY/WG/D 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 524,529 in HCV Genotype 1 (antibodies: [J6.27])

A/W 61.19% (n=6245)
V/W 34.16% (n=3486)
E/W 1.53% (n=156)
I/W 1.18% (n=120)
T/W 0.53% (n=54)
Q/W 0.38% (n=39)
M/W 0.20% (n=20)
H/W 0.20% (n=20)
D/W 0.16% (n=16)
L/W 0.12% (n=12)
A/R 0.07% (n=7)
N/W 0.06% (n=6)
S/W 0.05% (n=5)
N/S 0.03% (n=3)
A/F 0.02% (n=2)
V/F 0.02% (n=2)
G/W 0.02% (n=2)
L/L 0.02% (n=2)
V/* 0.01% (n=1)
V/C 0.01% (n=1)
K/W 0.01% (n=1)
A/* 0.01% (n=1)
P/W 0.01% (n=1)
V/G 0.01% (n=1)
R/L 0.01% (n=1)
M/S 0.01% (n=1)
A/S 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 1a (antibodies: [J6.27])

A/W 75.49% (n=5484)
V/W 18.80% (n=1366)
E/W 2.15% (n=156)
I/W 1.61% (n=117)
Q/W 0.54% (n=39)
T/W 0.52% (n=38)
M/W 0.28% (n=20)
D/W 0.18% (n=13)
L/W 0.11% (n=8)
S/W 0.07% (n=5)
A/R 0.06% (n=4)
H/W 0.04% (n=3)
A/F 0.03% (n=2)
V/F 0.03% (n=2)
G/W 0.03% (n=2)
L/L 0.03% (n=2)
V/* 0.01% (n=1)
V/C 0.01% (n=1)
K/W 0.01% (n=1)
A/* 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 1b (antibodies: [J6.27])

V/W 72.34% (n=2103)
A/W 25.90% (n=753)
H/W 0.58% (n=17)
T/W 0.55% (n=16)
N/W 0.17% (n=5)
A/R 0.10% (n=3)
D/W 0.10% (n=3)
I/W 0.10% (n=3)
P/W 0.03% (n=1)
V/G 0.03% (n=1)
R/L 0.03% (n=1)
L/W 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 2 (antibodies: [J6.27])

V/W 72.87% (n=384)
A/W 24.29% (n=128)
A/G 0.95% (n=5)
L/W 0.57% (n=3)
I/W 0.38% (n=2)
T/W 0.38% (n=2)
M/W 0.38% (n=2)
Q/W 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 2a (antibodies: [J6.27])

V/W 76.32% (n=58)
A/W 17.11% (n=13)
A/G 6.58% (n=5)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 2b (antibodies: [J6.27])

V/W 70.45% (n=248)
A/W 27.27% (n=96)
L/W 0.85% (n=3)
I/W 0.57% (n=2)
T/W 0.57% (n=2)
M/W 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 2c (antibodies: [J6.27])

V/W 77.42% (n=48)
A/W 19.35% (n=12)
M/W 1.61% (n=1)
Q/W 1.61% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 3 (antibodies: [J6.27])

V/W 41.59% (n=1150)
A/W 37.76% (n=1044)
L/F 9.98% (n=276)
T/W 2.89% (n=80)
S/F 1.84% (n=51)
I/W 1.08% (n=30)
E/W 0.98% (n=27)
V/F 0.90% (n=25)
N/W 0.54% (n=15)
A/F 0.51% (n=14)
S/W 0.33% (n=9)
M/W 0.29% (n=8)
L/W 0.18% (n=5)
D/W 0.18% (n=5)
I/F 0.11% (n=3)
R/W 0.11% (n=3)
V/R 0.11% (n=3)
V/L 0.11% (n=3)
G/W 0.07% (n=2)
A/L 0.07% (n=2)
K/W 0.07% (n=2)
T/K 0.04% (n=1)
A/S 0.04% (n=1)
Q/W 0.04% (n=1)
A/G 0.04% (n=1)
D/Y 0.04% (n=1)
H/W 0.04% (n=1)
T/F 0.04% (n=1)
Y/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 3a (antibodies: [J6.27])

V/W 47.81% (n=1147)
A/W 43.48% (n=1043)
T/W 3.33% (n=80)
I/W 1.25% (n=30)
E/W 1.13% (n=27)
N/W 0.63% (n=15)
S/W 0.38% (n=9)
M/W 0.33% (n=8)
V/F 0.25% (n=6)
L/W 0.21% (n=5)
D/W 0.21% (n=5)
R/W 0.13% (n=3)
V/R 0.13% (n=3)
V/L 0.13% (n=3)
G/W 0.08% (n=2)
A/L 0.08% (n=2)
K/W 0.08% (n=2)
I/F 0.04% (n=1)
T/K 0.04% (n=1)
A/S 0.04% (n=1)
Q/W 0.04% (n=1)
A/G 0.04% (n=1)
D/Y 0.04% (n=1)
A/F 0.04% (n=1)
L/F 0.04% (n=1)
H/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 3b (antibodies: [J6.27])

L/F 78.80% (n=275)
S/F 14.33% (n=50)
V/F 3.72% (n=13)
A/F 2.58% (n=9)
I/F 0.57% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 4 (antibodies: [J6.27])

V/W 78.97% (n=184)
A/W 10.30% (n=24)
L/W 2.58% (n=6)
D/W 2.15% (n=5)
I/W 1.29% (n=3)
N/W 1.29% (n=3)
S/W 0.86% (n=2)
H/W 0.86% (n=2)
V/L 0.43% (n=1)
N/F 0.43% (n=1)
Y/W 0.43% (n=1)
T/W 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 4a (antibodies: [J6.27])

V/W 97.48% (n=155)
A/W 1.26% (n=2)
V/L 0.63% (n=1)
L/W 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 4d (antibodies: [J6.27])

A/W 76.92% (n=10)
V/W 23.08% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 5 (antibodies: [J6.27])

Y/W 60.53% (n=23)
N/W 10.53% (n=4)
V/W 7.89% (n=3)
C/W 7.89% (n=3)
L/W 5.26% (n=2)
H/W 5.26% (n=2)
F/W 2.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 6 (antibodies: [J6.27])

L/W 39.83% (n=141)
N/W 37.57% (n=133)
F/W 6.78% (n=24)
A/W 3.67% (n=13)
V/W 3.11% (n=11)
I/W 1.98% (n=7)
H/W 1.41% (n=5)
S/W 1.41% (n=5)
T/W 1.13% (n=4)
A/F 0.85% (n=3)
K/W 0.56% (n=2)
R/W 0.56% (n=2)
D/W 0.56% (n=2)
V/F 0.28% (n=1)
L/L 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Subtype 6a (antibodies: [J6.27])

N/W 90.24% (n=111)
I/W 2.44% (n=3)
A/W 1.63% (n=2)
T/W 1.63% (n=2)
H/W 0.81% (n=1)
S/W 0.81% (n=1)
K/W 0.81% (n=1)
V/W 0.81% (n=1)
F/W 0.81% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 524,529 in HCV Genotype 7 (antibodies: [J6.27])

V/W 100.00% (n=2)
---------------------------------------------------------------------------------------

Motifs for binding location set: 529,530,533 in HCV Genotype 1 (antibodies: [H77.31])

WG/D 49.04% (n=5010)
WG/E 45.45% (n=4644)
WG/V 1.72% (n=176)
WG/A 1.30% (n=133)
WG/K 0.90% (n=92)
WG/N 0.54% (n=55)
WG/Q 0.25% (n=26)
WG/G 0.22% (n=22)
WG/R 0.09% (n=9)
WG/S 0.07% (n=7)
WG/T 0.06% (n=6)
RG/D 0.04% (n=4)
SG/D 0.04% (n=4)
FG/E 0.03% (n=3)
WG/H 0.03% (n=3)
*G/D 0.02% (n=2)
WV/D 0.02% (n=2)
LG/Y 0.02% (n=2)
WS/E 0.02% (n=2)
WG/I 0.02% (n=2)
RG/E 0.02% (n=2)
WC/E 0.01% (n=1)
CG/D 0.01% (n=1)
FG/Q 0.01% (n=1)
WG/Y 0.01% (n=1)
WG/M 0.01% (n=1)
RG/G 0.01% (n=1)
WR/E 0.01% (n=1)
GR/E 0.01% (n=1)
WE/E 0.01% (n=1)
LG/E 0.01% (n=1)
SG/E 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 1a (antibodies: [H77.31])

WG/D 68.77% (n=5000)
WG/E 26.68% (n=1940)
WG/A 1.65% (n=120)
WG/V 0.94% (n=68)
WG/N 0.76% (n=55)
WG/K 0.47% (n=34)
WG/G 0.19% (n=14)
WG/S 0.08% (n=6)
WG/T 0.07% (n=5)
RG/D 0.06% (n=4)
FG/E 0.04% (n=3)
WG/H 0.04% (n=3)
WG/R 0.03% (n=2)
*G/D 0.03% (n=2)
WV/D 0.03% (n=2)
WG/Q 0.03% (n=2)
LG/Y 0.03% (n=2)
WS/E 0.03% (n=2)
WG/I 0.03% (n=2)
WC/E 0.01% (n=1)
CG/D 0.01% (n=1)
FG/Q 0.01% (n=1)
WG/Y 0.01% (n=1)
WG/M 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 1b (antibodies: [H77.31])

WG/E 92.00% (n=2679)
WG/V 3.67% (n=107)
WG/K 1.99% (n=58)
WG/Q 0.82% (n=24)
WG/A 0.41% (n=12)
WG/D 0.27% (n=8)
WG/G 0.27% (n=8)
WG/R 0.24% (n=7)
RG/E 0.07% (n=2)
RG/G 0.03% (n=1)
WR/E 0.03% (n=1)
GR/E 0.03% (n=1)
WE/E 0.03% (n=1)
WG/T 0.03% (n=1)
LG/E 0.03% (n=1)
WG/S 0.03% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 2 (antibodies: [H77.31])

WG/E 94.71% (n=501)
WG/D 2.84% (n=15)
GE/E 0.95% (n=5)
WE/E 0.38% (n=2)
WG/Q 0.38% (n=2)
WR/D 0.19% (n=1)
WG/G 0.19% (n=1)
WG/K 0.19% (n=1)
WG/V 0.19% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 2a (antibodies: [H77.31])

WG/E 89.61% (n=69)
GE/E 6.49% (n=5)
WG/D 2.60% (n=2)
WE/E 1.30% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 2b (antibodies: [H77.31])

WG/E 96.01% (n=337)
WG/D 2.56% (n=9)
WG/Q 0.57% (n=2)
WR/D 0.28% (n=1)
WG/G 0.28% (n=1)
WG/K 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 2c (antibodies: [H77.31])

WG/E 95.31% (n=61)
WG/D 1.56% (n=1)
WE/E 1.56% (n=1)
WG/V 1.56% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 3 (antibodies: [H77.31])

WG/E 68.41% (n=1901)
WG/K 12.41% (n=345)
FG/E 12.23% (n=340)
WG/D 1.87% (n=52)
WG/V 1.55% (n=43)
WG/A 1.01% (n=28)
FG/K 0.58% (n=16)
WG/Q 0.54% (n=15)
FG/D 0.25% (n=7)
LG/E 0.14% (n=4)
WG/T 0.11% (n=3)
WS/E 0.11% (n=3)
RG/E 0.11% (n=3)
FG/Q 0.11% (n=3)
WG/G 0.07% (n=2)
GG/E 0.07% (n=2)
FG/V 0.07% (n=2)
WD/E 0.04% (n=1)
WS/V 0.04% (n=1)
LS/E 0.04% (n=1)
KS/E 0.04% (n=1)
SN/E 0.04% (n=1)
WG/L 0.04% (n=1)
YG/K 0.04% (n=1)
WG/N 0.04% (n=1)
WG/P 0.04% (n=1)
FG/T 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 3a (antibodies: [H77.31])

WG/E 78.54% (n=1896)
WG/K 14.29% (n=345)
WG/D 2.15% (n=52)
WG/V 1.78% (n=43)
WG/A 1.16% (n=28)
WG/Q 0.62% (n=15)
FG/E 0.17% (n=4)
LG/E 0.17% (n=4)
WG/T 0.12% (n=3)
WS/E 0.12% (n=3)
FG/K 0.12% (n=3)
RG/E 0.12% (n=3)
WG/G 0.08% (n=2)
GG/E 0.08% (n=2)
FG/Q 0.08% (n=2)
WD/E 0.04% (n=1)
WS/V 0.04% (n=1)
LS/E 0.04% (n=1)
KS/E 0.04% (n=1)
SN/E 0.04% (n=1)
WG/L 0.04% (n=1)
YG/K 0.04% (n=1)
WG/N 0.04% (n=1)
WG/P 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 3b (antibodies: [H77.31])

FG/E 94.54% (n=329)
FG/K 3.74% (n=13)
FG/D 1.15% (n=4)
FG/Q 0.29% (n=1)
FG/T 0.29% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 4 (antibodies: [H77.31])

WG/E 84.62% (n=198)
WG/D 9.40% (n=22)
WG/K 2.14% (n=5)
WG/V 1.71% (n=4)
WG/A 0.85% (n=2)
LG/E 0.43% (n=1)
FG/D 0.43% (n=1)
WG/G 0.43% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 4a (antibodies: [H77.31])

WG/E 85.00% (n=136)
WG/D 12.50% (n=20)
WG/V 1.25% (n=2)
WG/A 0.63% (n=1)
LG/E 0.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 4d (antibodies: [H77.31])

WG/E 100.00% (n=13)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 5 (antibodies: [H77.31])

WG/E 86.84% (n=33)
WG/D 10.53% (n=4)
WG/V 2.63% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 6 (antibodies: [H77.31])

WG/E 76.69% (n=273)
WG/V 10.67% (n=38)
WG/A 4.49% (n=16)
WG/M 2.53% (n=9)
WG/D 1.40% (n=5)
WG/K 1.40% (n=5)
FG/E 1.12% (n=4)
WG/Q 0.84% (n=3)
WG/W 0.28% (n=1)
WG/I 0.28% (n=1)
LG/E 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Subtype 6a (antibodies: [H77.31])

WG/E 96.80% (n=121)
WG/V 1.60% (n=2)
WG/W 0.80% (n=1)
WG/D 0.80% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 529,530,533 in HCV Genotype 7 (antibodies: [H77.31])

WG/E 100.00% (n=2)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 1 (antibodies: [e20])

T/LN/W/F/WG/D/W 60.84% (n=4866)
T/LN/F/F/WG/D/W 20.26% (n=1620)
T/LN/W/L/WG/D/W 13.57% (n=1085)
T/LN/W/I/WG/D/W 2.05% (n=164)
T/LN/W/V/WG/D/W 0.90% (n=72)
T/LN/F/I/WG/D/W 0.51% (n=41)
T/LN/F/L/WG/D/W 0.26% (n=21)
T/LS/W/F/WG/D/W 0.16% (n=13)
T/LN/F/V/WG/D/W 0.15% (n=12)
T/LN/W/M/WG/D/W 0.10% (n=8)
T/LS/F/F/WG/D/W 0.10% (n=8)
T/LN/F/F/SG/D/W 0.06% (n=5)
T/LT/W/F/WG/D/W 0.05% (n=4)
T/LN/L/F/WG/D/W 0.05% (n=4)
T/LN/R/F/WG/D/W 0.04% (n=3)
T/LN/W/F/FG/D/W 0.04% (n=3)
T/LN/W/F/WG/G/W 0.04% (n=3)
T/LN/F/S/WG/D/W 0.04% (n=3)
T/LN/W/F/WG/Y/W 0.03% (n=2)
T/LN/W/F/WV/D/W 0.03% (n=2)
T/LN/F/M/WG/D/W 0.03% (n=2)
A/LN/W/L/WG/D/W 0.03% (n=2)
T/PN/W/F/WG/D/W 0.03% (n=2)
T/LN/W/F/RG/D/W 0.03% (n=2)
T/LN/W/F/LG/G/W 0.03% (n=2)
T/LN/F/F/WG/G/W 0.03% (n=2)
T/LD/F/F/WG/D/W 0.03% (n=2)
T/LN/F/F/RG/D/W 0.03% (n=2)
T/LN/W/V/WS/D/W 0.03% (n=2)
M/LN/W/L/WG/D/W 0.03% (n=2)
T/LN/F/F/WG/N/W 0.03% (n=2)
T/PN/F/F/WG/D/W 0.03% (n=2)
T/LN/S/F/WG/D/W 0.03% (n=2)
T/LN/W/F/WG/V/W 0.01% (n=1)
T/LN/W/L/WC/G/W 0.01% (n=1)
T/LN/W/N/WG/D/W 0.01% (n=1)
T/LN/W/F/WG/N/W 0.01% (n=1)
T/LN/W/L/*G/D/W 0.01% (n=1)
T/LN/W/F/CG/D/W 0.01% (n=1)
T/LN/W/F/WG/D/R 0.01% (n=1)
T/LN/W/L/FG/D/W 0.01% (n=1)
T/LD/W/F/WG/D/W 0.01% (n=1)
T/LN/C/F/WG/D/W 0.01% (n=1)
T/SN/W/F/WG/D/W 0.01% (n=1)
S/LN/W/F/WG/D/W 0.01% (n=1)
T/LN/W/F/WG/D/G 0.01% (n=1)
T/LN/W/F/*G/D/W 0.01% (n=1)
T/LN/F/F/WG/A/W 0.01% (n=1)
T/LN/F/F/WG/D/R 0.01% (n=1)
T/LN/*/L/WG/D/W 0.01% (n=1)
T/LN/W/P/WG/D/W 0.01% (n=1)
T/LN/W/F/WG/D/T 0.01% (n=1)
M/LN/W/F/WG/D/W 0.01% (n=1)
T/LN/W/S/WG/D/W 0.01% (n=1)
T/LA/W/F/WG/D/W 0.01% (n=1)
T/LN/W/F/WG/D/* 0.01% (n=1)
T/VN/W/L/WG/D/W 0.01% (n=1)
T/LD/F/L/RG/D/W 0.01% (n=1)
T/LN/F/F/WR/D/W 0.01% (n=1)
T/LN/F/F/WG/C/W 0.01% (n=1)
T/LS/W/I/WG/D/W 0.01% (n=1)
T/LS/F/L/WG/D/W 0.01% (n=1)
T/LN/F/F/WE/D/W 0.01% (n=1)
T/LY/F/F/WG/D/W 0.01% (n=1)
T/LN/F/F/LG/D/W 0.01% (n=1)
T/LS/F/V/WG/D/W 0.01% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 1a (antibodies: [e20])

T/LN/W/F/WG/D/W 72.74% (n=4475)
T/LN/W/L/WG/D/W 17.62% (n=1084)
T/LN/F/F/WG/D/W 4.18% (n=257)
T/LN/W/I/WG/D/W 2.67% (n=164)
T/LN/W/V/WG/D/W 1.17% (n=72)
T/LN/F/L/WG/D/W 0.20% (n=12)
T/LS/W/F/WG/D/W 0.20% (n=12)
T/LN/W/M/WG/D/W 0.13% (n=8)
T/LN/F/I/WG/D/W 0.11% (n=7)
T/LT/W/F/WG/D/W 0.07% (n=4)
T/LN/R/F/WG/D/W 0.05% (n=3)
T/LN/W/F/FG/D/W 0.05% (n=3)
T/LN/W/F/WG/G/W 0.05% (n=3)
T/LN/W/F/WG/Y/W 0.03% (n=2)
T/LN/W/F/WV/D/W 0.03% (n=2)
T/LN/F/M/WG/D/W 0.03% (n=2)
A/LN/W/L/WG/D/W 0.03% (n=2)
T/PN/W/F/WG/D/W 0.03% (n=2)
T/LN/W/F/RG/D/W 0.03% (n=2)
T/LN/W/F/LG/G/W 0.03% (n=2)
T/LN/F/F/WG/G/W 0.03% (n=2)
T/LN/L/F/WG/D/W 0.03% (n=2)
T/LN/W/V/WS/D/W 0.03% (n=2)
M/LN/W/L/WG/D/W 0.03% (n=2)
T/LN/W/F/WG/V/W 0.02% (n=1)
T/LN/W/L/WC/G/W 0.02% (n=1)
T/LN/W/N/WG/D/W 0.02% (n=1)
T/LN/W/F/WG/N/W 0.02% (n=1)
T/LN/W/L/*G/D/W 0.02% (n=1)
T/LN/W/F/CG/D/W 0.02% (n=1)
T/LN/W/F/WG/D/R 0.02% (n=1)
T/LN/W/L/FG/D/W 0.02% (n=1)
T/LD/W/F/WG/D/W 0.02% (n=1)
T/LN/C/F/WG/D/W 0.02% (n=1)
T/SN/W/F/WG/D/W 0.02% (n=1)
S/LN/W/F/WG/D/W 0.02% (n=1)
T/LN/W/F/WG/D/G 0.02% (n=1)
T/LN/W/F/*G/D/W 0.02% (n=1)
T/LN/F/F/WG/A/W 0.02% (n=1)
T/LN/F/F/WG/D/R 0.02% (n=1)
T/LD/F/F/WG/D/W 0.02% (n=1)
T/LN/F/F/RG/D/W 0.02% (n=1)
T/LN/*/L/WG/D/W 0.02% (n=1)
T/LN/W/P/WG/D/W 0.02% (n=1)
T/LN/W/F/WG/D/T 0.02% (n=1)
M/LN/W/F/WG/D/W 0.02% (n=1)
T/LN/W/S/WG/D/W 0.02% (n=1)
T/LA/W/F/WG/D/W 0.02% (n=1)
T/LN/W/F/WG/D/* 0.02% (n=1)
T/VN/W/L/WG/D/W 0.02% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 1b (antibodies: [e20])

T/LN/F/F/WG/D/W 74.34% (n=1350)
T/LN/W/F/WG/D/W 21.20% (n=385)
T/LN/F/I/WG/D/W 1.82% (n=33)
T/LN/F/V/WG/D/W 0.66% (n=12)
T/LN/F/L/WG/D/W 0.39% (n=7)
T/LS/F/F/WG/D/W 0.39% (n=7)
T/LN/F/S/WG/D/W 0.17% (n=3)
T/LN/F/F/WG/N/W 0.11% (n=2)
T/PN/F/F/WG/D/W 0.11% (n=2)
T/LN/S/F/WG/D/W 0.11% (n=2)
T/LN/L/F/WG/D/W 0.11% (n=2)
T/LD/F/L/RG/D/W 0.06% (n=1)
T/LN/F/F/WR/D/W 0.06% (n=1)
T/LN/F/F/WG/C/W 0.06% (n=1)
T/LS/W/I/WG/D/W 0.06% (n=1)
T/LS/F/L/WG/D/W 0.06% (n=1)
T/LS/W/F/WG/D/W 0.06% (n=1)
T/LN/F/F/WE/D/W 0.06% (n=1)
T/LY/F/F/WG/D/W 0.06% (n=1)
T/LD/F/F/WG/D/W 0.06% (n=1)
T/LN/F/F/LG/D/W 0.06% (n=1)
T/LN/F/F/RG/D/W 0.06% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 2 (antibodies: [e20])

T/LN/F/F/WG/D/W 97.29% (n=466)
T/LN/F/L/WG/D/W 0.63% (n=3)
T/LN/F/F/WG/D/G 0.42% (n=2)
T/LN/C/F/WG/D/W 0.42% (n=2)
T/LN/F/I/WG/N/W 0.21% (n=1)
H/LT/F/V/WG/D/W 0.21% (n=1)
T/LK/F/F/WG/D/W 0.21% (n=1)
T/LN/F/F/WR/D/W 0.21% (n=1)
T/LN/F/V/WG/D/W 0.21% (n=1)
I/LN/F/F/WG/D/W 0.21% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 2a (antibodies: [e20])

T/LN/F/F/WG/D/W 95.65% (n=66)
T/LN/F/I/WG/N/W 1.45% (n=1)
T/LN/F/F/WG/D/G 1.45% (n=1)
H/LT/F/V/WG/D/W 1.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 2b (antibodies: [e20])

T/LN/F/F/WG/D/W 97.72% (n=343)
T/LN/C/F/WG/D/W 0.57% (n=2)
T/LN/F/L/WG/D/W 0.57% (n=2)
T/LK/F/F/WG/D/W 0.28% (n=1)
T/LN/F/F/WR/D/W 0.28% (n=1)
T/LN/F/V/WG/D/W 0.28% (n=1)
T/LN/F/F/WG/D/G 0.28% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 2c (antibodies: [e20])

T/LN/F/F/WG/D/W 95.45% (n=21)
I/LN/F/F/WG/D/W 4.55% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 3 (antibodies: [e20])

T/LN/F/F/WG/D/W 69.43% (n=1692)
T/LN/F/I/WG/D/W 18.59% (n=453)
T/LS/F/I/FG/D/W 3.04% (n=74)
T/LN/F/L/WG/D/W 2.09% (n=51)
T/LN/F/I/FG/D/W 1.93% (n=47)
T/LS/F/M/FG/D/W 1.19% (n=29)
T/LN/F/F/FG/D/W 0.53% (n=13)
T/LN/F/M/WG/D/W 0.41% (n=10)
T/LN/F/V/WG/D/W 0.33% (n=8)
T/LN/F/L/FG/D/W 0.33% (n=8)
T/LN/F/M/FG/D/W 0.25% (n=6)
A/LN/F/F/WG/D/W 0.16% (n=4)
T/LS/F/F/FG/D/W 0.16% (n=4)
T/LN/F/F/WS/D/W 0.12% (n=3)
T/LN/F/F/RG/D/W 0.12% (n=3)
T/LN/F/F/LG/D/W 0.12% (n=3)
T/PN/F/F/WG/D/W 0.08% (n=2)
T/LD/F/F/WG/D/W 0.08% (n=2)
T/LH/F/F/WG/D/L 0.08% (n=2)
T/PN/F/I/WG/D/W 0.08% (n=2)
T/LN/F/F/WD/D/W 0.04% (n=1)
T/PT/F/F/WG/D/W 0.04% (n=1)
T/RN/F/F/WG/D/W 0.04% (n=1)
T/GN/F/I/WG/D/W 0.04% (n=1)
T/LN/S/I/WG/D/W 0.04% (n=1)
T/LN/F/I/WS/D/W 0.04% (n=1)
T/LN/F/F/WG/D/R 0.04% (n=1)
T/LS/F/F/WG/D/W 0.04% (n=1)
A/LN/F/I/WG/D/W 0.04% (n=1)
T/LN/L/F/WG/D/W 0.04% (n=1)
T/LN/F/F/WG/G/W 0.04% (n=1)
T/LN/F/F/WG/D/C 0.04% (n=1)
T/LN/F/D/WG/E/W 0.04% (n=1)
T/LN/F/I/GG/D/W 0.04% (n=1)
T/LN/F/F/LS/D/W 0.04% (n=1)
T/LN/F/F/LG/N/W 0.04% (n=1)
T/LN/F/F/WG/D/* 0.04% (n=1)
T/LN/S/F/WG/D/W 0.04% (n=1)
T/RN/S/F/WG/A/W 0.04% (n=1)
T/LN/F/F/GG/D/W 0.04% (n=1)
T/LN/F/I/YG/D/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 3a (antibodies: [e20])

T/LN/F/F/WG/D/W 74.72% (n=1688)
T/LN/F/I/WG/D/W 20.05% (n=453)
T/LN/F/L/WG/D/W 2.21% (n=50)
T/LN/F/M/WG/D/W 0.44% (n=10)
T/LN/F/V/WG/D/W 0.35% (n=8)
A/LN/F/F/WG/D/W 0.18% (n=4)
T/LN/F/F/FG/D/W 0.18% (n=4)
T/LN/F/F/WS/D/W 0.13% (n=3)
T/LN/F/F/RG/D/W 0.13% (n=3)
T/LN/F/F/LG/D/W 0.13% (n=3)
T/LN/F/I/FG/D/W 0.13% (n=3)
T/PN/F/F/WG/D/W 0.09% (n=2)
T/LD/F/F/WG/D/W 0.09% (n=2)
T/LH/F/F/WG/D/L 0.09% (n=2)
T/PN/F/I/WG/D/W 0.09% (n=2)
T/LN/F/F/WD/D/W 0.04% (n=1)
T/PT/F/F/WG/D/W 0.04% (n=1)
T/RN/F/F/WG/D/W 0.04% (n=1)
T/GN/F/I/WG/D/W 0.04% (n=1)
T/LN/S/I/WG/D/W 0.04% (n=1)
T/LN/F/I/WS/D/W 0.04% (n=1)
T/LN/F/F/WG/D/R 0.04% (n=1)
T/LS/F/F/WG/D/W 0.04% (n=1)
A/LN/F/I/WG/D/W 0.04% (n=1)
T/LN/L/F/WG/D/W 0.04% (n=1)
T/LN/F/F/WG/G/W 0.04% (n=1)
T/LN/F/F/WG/D/C 0.04% (n=1)
T/LN/F/D/WG/E/W 0.04% (n=1)
T/LN/F/I/GG/D/W 0.04% (n=1)
T/LN/F/F/LS/D/W 0.04% (n=1)
T/LN/F/F/LG/N/W 0.04% (n=1)
T/LN/F/F/WG/D/* 0.04% (n=1)
T/LN/S/F/WG/D/W 0.04% (n=1)
T/RN/S/F/WG/A/W 0.04% (n=1)
T/LN/F/F/GG/D/W 0.04% (n=1)
T/LN/F/I/YG/D/W 0.04% (n=1)
T/LN/F/L/FG/D/W 0.04% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 3b (antibodies: [e20])

T/LS/F/I/FG/D/W 46.25% (n=74)
T/LN/F/I/FG/D/W 25.63% (n=41)
T/LS/F/M/FG/D/W 18.13% (n=29)
T/LN/F/L/FG/D/W 3.75% (n=6)
T/LS/F/F/FG/D/W 2.50% (n=4)
T/LN/F/F/FG/D/W 1.88% (n=3)
T/LN/F/M/FG/D/W 1.88% (n=3)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 4 (antibodies: [e20])

T/LN/F/F/WG/D/W 86.83% (n=178)
T/LN/F/L/WG/D/W 5.37% (n=11)
T/LN/W/F/WG/D/W 3.41% (n=7)
T/LN/F/I/WG/D/W 1.95% (n=4)
T/LN/F/F/WG/D/V 0.49% (n=1)
T/LN/L/F/WG/D/W 0.49% (n=1)
T/LS/F/F/WG/D/W 0.49% (n=1)
T/LN/F/M/FG/D/W 0.49% (n=1)
T/LN/F/F/WG/N/W 0.49% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 4a (antibodies: [e20])

T/LN/F/F/WG/D/W 98.48% (n=130)
T/LN/F/F/WG/D/V 0.76% (n=1)
T/LN/F/L/WG/D/W 0.76% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 4d (antibodies: [e20])

T/LN/F/F/WG/D/W 84.62% (n=11)
T/LN/L/F/WG/D/W 7.69% (n=1)
T/LN/F/L/WG/D/W 7.69% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 5 (antibodies: [e20])

T/LN/F/M/WG/D/W 35.14% (n=13)
T/LN/F/L/WG/D/W 24.32% (n=9)
T/LN/F/F/WG/D/W 18.92% (n=7)
T/LN/F/I/WG/D/W 18.92% (n=7)
T/LN/F/V/WG/D/W 2.70% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 6 (antibodies: [e20])

T/LN/F/F/WG/D/W 82.81% (n=183)
T/LN/F/L/WG/D/W 7.24% (n=16)
T/LN/F/I/WG/D/W 3.62% (n=8)
T/LN/F/M/WG/D/W 1.36% (n=3)
T/LS/F/F/WG/D/W 1.36% (n=3)
T/LN/F/F/FG/D/W 0.90% (n=2)
T/LN/F/L/FG/D/W 0.90% (n=2)
T/LN/W/F/WG/D/W 0.90% (n=2)
T/LN/F/V/WG/D/W 0.45% (n=1)
T/LN/W/L/WG/D/W 0.45% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Subtype 6a (antibodies: [e20])

T/LN/F/F/WG/D/W 98.02% (n=99)
T/LN/F/L/WG/D/W 0.99% (n=1)
T/LN/F/M/WG/D/W 0.99% (n=1)
---------------------------------------------------------------------------------------
Motifs for binding location set: 425,427,428,437,442,529,530,535,616 in HCV Genotype 7 (antibodies: [e20])

T/LN/F/F/WG/D/W 100.00% (n=2)
---------------------------------------------------------------------------------------


